US20210307902A1 - Prosthetic Heart Valve Having an Improved Tubular Seal - Google Patents
Prosthetic Heart Valve Having an Improved Tubular Seal Download PDFInfo
- Publication number
- US20210307902A1 US20210307902A1 US17/351,868 US202117351868A US2021307902A1 US 20210307902 A1 US20210307902 A1 US 20210307902A1 US 202117351868 A US202117351868 A US 202117351868A US 2021307902 A1 US2021307902 A1 US 2021307902A1
- Authority
- US
- United States
- Prior art keywords
- cases
- tubular seal
- end region
- inches
- fabric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2427—Devices for manipulating or deploying heart valves during implantation
- A61F2/2439—Expansion controlled by filaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0057—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof stretchable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0037—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in height or in length
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/006—Additional features; Implant or prostheses properties not otherwise provided for modular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0069—Sealing means
Definitions
- This document provides prosthetic heart valves having an improved tubular seal.
- the human heart contains four valves: a tricuspid valve, a pulmonic valve, a mitral valve and an aortic valve.
- the main purpose of the valves is to maintain unimpeded forward flow of blood through the heart and the major blood vessels connected to the heart, for example, the pulmonary artery and the aorta.
- any one of the four heart valves may malfunction and result in either stenosis (impeded forward flow) and/or backward flow (regurgitation). Either process burdens the heart and may lead to serious problems, for example, heart failure.
- Various procedures for fixing or replacing defective heart valves are known in the art.
- artificial heart valves can be implanted in the heart of a patient to replace a diseased or damaged heart valve with a prosthetic equivalent to minimize stenosis and regurgitation.
- Prosthetic heart valves can have a variety of designs. Two major types of prosthetic heart valves include mechanical heart valves and bioprosthetic heart valves.
- Mechanical heart valves can be made of synthetic materials, such as plastics or metals, while bioprosthetic heart valves can be made of biologic tissue mounted on a fabric covered plastic or metal frame.
- Bioprosthetic heart valves can include animal tissue, such as porcine or bovine tissue, that has been chemically treated to make the valve suitable for implantation in a human. Bioprosthetic valves do not generally require a patient to undergo anticoagulant therapy, which is typically required when using mechanical valves. But bioprosthetic valves can be more prone to device wear such as tears in the valve tissue that may require the valve to be replaced. There is therefore a need to further improve the design of bioprosthetic valves to retain its functionality during the life of the patient.
- Prosthetic heart valves provided herein can have a structure adapted to retain functionality during the life of the patient and to minimize stenosis and regurgitation by having an improved connection between different parts of the prosthetic heart valve.
- a tubular seal in Example 1, includes an outflow end region and an inflow end region.
- the inflow end region can include a portion of a polymeric web retaining a woven fabric, wherein the woven fabric has a non-linear edge defining an interface between the inflow end region and the outflow end region.
- Example 2 the tubular seal of Example 1, wherein polymeric web includes an elastomeric polymer matrix and the woven fabric is retained within the elastomeric polymer matrix.
- Example 3 the tubular seal of Example 1 or Example 2, wherein the woven fabric includes non-elastic fibers.
- Example 4 the tubular seal of Example 1-3, wherein the woven fabric includes fibers in a warp direction and fibers in a waft direction, wherein the fibers in both the warp direction and the waft direction are angled with respect to a central axis of the tubular seal.
- Example 5 the tubular seal of Example 4, wherein the fibers in both the warp direction and the waft direction are angled at an angle of between 5 degrees and 70 degrees with respect to the central axis of the tubular seal.
- Example 6 the tubular seal of Example 4, wherein the fibers are arranged within the tubular member to form an angle of about 45 degrees with respect to the central axis of the tubular seal.
- Example 7 the tubular seal of one of Examples 1-6, wherein the interface of the woven fabric has a scalloped shape.
- Example 8 the tubular seal of Example 7, wherein the interface has a major radius Ra that ranges from about 0.050 inches to about 0.100 inches.
- Example 9 the tubular seal of Example 7, wherein the interface has a minor radius Ri that ranges from about from about 0.020 inches to about 0.040 inches.
- Example 10 the tubular seal of Example 7, wherein the interface has a transition zone length that ranges from about 0.110 inches to about 0.160 inches.
- a tubular seal for a prosthetic heart valve includes an elastomeric polymer matrix and a woven fabric includes a plurality of non-elastic fibers retained within an inflow end region of the elastomeric polymer matrix.
- the woven fabric can include a non-linear edge within the elastomeric polymer matrix.
- Example 12 the tubular seal of one of Example 11, wherein the non-linear edge of the woven fabric has a sinusoidal or scalloped shape.
- Example 13 the tubular seal of one of Examples 11 or 12, wherein the non-elastic fibers include a polyester.
- Example 14 the tubular seal of one of Examples 11-13, wherein the elastomeric polymer matrix includes a polymer selected from polycarbonates, polyurethane, silicones, and combinations thereof.
- Example 15 the tubular seal of one of Examples 11-14, wherein the inflow end region includes a first substantially uniform thickness and an outflow end region includes median thickness that is less than the first substantially uniform thickness.
- a prosthetic heart valve includes an expandable tubular member, a plurality of leaflets and a tubular seal.
- the plurality of leaflets can be secured together alongside edges and retained within the expandable tubular member, each leaflet having a bottom edge at a blood inflow end of the expandable tubular member and a free edge at a blood outflow end of the expandable tubular member.
- the tubular seal can include a polymeric web secured to the bottom edge of each leaflet and along an outer portion of the expandable tubular member.
- the tubular seal can include an outflow end region and an inflow end region.
- the inflow end region can be a portion of polymeric web retaining a woven fabric, wherein the woven fabric has a non-linear edge defining the interface between the inflow end region and the outflow end region.
- Example 17 the prosthetic heart valve of Example 16, wherein polymeric web includes an elastomeric polymer matrix and the woven fabric is retained within the elastomeric polymer matrix.
- Example 18 the prosthetic heart valve of Example 16, wherein the woven fabric includes the non-elastic fibers.
- Example 19 the prosthetic heart valve of Example 18, wherein the woven fabric includes fibers in a warp direction and fibers in a waft direction, wherein the fibers in both the warp direction and the waft direction are angled with respect to a central axis of the tubular seal.
- Example 20 the prosthetic heart valve of Example 19, wherein the fibers in both the warp direction and the waft direction are angled at an angle of between 5 degrees and 70 degrees with respect to the central axis of the tubular seal.
- Example 21 the prosthetic heart valve of Example 19, wherein the fibers are arranged within the tubular member to form an angle of about 45 degrees with respect to the central axis of the tubular seal.
- Example 22 the prosthetic heart valve of Example 16, wherein the woven fabric includes non-elastic fibers arranged in the polymeric web to allow the tubular seal to stretch in axial and radial directions.
- Example 23 the prosthetic heart valve of Example 16, wherein the non-linear edge of the woven fabric has a sinusoidal or scalloped shape.
- Example 24 the prosthetic heart valve of Example 16, wherein the inflow end region includes a first substantially uniform thickness and the outflow end region includes median thickness that is less than the first substantially uniform thickness.
- Example 25 the prosthetic heart valve of Example 16, wherein the outflow end region includes a plurality of grommets.
- a tubular seal for a prosthetic heart valve includes an elastomeric polymer matrix and a woven fabric that includes a plurality of non-elastic fibers retained within an inflow end region of the elastomeric polymer matrix.
- the woven fabric includes a non-linear edge within the elastomeric polymer matrix.
- Example 27 the tubular seal of Example 26, wherein the non-linear edge of the woven fabric has a sinusoidal or scalloped shape defining an interface between the inflow end region and the outflow end region.
- Example 28 the tubular seal of Example 27, wherein the interface has a major radius R a that ranges from about 0.050 inches to about 0.100 inches.
- Example 29 the tubular seal of Example 27, wherein interface has a minor radius R i that ranges from about from about 0.020 inches to about 0.040 inches.
- Example 30 the tubular seal of Example 27, wherein the interface has a transition zone length that ranges from about 0.110 inches to about 0.160 inches.
- Example 31 the tubular seal of Example 26, wherein the non-elastic fibers include a polyester.
- Example 32 the tubular seal of Example 26, wherein the elastomeric polymer matrix includes a polymer selected from polycarbonates, polyurethane, silicones, and combinations thereof.
- Example 33 the tubular seal of Example 26, wherein the inflow end region includes a first substantially uniform thickness and the outflow end region includes median thickness that is less than the first substantially uniform thickness.
- Example 34 the tubular seal of Example 26, wherein a thickness for the inflow end region ranges from about 0.0016 inches to about 0.0023 inches, or from about 40 microns to about 60 microns.
- a method in Example 35, includes forming at least a portion of a tubular seal that includes a woven fabric within a matrix by dipping a mandrel with a first coating composition that includes at least one elastomeric polymer.
- the method can also include drying the first coating composition and positioning the woven fabric on the mandrel such that fibers within the fabric are oriented at an angle of about 45 degrees with respect to a central axis of the tubular seal.
- the method can further include applying a second coating composition on the mandrel, the second coating composition being different than the first coating composition and removing the tubular seal from the mandrel.
- Prosthetic heart valves provided herein can additionally have a reduced unexpanded profile.
- prosthetic heart valves provided herein include a plurality of anchor elements.
- anchor elements can be secured to an expandable tubular member.
- the expandable tubular member can be a braided stent.
- prosthetic heart valves provided herein include three or more leaflets.
- the leaflets can have a body portion and sleeve portions one or both sides. In some cases, sides of the body portions can be secured together and sleeve portions secured to anchor elements (e.g., anchor elements attached to a braided stent).
- prosthetic heart valves provided herein can include a tubular seal.
- the tubular seal can be secured to bottom edges of body portions of the leaflets.
- the seal can be secured to a blood inlet side of an expandable member.
- tubular seals provided herein can be applied to a variety of prosthetic heart valves provided herein (and within the scope of the claims), additional details about the overall structure of an exemplary prosthetic heart valve are provided below.
- FIGS. 1A-1I illustrate an exemplary prosthetic heart valve and an exemplary deployment device provided herein.
- FIGS. 1A and 1B are perspective views of the heart valve provided herein connected to the deployment device.
- FIG. 1C is a side view of the exemplary prosthetic heart valve.
- FIGS. 1D-1I illustrate how the exemplary heart valve provided herein can be delivered by the deployment device.
- FIGS. 2A-2C illustrates an exemplary leaflet, which can be used in prosthetic heart valves provided herein.
- FIG. 2A illustrates a rounded notch in a leaflet where a leaflet can be secured to an adjacent leaflet.
- FIGS. 2B and 2C illustrate a side portion of the exemplary leaflet.
- FIG. 2B depicts the rounded notch in an armpit of the exemplary leaflet.
- FIG. 2C depicts attachment elements in the armpit of the exemplary leaflet.
- FIG. 3 illustrates another exemplary leaflet, which can be used in prosthetic heart valves provided herein.
- FIG. 3 depicts apertures in a body of the exemplary leaflet.
- FIGS. 4A-4G illustrate how adjacent leaflets can be stitched together in prosthetic heart valves provided herein.
- FIGS. 5A-5C illustrate a cross stich provided herein for connecting a seal to a braided stent in an exemplary prosthetic heart valve provided herein.
- FIG. 5A shows a front view of a seal having apertures and stitch patterns used for securing the seal to the braided stent.
- FIG. 5B depicts a close up view of a cross stitch and a portion of a circumferential stitch used for securing the seal to the braided stent.
- FIG. 5C depicts a cross-sectional view showing the cross stitch and a portion of the circumferential stitch.
- FIG. 6 depicts an apparatus that can be used to form a tubular seal provided herein.
- FIGS. 7A-7G illustrate exemplary tubular seals that include a fabric having a non-linear edge positioned within a polymeric web or matrix in a prosthetic heart valve provided herein.
- FIGS. 8A-8C illustrate an exemplary tubular seal having a scalloped, non-linear edge in a prosthetic heart valve provided herein.
- FIGS. 1A and 1B illustrate an exemplary prosthetic heart valve 100 provided herein.
- FIGS. 1A and 1B are perspective views of prosthetic heart valve 100 connected to a deployment device 190 .
- FIG. 1C is a side view of prosthetic heart valve 100 .
- prosthetic heart valve 100 includes an expandable member 110 , three leaflets 200 , three anchor elements 120 that secure sleeve portions 216 of leaflets 200 to expandable member 110 , and a tubular seal 130 secured around a blood inflow end of prosthetic heart valve 100 .
- FIG. 1A does not show components that are located underneath tubular seal 130 , but FIG.
- Anchor elements 120 can include post leg compression elements 122 and clamping support structures 126 adapted to provide support along opposite sides of the sleeve portions 216 . Expandable member 110 in
- FIGS. 1A-1I is a braided stent (which can also be described as a braided anchor element), which is adapted to transition between a restricted state having a smaller diameter and an expanded state having a larger diameter.
- Expandable member 110 can be self-expanding, mechanically expanded, or a combination thereof
- FIGS. 1D-1I depict how an exemplary heart valve delivery system 180 can deliver and deploy prosthetic heart valve 100 provided herein within a blood vessel.
- System 180 can include a sheath 182 for retaining prosthetic heart valve 100 with the expandable member 110 in a restricted state.
- Tubular seals provided herein can have a uniform thickness or a thickness that has a non-linear interface between an inflow end region and an outflow end region to provide a transition zone between a thinner outflow end region to the thicker inflow end region that facilitates loading of prosthetic heart valve 100 into sheath 182 .
- a substantially uniform thickness or a transition zone can reduce the probability for sections of the tubular seal to catch on an outer rim of sheath 182 during loading of prosthetic heart valve 100 in a restricted state.
- tubular seals provided herein can allow for radial and/or axial expansion of the tubular seal in portions including non-elastic fibers, accordingly, a tubular seal used in prosthetic heart valves provided herein can have a non-expanded diameter that expands to the predetermined outer diameter of the expandable member and that stretches to an axially elongated but radially restricted configuration when prosthetic heart valve 100 is in a restricted state to further reduce the profile of prosthetic heart valve 100 within sheath 182 .
- anchor elements 120 FIGS. 1A-1C
- a pull line 194 can be connected to a nose cap 196 , or end cap, which is positioned at the end of sheath 182 .
- the pull line 194 can extend through expandable member 110 and through the valve opening between the leaflets 200 .
- FIGS. 1D-1I once a distal end of sheath 182 is delivered through the circulatory system to an appropriate location (e.g., within the heart), prosthetic heart valve 100 can be deployed.
- prosthetic heart valve 100 can be pushed out of sheath 182 .
- expandable member 110 can self-expand upon exiting sheath 182 .
- expandable member 110 can self-expand to a first intermediate diameter
- system 180 can mechanically expand expandable member 110 to a larger deployment diameter.
- anchor elements 120 can include a locking mechanism to clip a portion of expandable member when the expandable member 110 is expanded to a predetermined locking diameter.
- system 180 can mechanically expand expandable member 110 to a predetermined locking diameter.
- system 180 can compress expandable member 110 between pushing prongs 192 and nose cap 196 by moving pull line 194 relative to pushing prongs 192 .
- the predetermined locking diameter can be adapted to set the diameter of prosthetic heart valve 100 during implantation. After prosthetic heart valve 100 is set, system 180 can move pull line 194 and nose cap 196 relative to pushing prongs 192 to move the end cap through the opening between leaflets 200 in prosthetic heart valve 100 . Pushing prongs 192 can then be retracted from anchor elements 120 and retracted into sheath 182 .
- pushing prongs 192 can include a shape member material adapted to help radially expand expandable member 110 as the expandable member 110 exits sheath 182 .
- a control handle 188 can be used to control the relative movements of sheath 182 , pushing prongs 192 , and pull wire 194 .
- Prosthetic heart valves provided herein can be adapted to mitigate damage that may occur to valves during delivery and implantation.
- one or more radiopaque markers can be secured to prosthetic heart valves provided herein.
- expandable member 110 includes a radiopaque marker 112 .
- Any suitable radiopaque material such as platinum, palladium, gold, tantalum, or alloys thereof
- One or more radiopaque markers can be used with an imaging system to help a physician ensure that a valve is set in an appropriate location.
- prosthetic heart valves provided herein include at least three radiopaque markers.
- prosthetic heart valve 100 can include a plurality of leaflets 200 .
- prosthetic heart valve 100 includes three leaflets 200 .
- prosthetic heart valves provided herein can have any suitable number of leaflets, such as two, three, four, five, or more leaflets.
- leaflets 200 are secured to one another.
- leaflets 200 can be secured to one another by a suture (not shown) or a plurality of sutures.
- Leaflets 200 can be sutured alongside edges of a body portion of each leaflet.
- prosthetic heart valves provided herein can include a single line of sutures, which can be adapted to minimize leaks, minimize the width of a seam, and/or minimize the profile of a replacement heart valve during a percutaneous insertion. In some cases, prosthetic heart valves provided herein can include multiple lines of sutures.
- Expandable member 110 can have any suitable structure, arrangement, or material.
- expandable member 110 can include a braided wire stent.
- a braided wire stent For example, U.S. Publication Number 2005/0143809, titled, “Methods and Apparatus for Endovascularly Replacing a Heart Valve,” and filed on Nov. 5, 2004, which is herein incorporated by reference for its disclosure of possible structures and materials for a braided wire stent, discloses a braided wire stent.
- expandable member 110 includes a shape memory material (e.g., a nickel-titanium alloy or a cobalt-chromium alloy).
- FIGS. 2A-2C provide illustrations of an exemplary leaflet 200 that includes a body portion 214 and sleeve portions 216 .
- body portion 214 has a bottom edge 222 , a first side edge 226 , a second side edge 228 , and a free edge 224 .
- Leaflet 200 further includes a front (i.e., a side facing the blood inflow end of a prosthetic heart valve), a back (i.e., a side facing the blood outflow end), a first side adjacent to the first side edge 226 , and a second side adjacent to the second side edge 228 .
- the front of leaflet 200 has a different texture than the back.
- the back or front can have a non-textured or textured surface to mitigate calcium buildup on the surfaces.
- the back of leaflet 200 may be prone to calcium build due to a cusp-shaped, concave surface, thus it can be beneficial to have a textured surface on the back of leaflet 200 to mitigate calcification issues.
- Leaflets can be made of various synthetic or non-synthetic materials.
- the leaflet 200 is made from tissue obtained from an animal, e.g., a pig or a cow.
- leaflet 200 is made from bovine pericardium.
- leaflets 200 can be made from a synthetic polymers or composites.
- Leaflets 200 can be assembled into a heart valve by aligning the opposite side regions of at least two adjacent leaflets 200 and stitching the leaflets 200 together along stitch line 246 , which is shown in FIG. 2C .
- leaflet 200 defines at least one notch 232 , 234 between at least one of the two side edges 226 , 228 and a corresponding adjacent sleeve portion 216 .
- Each notch 232 , 234 can be located along side edges 228 , 226 at a location adjacent to the sleeve portions 216 , e.g., at an “armpit” of leaflet 200 as depicted in FIGS. 2A and 2B .
- leaflet 200 can define a notch along the length of side edges 228 , 226 .
- a notch can be defined along sleeve portion 216 .
- multiple notches can be located along sleeve portion 216 , side edges 228 , 226 , and/or at the armpit of the leaflet 200 .
- body portion 214 of leaflet 200 has a conical frustum shape defined by bottom edge 222 , first side edge 226 , second side edge 228 , and free edge 224 .
- Other suitable shapes for the body portion can include, but are not limited to, for example, a generally square, rectangular, triangular or trapezoidal shaped body portion.
- the sleeve portions 216 can extend outwardly from the body portion 214 of the leaflet 200 .
- Each sleeve portion 216 can oriented at an angle relative to a portion of the body portion, e.g., free edge 224 of body portion 214 .
- Sleeve portions 214 as shown, can be generally rectangular-shaped extensions with lateral free ends. In some cases, sleeve portions 214 can have rounded free ends.
- notches 232 , 234 can be generally U-shaped. Other suitable notch shapes can include, but are not limited to, a V-shaped, rectangular-shaped, oval-shaped, and circular notch. In some cases, notches 232 , 234 can have rounded edges to smooth the transition between a notch 232 , 234 and side edges 228 , 226 of leaflet 200 . Notches 232 , 234 can have a length dimension that can range from about 0.5 millimeters (mm) to about 4 mm (from about 0.02 inches to about 0.20 inches).
- notches 232 , 234 can be shaped and sized to accommodate attachment of post leg compression elements 122 .
- Post leg compression elements 122 can be a part of anchor elements 120 (shown in FIGS. 1A-1C ) that compress and restrain sleeve portions 216 along the same line as the stitch line 246 .
- suture 258 can be used to apply an appropriate and consistent compressive force between post leg compression elements 122 in order to prevent leakage through sleeve portions 216 of leaflets 200 . Since suture 258 pass through notches 232 , 234 , it does not need to pass through body portion 214 at or near the armpit of leaflet 200 .
- a notched leaflet 200 can improve valve opening capabilities and the reliability of prosthetic heart valves provided herein.
- FIG. 3 illustrates another exemplary leaflet 300 , which can be used in prosthetic heart valves provided herein.
- leaflet 300 can include a body portion 314 and at least two opposite sleeve portions 316 .
- the body portion 314 can be defined by at least two side edges 326 , 328 adjacent each sleeve portion 316 .
- Leaflet 300 can define two apertures 332 and 334 .
- Each aperture 332 , 334 can be positioned adjacent side edges 326 , 328 and the corresponding adjacent sleeve portion 316 .
- body portion 314 has a bottom edge 322 , a first side edge 326 , a second side edge 328 , and a free edge 324 .
- Leaflet 300 further includes a front, a back, a first side adjacent to the first side edge 326 , and a second side adjacent to the second side edge 328 .
- Leaflets 300 can be assembled into a heart valve by aligning the opposite side regions of at least two adjacent leaflets 300 and stitching the leaflets 300 together along stitch line 246 , as shown in FIG. 2C .
- leaflet 300 defines apertures 332 and 334 adjacent side edges 328 , 326 and adjacent one of the sleeve portions 316 .
- Apertures 332 and 334 can be generally circular in shape. Other suitable aperture shapes can include, but are not limited to, for example, a rectangular, oval, triangular, or diamond-shaped aperture.
- apertures 332 , 334 can have a length dimension or a diameter from about 0.5 mm to about 4 mm (or about 0.02 inches to about 0.20 inches).
- one or more apertures 332 , 334 can be located in the side edges 328 , 326 and/or the sleeve portions 316 of the leaflet 300 . In some cases, multiple apertures can be located in a region that is adjacent to the side edges 328 , 326 and the sleeve portions 316 .
- Apertures 332 , 334 in the leaflets 300 can allow one leaflet to be secured to an adjacent leaflet. Similar to the notches discussed above, apertures 332 and 334 can be shaped and sized to accommodate attachment of post leg compression elements 122 .
- post leg compression elements 122 can be a part of anchor elements 120 that compress and restrain sleeve portions 216 along the same line as the stitch line 246 .
- a suture 258 can be used to apply an appropriate and consistent compressive force between the post leg compression elements 122 in order to prevent leakage through sleeve portions 216 of the leaflets 200 .
- sutures that pierce the body portion 214 at or near the armpit of the leaflet can create stress concentrations at or near the armpit of the leaflet that may result in tearing.
- Apertures 332 and 334 and post leg compression elements 122 can minimize this potential tearing caused by sutures near the armpit location by being positioned proximate to the post leg compression elements near the armpit.
- Apertures 332 , 334 create enlarged openings that allow suture 258 to pass therethrough without pulling or stretching adjacent tissue areas. Accordingly, leaflets 300 used in prosthetic heart valves provided herein can improve the reliability of prosthetic heart valves.
- FIGS. 4A-4G depict how leaflets 200 can be connected (or jointed) with an improved stitch discussed herein.
- stitch 446 can be a single continuous line stitch traveling along a stitch line in a forward direction and back in a reverse direction.
- stitch 446 can run along a leaflet from a bottom edge to a side edge of the leaflet (e.g., bottom edge 222 to side edge 226 of leaflet 200 in FIG. 2A-2B ).
- stitch 446 can run from a side edge to a notch of a leaflet (e.g., side edge 226 to notch 234 of leaflet 200 in FIG. 2A-2B ).
- stitch 446 can include a plurality of perpendicular loop segments 434 extending through an aperture in the two leaflets, around outer side edges of the two attached leaflets, and back through the aperture.
- Stitch 446 can include a plurality of parallel segments 436 extending between adjacent apertures along the stitch line.
- Stitch 446 can include two perpendicular loop segments 434 extending through apertures formed in the stitch line. In some cases, a first perpendicular loop segment 434 for a first aperture in the stitch line is formed when the stitch is formed in the forward direction and a second perpendicular loop segment 434 for the first aperture is formed in the reverse direction.
- parallel segments 436 made in a forward direction alternate between opposite sides of the two leaflets between each aperture in the stitch line.
- parallel segments 436 made in a reverse direction are formed on an opposite side of the two leaflets from parallel segments 436 made in a forward direction.
- opposite parallel segments 436 made in the forward and reverse directions can provide a continuous compressive force along the entire length of the stitch line.
- Perpendicular loop segments 434 can provide compressive force to reinforce a seal formed between the two leaflets along the stitch line.
- Stitch 446 can include any appropriate number of perpendicular loop segments formed through any appropriate number of apertures. As shown, stitch 446 includes six perpendicular loop segments formed through six apertures (two perpendicular loop segments per aperture). In some cases, stitch 446 can include up to twelve perpendicular loop segments formed through six or more apertures. In some cases, a stitch connecting side edge segments of leaflets can be formed using between 3 and 20 apertures and include between 3 and 40 perpendicular loop segments. In some cases, apertures can be positioned from about 0.2 mm to about 10 mm apart (or about 0.008 inches to about 0.4 inches apart). In some cases, apertures can be positioned from about 0.2 mm to about 10 mm (or about 0.008 inches to about 0.4 inches) away from the side edges of the leaflets.
- Stitch 446 can be formed in a process depicted in FIGS. 4A-4G .
- a thread needle 410 can be passed through aligned leaflet side edges 226 a and 226 b to create a first aperture at a location near bottom edges 222 , e.g., a location approximately 1 mm from the bottom edges 222 .
- the leaflet side edges 226 a and 226 b can be retained in a desired configuration by clamping the leaflets between clamp sides 422 and 424 . Needle 410 pulls a leading end 431 of a thread 432 through the first aperture. As shown in FIG.
- needle 410 can then form a second aperture adjacent to the first aperture along the stitch line (towards the leaflet sleeve portion) about 0.5 mm away from the first aperture to pull leading end 431 of thread 432 through the second aperture to form a first parallel segment.
- a perpendicular loop segment 434 can be made by guiding needle 410 around the leaflet side edges and re-enter the second aperture from a backside. Thread 432 can be pulled through the second aperture until it sits firmly against the leaflet material (e.g., leaflet pericardium tissue).
- FIG. 4D shows a second parallel segment, which can be made by pushing needle 410 through leaflet tissue along the stitch line to form a third aperture approximately 1 mm from the second aperture (towards the sleeve segments of the leaflet).
- a second perpendicular loop segment 434 can be formed by again having needle 410 loop around the leaflet side edges and reenter the third aperture through the backside. This is repeated up to notch 234 to form a total of six parallel segments 436 and six perpendicular loop segments 434 in a forward direction, as shown in FIG. 4F .
- the stitch pattern can then be repeated in a reverse direction towards the bottom edges 222 of the leaflets through the previously formed apertures.
- each aperture can include two perpendicular loop segments 434 and parallel segments on the opposite sides can be formed from the parallel segments that were created in the forward direction, as shown in FIG. 4G .
- the method and stitches depicted in FIGS. 4A-4G can be applicable to leaflets 200 , 300 discussed herein.
- Stitch 446 and other stitches provided herein can improve the reliability of a seal formed along a stitch line, create fewer apertures through the leaflets, and simplify the stitching operation. Having fewer apertures can help minimize the occurrence of blood leakage through the apertures.
- the single continuous line of stitch 446 using a single row of apertures can minimize a width of a side edge portion needed to form a continuous seal along the side edges of the leaflets, thus providing a reduced restricted profile for prosthetic heart valves provided herein.
- U.S. Pat. No. 8,778,020 describes a variety of ways that leaflets can be sutured together using combinations of whip stitches and running stitches, but these stitches require additional apertures and multiple lines.
- Perpendicular loop segments 434 can stitch a plurality of leaflets together, similar to the whip stitches discussed in U.S. Pat. No. 8,778,020.
- Parallel segments 436 can secure valve leaflets to one another, similar to the running stitches discussed in U.S. Pat. No. 8,778,020.
- stitch 446 can provide an improved attachment between side edges of leaflets in prosthetic heart valves provided herein, some embodiments of prosthetic heart valves provided herein can use other stitch patterns, such as those described in U.S. Pat. No. 8,778,020, which is hereby incorporated by reference.
- Important characteristics of a suture thread can include, but are not limited to, adequate tensile strength, abrasion resistance and creep rupture resistance characteristics that allow the device to be delivered into and sustain implantation within a human anatomy.
- the thread used for suturing together portions of the heart valve, e.g., side edges of the leaflets can be composed of biocompatible materials that include, but are not limited to, polyethylene such as ultra high molecular weight polyethylene (UHMWPE), polyester (PET), and a combination thereof.
- UHMWPE ultra high molecular weight polyethylene
- PET polyester
- tubular seal 130 of prosthetic heart valve 100 can be secured to bottom edges 222 ( FIG. 2A ) of body portion 214 of leaflet 200 by a circumferential running stitch 134 .
- tubular seal 130 can be secured to expandable member 110 by fasteners, such as grommets 136 , and extended around the outside of expandable member 110 to provide a seal that minimizes blood leakage around the leaflets 200 of an implanted prosthetic heart valve 100 .
- fasteners such as grommets 136
- FIGS. 5A-5C provide an improved tubular seal stitching pattern can include a cross stitch 132 between tubular seal 130 and expandable member 110 .
- a blood inlet side of expandable member 110 e.g., braided anchor element
- FIGS. 5A-5C illustrate how the tubular seal 130 can be secured to the expandable member 110 , e.g., a braided stent, by a plurality of cross stitches connecting the tubular seal 130 to a pair of overlapping wire members of the braided stent.
- expandable member 110 can be a braided stent including one or more wires having a first set of segments 114 extending helically in a first direction and a second set of segments 116 extending helically in a second direction such that the first set of segments 114 cross the second set of segments 116 at intersection points 118 .
- one or more wires can have inflow crowns 115 at an end of the braided stent where the wires transition from first segments 114 to second segments 116 .
- cross stitches 132 secure tubular seal 130 at an intersection 118 to two crossing segments 114 , 116 of the braided stent.
- a separate circumferential running stitch 134 can be inserted into preformed apertures 133 to secure the adaptive seal to bottom edges 222 of leaflets 200 shown in FIGS. 2A and 2C .
- Cross-stitches around the intersections 118 can increase the strength of an attachment of tubular seal 130 to the expandable member 110 while also allowing for improved load transfer to the expandable member 110 .
- the cross stitches secure tubular seal 130 at intersections 118 located immediately above (proximal) the inflow crowns 115 .
- Cross stitches 132 can be formed by passing two stitches 132 a, 132 b of a suture in orthogonal directions over the intersections 118 and through the tubular seal 130 .
- preformed apertures 131 for cross stitch 132 can be formed in the tubular seal 130 .
- a portion of the tubular seal 130 that is sutured by cross stitch 132 includes an internal fabric, such as those discussed below.
- Each cross stitch 132 can be knotted independently. As shown in FIG. 5C , cross stitches 132 each include a separate knot 137 . Additionally, cross stitches 132 can be arranged to not pass through leaflets 200 . Cross stitches 132 can be repeated at a plurality of intersections 118 ( FIG. 5A ) circumferentially around an inflow end of a prosthetic heart valve provided herein such that an entire circumference of tubular seal 130 is securely attached.
- each intersection 118 immediately adjacent to inflow crowns 115 is sutured to tubular seal 130 via a cross stitch provided herein.
- the tubular seal stitching pattern provided herein can increase the strength of the attachment between the tubular seal 130 and the expandable member 110 while also allowing for improved load transfer to the expandable member 110 through the use of the plurality of cross stitches.
- tubular seal 130 of prosthetic heart valve 100 can have various suitable structures, arrangements, or materials that allow tubular seal 130 to be secured to leaflets 200 within prosthetic heart valve 100 .
- Various suitable structures, arrangements, or materials of tubular seal 130 can be used to allow tubular seal 130 to extend around the outside of expandable tubular member 110 to prevent blood leakage around leaflets 200 .
- FIG. 6 shows an exemplary mandrel 600 that can be used to construct a tubular seal.
- the mandrel 600 includes a taper which results in a tubular seal having a slightly smaller diameter proximal end compared to the diameter of the distal end.
- the diameter of the proximal end can include a diameter reduction of about 3% to about 30% as compared to the diameter of the distal end.
- the taper allows the tubular seal to be removed from the mandrel with relative ease upon completion of the fabrication process.
- the smaller proximal diameter of the tubular seal tends to cause the proximal projections to lie more firmly against an anchor element of the replacement heart valve.
- the surface of the mandrel may be textured to create a tubular seal with a reduced contact area.
- the mandrel can be textured using a bead blasting process. In combination with the selection of a relatively hard outer layer, a textured seal surface is believed to result in a lower friction surface.
- FIG. 7A shows a tubular seal 730 that includes an inflow end region 740 and an outflow end region 750 .
- tubular seal 730 can include a polymeric web.
- the polymeric web can be a thin film, a porous layer, a mesh-like or net-like structure, or a porous network, e.g., a polymeric matrix.
- inflow end region 740 of tubular seal 130 can include a polymeric web.
- inflow end region 740 can be a portion of a polymeric web retaining a fabric.
- polymeric web can include an elastic material.
- the polymeric web can include an elastomeric matrix.
- inflow end region 740 can be secured to bottom edges of a plurality of leaflets at an inflow end of a prosthetic heart valve provided herein, e.g., prosthetic heart valve 100 , and have outflow end region 750 extend around an outer surface of an expandable member (e.g., a braided stent) to restrict blood flow around the leaflets.
- an expandable member e.g., a braided stent
- a fabric can be embedded within the polymeric web such that the polymeric web forms a polymeric matrix around the fabric.
- the polymeric web can include an elastic material.
- an elastic polymeric web can conform to adjacent surfaces of a prosthetic heart valve provided herein to prove a resilient seal.
- the elastomeric polymer matrix can furthermore conform to the expandable member as the expandable member changed between a restricted configuration and an expanded configuration.
- an elastic material can allow the tubular seal to return to its original length when the expandable member returns to the restricted configuration without tearing.
- tubular seal 130 can include one or more layers of an elastomeric polymer.
- tubular seal 130 can include a polycarbonate, polyurethane, silicone, polytetrafluoroethylene (PTFE), or a combination thereof.
- suitable materials include, but are not limited to, natural and synthetic rubbers, including cis-1,4-polyisoprene rubber, styrene/butadiene copolymers, polybutadiene rubber, styrene/isoprene/butadiene rubber, butyl rubber, halobutyl rubber, polyurethane elastomers including elastomers based on both aromatic and aliphatic isocyanates, flexible polyolefins including flexible polyethylene and polypropylene homopolymers and copolymers, styrenic thermoplastic elastomers, polyamide elastomers, polyamide-ether elastomers, ester-ether or ester-ester elastomers, flexible ionomers, thermoplastic vulcanizates, flexible poly(vinyl chloride) homopolymers and copolymers, acrylic polymers, and a combination thereof.
- natural and synthetic rubbers including cis-1,4-polyis
- tubular seal 130 can include an aliphatic polycarbonate-based thermoplastic urethane.
- tubular seal 130 can include an elastomeric polymer having a hardness ranging from 3.07 MPa to 9.9 MPa, or a durometer ranging from 75 Shore A to 75 Shore D using ASTM standard D2240 in force on Jan. 1, 2014.
- tubular seal 130 can include a polymeric material having the mechanical properties shown in Table I below. Notably, all of the listed ASTM standards refers to the standard in force on Jan. 1, 2014.
- tubular seal 130 can include attachment structures, e.g., grommets 136 , to improve the attachment of the tubular seal 130 to leaflets 200 and/or expandable member 110 .
- attachment structures e.g., grommets 136
- tubular seal 730 can include a fabric retained by a polymeric web such that the fabric reinforces the polymeric web to allow the tubular seal to be secured to a prosthetic heart valve provided herein.
- inflow end region 740 of tubular seal 730 can include a fabric embedded within an elastomeric material.
- outflow end region 750 of tubular seal 730 can include a plurality of grommets 732 .
- the fabric of inflow end region 740 can be a woven material. In some cases, the fabric can have warp threads and/or weft threads.
- the fabric can be composed of fibers having an average thread diameter from about 0.5 microns to about 50 microns (or from about 0.00002 inches to about 0.002 inches), more preferably from about 20 micron to about 40 microns (or about 0.0008 inches to about 0.002 inches). More preferably, in some cases, the fabric is composed of fibers having a thread diameter of about 27 microns (or about 0.0011 inches).
- the fabric can include non-elastomeric fibers, or non-elastic fibers.
- Suitable non-elastomeric fiber materials include, but are not limited to, polyolefins, polyesters such as PES 38/31 manufactured by SaatiTech, and polyamides. More particularly, the polyolefins can include, for example, polyethylenes, polypropylenes, polybutenes, ethylene copolymers, propylene copolymers, butene copolymers, and combinations thereof. Because the fabric can include non-elastic fibers, inflow end region 740 and outflow end region 750 can have different overall elastic properties.
- the fabric of a tubular seal has a non-linear edge defining an interface 753 between inflow end region 740 and the outflow end region 750 .
- interface 753 between the inflow end region 740 and the outflow end region 750 can be non-linear due to a non-linear edge of the fabric within inflow end region 740 .
- the non-linear edge can be sinusoidal 753 .
- the non-linear edge can be a zigzagged edge 754 , a stepped edge 755 , or a scalloped edge 756 , 772 , 782 .
- FIGS. 7E and 7F provide alternative embodiments of tubular seals 770 , 780 having scalloped, non-linear edges. As shown, the scalloped, non-linear edges define non-linear circumferential interfaces 772 , 782 between an inflow end region 774 , 784 and an outflow end region 776 , 786 . Interfaces 772 , 782 , as shown in FIGS. 7E and 7F , have a scalloped shape defined by a major radius R a , a minor radius R i , a wavelength ( ⁇ ) and a transition zone length (l).
- major radius R a can be the radius proximate the inflow end region and minor radius R i can be the radius proximate the outflow end region. In some cases, major radius R a can be the radius proximate the outflow end region and minor radius R i can be the radius proximate the inflow end region. As shown in FIGS. 7E and 7F , major radius R a is larger than the minor R i . In some cases, major and minor radii R a , R i are equal and form a sinusoidal-shaped interface. In some cases, the ratio between major radius Ra and minor radius R i can range from 1:1 to 2:1, 2:1 to 3:1, from 3:1 to 4:1, or from 4:1 to 5:1.
- a necked region 790 can be formed between minor radius R i and major radius R a .
- minor radius R i can form bulbous ends, as shown in FIG. 7F , to increase the interface length and improve durability of tubular seal 780 at or near interface 782 .
- the interfaces described herein provide the benefit of preventing or minimizing tear propagation in the tubular seal while providing sufficient bond strength to maintain the bond between the inflow and outflow end regions of the tubular seal. In some cases, the interfaces described herein can prevent or minimize a tear from propagating further at the interface region by redirecting the tear or by providing a barrier to the tear.
- the major radius R a and/or the minor radius R i can range from about 1.3 millimeters to about 2.54 millimeters (or about 0.050 inches to about 0.100 inches), from about 1.8 millimeters to about 2.0 millimeters (or about 0.070 inches to about 0.080 inches), from about 2.0 millimeters to about 2.54 millimeters (or about 0 . 080 inches to about 0.100 inches), or from about 2.3 millimeters to about 2.4 millimeters (or about 0.090 to about 0.095 inches).
- the major radius R a and/or the minor radius R i can range from about 0.51 millimeters to about 0.76 millimeters (or about 0.020 inches to about 0.030 inches), from about 0.76 millimeters to about 1.0 millimeters (or about 0.030 inches to about 0.040 inches), from about 1.0 millimeters to about 1.3 millimeters (or about 0.040 inches to about 0.050 inches), from about 0.51 millimeters to about 1.0 millimeters (about 0.020 inches to about 0.040 inches), or from about 0.51 millimeters to about 1.3 millimeters (or about 0.020 inches to about 0.050 inches).
- the wavelength ( ⁇ ) of the scalloped-shaped interface can range from about 2.5 millimeters to about 1.0 millimeters (or about 0.10 inches to about 0.40 inches), from about 3.8 millimeters to about 5.1 millimeters (or about 0.15 inches to about 0.20 inches), or from about 5.1 millimeters to about 6.35 millimeters (or about 0.20 inches to about 0.25 inches).
- the transition zone length can be measured as a distance between the crest of the minor radius R i and the trough of the major radius R a .
- the transition zone length can range from about 2.8 millimeters to about 3.0 millimeters (or about 0.110 inches to about 0.120 inches), from about 3.0 millimeters to about 3.3 millimeters (or about 0.120 inches to about 0.130 inches), from about 3.3 millimeters to about 3.6 millimeters (or about 0.130 inches to about 0.140 inches), from about 3.6 millimeters to about 3.8 millimeters (or about 0.140 inches to about 0.150 inches), from about 3.8 millimeters to about 4.1 millimeters (or about 0.150 inches to about 0.160 inches), or from about 2.8 millimeters to about 4.1 millimeters (or about 0.110 inches to about 0.160 inches).
- inflow end region 740 can be thicker than outflow end region 750 because of the presence of a fabric within inflow end region 740 .
- inflow end region 740 can have a thickness of about 70 microns (0.0028 inches).
- outflow end region 750 can have a thickness of about 50 microns (about 0.0020 inches).
- Other suitable thicknesses for inflow end region 740 include thicknesses ranging from about 50 microns to about 90 microns (about 0.0020 inches to about 0.0035 inches), or more preferably, from about 60 microns to about 80 microns (about 0.0025 inches to about 0.0031 inches).
- Suitable thicknesses for outflow end region 750 include thicknesses ranging from about 30 microns to about 70 microns (about 0.0011 inches to about 0.0028 inches), or more preferably, from about 40 microns to about 60 microns (about 0.0016 inches to about 0.0023 inches). In some cases, suitable thickness ratios of inflow end region 740 relative to outflow end region 750 can range from 1:1 to 1.2:1, from 1.2:1 to 1.4:1, from 1.4:1 to 1.5:1, and from 1.5:1 to 2:1.
- a non-linear edge can providing a non-linear interface, e.g., interface 753 , between inflow end region 740 and outflow end region 750 .
- a prosthetic heart valve that has non-linear interface 753 may have an increased overall diameter that tapers more gradually than a prosthetic heart valve that has a linear interface.
- the non-linear edge of the fabric can gradually transition the change in elastic properties between the outflow end region 750 and inflow end region 740 , mitigating the formation of stress concentrators along an interface that can cause tearing in the tubular member. Additionally, the non-linear shape of interface 753 can minimize or prevent the propagation of tears.
- the fabric can be arranged in inflow end region 740 to allow for the fabric within inflow end region 740 to stretch in axial and/or radial directions to allow tubular seal 730 to stretch along with an expandable member during implantation.
- the seal can cause non-uniform crimping during manufacturing or damage the expandable member during device deployment.
- a woven fabric can be arranged to have the warp and the waft extend in directions oblique to the axis of tubular seal 730 .
- both the warp and the waft can extend at an angle between 30 degrees and 60 degrees with the axis of tubular seal 730 . In some cases, both the warp and the waft can extend at an angle between 5 degrees and 70 degrees with the axis of tubular seal 730 . In some cases, the warp and waft can be arranged within the tubular member 730 to form an angle of about 45 degrees with the axis of tubular seal 730 .
- the fabric can be a knit fabric arranged to allow for a predetermined amount of stretch in the axial and/or radial directions. Limiting the fabric within inflow end region 740 from stretching in a direction oblique to the axis can prevent the fabric from bunching and minimize non-uniform crimping during manufacturing.
- U.S. Patent Application No. 2013/0090729 which is hereby incorporated by reference in its entirety.
- U.S. Pat. No. 8,778,020 describes a seal that includes a multilayer, cylindrical seal body having projections alternating with recesses along the proximal edge of the seal body with proximal reinforcing grommets and a distal reinforcing band, which may be formed from a woven or nonwoven fabric and either incorporated within the interior of the multilayer seal body or adhered to the surface thereof.
- tubular seals described in U.S. Patent Application No. 2013/0090729 can be modified to include a fabric arrangement that allows a seal to stretch in axial and/or radial directions.
- elastomeric materials provided herein can be incorporated into the tubular seals disclosed in U.S. Patent Application No. 2013/0090729.
- the tubular seals described in U.S. Patent Application No. 2013/0090729 can be modified to include the non-linear interface 753 provided herein.
- tubular seal 730 can be created by producing one or more layers of elastomeric polymer, applying the fabric and grommets 732 to the one or more layers of elastomeric polymer, and overcoating the fabric and grommets 732 with one or more additional layers of elastomeric material. In some cases, different layers can have different elastomeric properties.
- tubular seals can include a radially innermost layer including at least one elastomeric polymer, e.g., a polycarbonate and a polyurethane; a radially outermost layer including at least one elastomeric polymer, e.g., a polycarbonate and a polyurethane; and at least one inner layer disposed between the radially outermost layer and a radially innermost layer.
- the modulus of elasticity of the innermost layer is less than the modulus of elasticity of the radially innermost outer layer and the modulus of elasticity of the radially outermost outer layer.
- the elongation to break of the inner layer is greater than the elongation to break of the radially innermost outer layer and the elongation to break of the radially outermost outer layer.
- the radially innermost outer layer and the radially outermost outer layer have been depicted as including the same material, it will be appreciated that they may be compositionally the same or different.
- multilayer tubular seals provided herein may be formed in a variety of ways.
- multilayer tubular seals provided herein may be formed by successive applications of a polymer solution to an appropriately shaped mandrel, such as that illustrated in FIG. 6 .
- the mandrel may be mounted to an appropriate holding fixture in a spray booth.
- a first coating composition including a carrier and at least one polymer may be applied to the mandrel 600 and subsequently dried to form a first coated mandrel.
- the first coating composition includes one or more elastomeric polymers, e.g, polycarbonate and/or a polyurethane, and a volatile carrier.
- the coating composition may be applied as a single layer or multiple layers to achieve the desired dried coating thickness.
- the grommets 732 ( FIG. 7A ) and the fabric may be positioned on the first coated mandrel by inserting locating pins 620 in apertures 610 in the tapered mandrel 600 of FIG. 6 that align with corresponding perforations 30 provided in the grommets 32 , 34 , 36 and the fabric 40 . In FIG. 6 , only one pin 620 has been illustrated for clarity.
- the fabric can be cut to a suitable shape having a non-linear edge using any suitable method.
- the fabric can be die cut.
- the fabric can be cut with a blade.
- the fabric can be cut using a femtosecond laser.
- a femtosecond laser cut fabric mitigates the chances of forming stress concentrators along the edge of the fabric.
- a second coating composition including a carrier and at least one polymer may be applied to the first coated mandrel, the fabric, and the plurality of grommets.
- the second coating composition includes one or more elastomeric polymers, e.g, polycarbonate and/or a polyurethane, and a volatile carrier.
- the carrier of the second coating composition may be removed, thereby forming a second coated mandrel.
- the second coating composition may be applied as a single layer or as multiple layers to achieve the desired dried coating thickness.
- the second coating composition may be different from the first coating composition.
- the second coating composition may be composed of the same material as the first coating composition.
- a third coating composition including a carrier and at least one polymer may be applied to the second coated mandrel.
- the third coating composition includes one or more elastomeric polymers, e.g, polycarbonate and/or a polyurethane, and a volatile carrier.
- the carrier of the third coating composition may be removed thereby forming a tubular seal precursor.
- the third coating composition may be applied as a single layer or as multiple layers to achieve the desired dried coating thickness.
- the third coating composition may be different from the first coating composition.
- the third coating composition may be the same as the first coating composition.
- the third coating composition may be different from the second coating composition.
- the third coating composition may be the same as the second coating composition.
- the tubular seal precursor may be inspected to ensure that it is fully formed and meets dimensional specifications, such as a thickness specification.
- a suitable thickness for the tubular seal precursor can range from about 30 microns to about 75 microns (about 0.001 inches to about 0.0030 inches) or from about 50 microns to about 120 microns (about 0.002 inches to about 0.0047 inches).
- tubular seal precursor examples include a range from about 20 microns to about 40 microns (about 0.0008 inches to about 0.002 inches), about 30 microns to about 50 microns (about 0.001 inches to about 0.002 inches), about 50 microns to about 75 microns (about 0.002 inches to about 0.0029 inches), about 50 microns to about 100 microns (about 0.002 inches to about 0.004 inches), about 100 microns to about 120 microns (about 0.004 inches to about 0.0047 inches), about 100 microns to about 150 microns (about 0.004 inches to about 0.0059 inches), about 150 microns to about 200 microns (about 0.0059 inches to about 0.0079 inches), as well as any thickness value within any of the listed ranges.
- the tubular seal precursor may be inspected to ensure that it meets certain functional specifications, e.g., tensile and frictional specifications.
- the tubular seal precursor may then be trimmed by laser cutting, or blade cutting, to conform to dimensional specifications and removed from the tapered seal-forming mandrel as a formed tubular seal.
- at least some preformed apertures for suturing tubular seal to expandable member 110 and/or leaflets 200 can be performed by laser cutting.
- at least some of the grommets may be formed by a laser cutting operation performed on a tubular seal precursor.
- 7A may be added to the multilayer, generally cylindrical seal, in a step not illustrated, as a proximal band. Subsequent laser cutting of the tubular seal precursor would then simultaneously form grommets 732 by removing the portions of the proximal band located between the projections.
- coating compositions may be selected to provide a relatively stiff dried polymer such as a dried polymer having a Shore D hardness of about 55, or a hardness of about 6.21 Megapascals (MPa).
- coating compositions may be selected to provide a relatively elastomeric dried polymer such as a dried polymer having a Shore A hardness of about 80, or a hardness of about 3.45 MPa.
- the first and third dried polymer layers may have a Shore D hardness of 55, or a hardness of 6.21 MPa
- the second layer may have a Shore A hardness of 80, or a hardness of 3.45 MPa.
- the plurality of grommets and the fabric can be positioned between the first and second coating layers. In some cases, the plurality of grommets and the fabric can be positioned elsewhere within the tubular seal, e.g., within a layer, or on the radially innermost or radially outermost surface of the tubular seal.
- a tubular seal 760 can include a woven or non-woven fabric embedded throughout a polymer or metal matrix structure.
- at least one leaflet of the heart valve can be secured to the tubular seal in a portion of the tubular seal including the woven or non-woven fabric to minimize blood leakage between the tubular seal and the leaflets.
- FIGS. 8A-8C are illustrations of an exemplary tubular seal 800 secured to an exemplary prosthetic heart valve provided herein.
- Tubular seal 800 as shown in FIGS. 8A-8C , includes a non-linear edge interface 820 between an inflow end region 840 and an outflow end region 750 .
- FIG. 8A shows tubular seal 800 advancing from a distal end of a deployment device provided herein and expanding radially.
- FIG. 8B provides an illustration of tubular seal 800 in a further radially expanded and deployed state.
- FIG. 8C provides a close up illustration of non-linear interface 820 of tubular seal 800 .
- tubular seal 800 includes a fabric in inflow end region 840 that has a non-linear edge defining a non-linear circumferential interface 820 between inflow end region 840 and outflow end region 850 .
- the non-linear edge of the fabric forms a scalloped-shaped interface 820 .
- the non-linear edge can form a sinusoidal, scalloped, or zigzagged shaped interface.
- the non-linear interface between inflow end region 840 and outflow end region 850 can disperse stress that forms along the interface during stretching of the tubular seal, limit or redirect tear propagation in outflow end region 850 back towards inflow end region 840 , and provide a transition zone where the overall outer diameter of the tubular member transitions between a thinner outflow end region thickness to a thicker inflow end region thickness. Variations in thickness between inflow end region 840 and outflow end region 850 can be due to the presence of the fabric within inflow end region 840 .
- a tubular seal having a non-linear interface can exhibit a different tensile failure mode than a tubular seal with a linear interface, because the tear propagation has been limited or redirected at interface 820 .
- Advantages of having non-linear interface 820 thus includes increasing the durability of tubular seal 800 at interface 820 .
- prosthetic heart valves provided herein include a tubular seal including a woven fabric within an elastomeric matrix where the woven fabric has a non-linear edge within the elastomeric matrix around the circumference of the tubular seal.
- the matrix structure can be made of elastomeric material.
- tubular seal 800 can be made of the fabric alone.
- non-elastic fibers 860 can be part of a knit fabric used in tubular seals provided herein.
- the fabric is a woven or nonwoven fabric having non-elastic fibers 860 arranged to allow the seal radially expand.
- the fabric can, for example, include non-elastic fiber 860 arranged to allow a portion of tubular seal 800 to stretch in axial and/or radial directions relative to the axis of the tubular seal 800 .
- the woven fabric having non-elastic fiber 860 can be positioned along a front edge of a tubular seal positioned to be secured to an expandable member.
- the non-elastic fiber 860 can be arranged at an of between 5 degrees and 70 degrees relative to a central axis of the tubular seal such that the non-elastic fiber 860 allow for a limited stretching of the tubular seal in an axial direction and/or a radial direction.
- the non-elastic fiber 860 can be part of a woven fabric having fiber in a warp direction and fibers in a waft direction each oriented at an angle of between 5 degrees and 70 degrees relative to a central axis of the tubular seal.
- the non-elastic fiber 860 do not individually stretch, a woven structure can be stretched in directions non-parallel with the orientation of the fiber 860 .
- the non-elastic fiber 860 can be arranged within the tubular member 760 to form an angle of about 45 degrees with the axis of the tubular seal.
- the fabric can be a knit fabric arranged to allow for a predetermined amount of stretch in the axial and/or radial directions.
- fibers 860 of the fabric can allow for the expandable member to be secured to the leaflets and/or to the expandable member.
- stitches or sutures can extend around the non-elastic fiber 860 within the matrix to ensure that the stitches or sutures do not cause the tubular seal to tear. Tears in the tubular seal can result in leakage of blood past a prosthetic heart valve, which can result in heart failure.
- the non-elastic fiber 860 within the tubular seal can be dispersed throughout a matrix structure, e.g., an elastomeric polymer matrix.
- a fabric of the non-elastic fiber 860 can be throughout the tubular seal.
- the fabric within the matrix, e.g., an elastomeric polymer matrix, can be arranged to allow for a limited amount of expansion of the tubular seal in a radial direction and/or an axial direction.
- non-elastic fiber 860 dispersed throughout the tubular seal can simplify the production of the tubular seal, allow for sutures to be used to attach any section of the tubular seal to one or more other portions of a prosthetic heart valve provided herein, and provide a substantially uniform thickness.
- a tubular seal having a uniform thickness can facilitate loading of a prosthetic heart valve provided herein into a delivery sheath because non-uniform sections of a seal can catch on a delivery sheath and potentially tear the tubular seal.
- a tubular seal provided herein can include an inflow end region and an outflow end region with the inflow end region including a fabric of non-elastic fiber 860 .
- the inflow end region can be secured to the bottom edges of leaflets and/or an inflow end of the expandable member by stitches and/or sutures.
- an outflow end region can include grommets for attachment to an outer surface of the expandable member.
- the fabric can be arranged to allow for the inflow end region to be expanded in a radial and/or axial direction, which can mitigate the transition in elasticity at the interface between an inflow end region and the outflow end region.
- An abrupt transition in elasticity between the inflow end region and the outflow end region can result in a stress concentrator along the interface, which can result in a tear along the interface.
- the fabric can be made of polymeric materials that include, but are not limited to, polyesters, polyolefins such as polyethylene and polypropylene, polyamides, nylons, and combinations thereof.
- the fabric can have a thickness ranging from about 40 to about 80 microns (about 0.002 inches to about 0.003 inches).
- the fabric can be woven such that spacings between individual fiber 860 create openings in the fabric that together constitutes from about 20% to about 40% of a fabric surface.
- tubular seal 800 can be created by coating a continuous tube of fabric including non-elastic fiber 860 with an elastomeric polymer and cutting the tube into individual tubular seals or portions of tubular seals.
- portions of the tubular seal having fabric can be created on a separate mandrel and later bonded to portions of the tubular seal that do not have fabric.
- a tube of fabric can be stretched in an axial direction during the coating of the fabric with the elastomeric polymer to enable the tubular seal to have more stretch in a radial direction than an axial direction.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
A tubular seal includes an outflow end region and an inflow end region. The inflow end region is a portion of a polymeric web retaining a woven fabric, wherein the woven fabric has a non-linear edge defining an interface between the inflow end region and the outflow end region.
Description
- This application is a continuation of U.S. application Ser. No. 16/139,256, filed Sep. 24,2018, which is a continuation of U.S. application Ser. No. 15/059,840, filed Mar. 3, 2016, which claims priority to U.S. Provisional Application No. 62/133,048, filed Mar. 13, 2015.
- This document provides prosthetic heart valves having an improved tubular seal.
- The human heart contains four valves: a tricuspid valve, a pulmonic valve, a mitral valve and an aortic valve. The main purpose of the valves is to maintain unimpeded forward flow of blood through the heart and the major blood vessels connected to the heart, for example, the pulmonary artery and the aorta. As a result of a number of disease processes, both acquired and congenital, any one of the four heart valves may malfunction and result in either stenosis (impeded forward flow) and/or backward flow (regurgitation). Either process burdens the heart and may lead to serious problems, for example, heart failure. Various procedures for fixing or replacing defective heart valves are known in the art. In some cases, artificial heart valves can be implanted in the heart of a patient to replace a diseased or damaged heart valve with a prosthetic equivalent to minimize stenosis and regurgitation.
- Prosthetic heart valves can have a variety of designs. Two major types of prosthetic heart valves include mechanical heart valves and bioprosthetic heart valves. Mechanical heart valves can be made of synthetic materials, such as plastics or metals, while bioprosthetic heart valves can be made of biologic tissue mounted on a fabric covered plastic or metal frame. Bioprosthetic heart valves can include animal tissue, such as porcine or bovine tissue, that has been chemically treated to make the valve suitable for implantation in a human. Bioprosthetic valves do not generally require a patient to undergo anticoagulant therapy, which is typically required when using mechanical valves. But bioprosthetic valves can be more prone to device wear such as tears in the valve tissue that may require the valve to be replaced. There is therefore a need to further improve the design of bioprosthetic valves to retain its functionality during the life of the patient.
- Prosthetic heart valves provided herein can have a structure adapted to retain functionality during the life of the patient and to minimize stenosis and regurgitation by having an improved connection between different parts of the prosthetic heart valve.
- In Example 1, a tubular seal includes an outflow end region and an inflow end region. The inflow end region can include a portion of a polymeric web retaining a woven fabric, wherein the woven fabric has a non-linear edge defining an interface between the inflow end region and the outflow end region.
- In Example 2, the tubular seal of Example 1, wherein polymeric web includes an elastomeric polymer matrix and the woven fabric is retained within the elastomeric polymer matrix.
- In Example 3, the tubular seal of Example 1 or Example 2, wherein the woven fabric includes non-elastic fibers.
- In Example 4, the tubular seal of Example 1-3, wherein the woven fabric includes fibers in a warp direction and fibers in a waft direction, wherein the fibers in both the warp direction and the waft direction are angled with respect to a central axis of the tubular seal.
- In Example 5, the tubular seal of Example 4, wherein the fibers in both the warp direction and the waft direction are angled at an angle of between 5 degrees and 70 degrees with respect to the central axis of the tubular seal.
- In Example 6, the tubular seal of Example 4, wherein the fibers are arranged within the tubular member to form an angle of about 45 degrees with respect to the central axis of the tubular seal.
- In Example 7, the tubular seal of one of Examples 1-6, wherein the interface of the woven fabric has a scalloped shape.
- In Example 8, the tubular seal of Example 7, wherein the interface has a major radius Ra that ranges from about 0.050 inches to about 0.100 inches.
- In Example 9, the tubular seal of Example 7, wherein the interface has a minor radius Ri that ranges from about from about 0.020 inches to about 0.040 inches.
- In Example 10, the tubular seal of Example 7, wherein the interface has a transition zone length that ranges from about 0.110 inches to about 0.160 inches.
- In Example 11, a tubular seal for a prosthetic heart valve includes an elastomeric polymer matrix and a woven fabric includes a plurality of non-elastic fibers retained within an inflow end region of the elastomeric polymer matrix. The woven fabric can include a non-linear edge within the elastomeric polymer matrix.
- In Example 12, the tubular seal of one of Example 11, wherein the non-linear edge of the woven fabric has a sinusoidal or scalloped shape.
- In Example 13, the tubular seal of one of Examples 11 or 12, wherein the non-elastic fibers include a polyester.
- In Example 14, the tubular seal of one of Examples 11-13, wherein the elastomeric polymer matrix includes a polymer selected from polycarbonates, polyurethane, silicones, and combinations thereof.
- In Example 15, the tubular seal of one of Examples 11-14, wherein the inflow end region includes a first substantially uniform thickness and an outflow end region includes median thickness that is less than the first substantially uniform thickness.
- In Example 16, a prosthetic heart valve includes an expandable tubular member, a plurality of leaflets and a tubular seal. The plurality of leaflets can be secured together alongside edges and retained within the expandable tubular member, each leaflet having a bottom edge at a blood inflow end of the expandable tubular member and a free edge at a blood outflow end of the expandable tubular member. The tubular seal can include a polymeric web secured to the bottom edge of each leaflet and along an outer portion of the expandable tubular member. The tubular seal can include an outflow end region and an inflow end region. The inflow end region can be a portion of polymeric web retaining a woven fabric, wherein the woven fabric has a non-linear edge defining the interface between the inflow end region and the outflow end region.
- In Example 17, the prosthetic heart valve of Example 16, wherein polymeric web includes an elastomeric polymer matrix and the woven fabric is retained within the elastomeric polymer matrix.
- In Example 18, the prosthetic heart valve of Example 16, wherein the woven fabric includes the non-elastic fibers.
- In Example 19, the prosthetic heart valve of Example 18, wherein the woven fabric includes fibers in a warp direction and fibers in a waft direction, wherein the fibers in both the warp direction and the waft direction are angled with respect to a central axis of the tubular seal.
- In Example 20, the prosthetic heart valve of Example 19, wherein the fibers in both the warp direction and the waft direction are angled at an angle of between 5 degrees and 70 degrees with respect to the central axis of the tubular seal.
- In Example 21, the prosthetic heart valve of Example 19, wherein the fibers are arranged within the tubular member to form an angle of about 45 degrees with respect to the central axis of the tubular seal.
- In Example 22, the prosthetic heart valve of Example 16, wherein the woven fabric includes non-elastic fibers arranged in the polymeric web to allow the tubular seal to stretch in axial and radial directions.
- In Example 23, the prosthetic heart valve of Example 16, wherein the non-linear edge of the woven fabric has a sinusoidal or scalloped shape.
- In Example 24, the prosthetic heart valve of Example 16, wherein the inflow end region includes a first substantially uniform thickness and the outflow end region includes median thickness that is less than the first substantially uniform thickness.
- In Example 25, the prosthetic heart valve of Example 16, wherein the outflow end region includes a plurality of grommets.
- In Example 26, a tubular seal for a prosthetic heart valve includes an elastomeric polymer matrix and a woven fabric that includes a plurality of non-elastic fibers retained within an inflow end region of the elastomeric polymer matrix. The woven fabric includes a non-linear edge within the elastomeric polymer matrix.
- In Example 27, the tubular seal of Example 26, wherein the non-linear edge of the woven fabric has a sinusoidal or scalloped shape defining an interface between the inflow end region and the outflow end region.
- In Example 28, the tubular seal of Example 27, wherein the interface has a major radius Ra that ranges from about 0.050 inches to about 0.100 inches.
- In Example 29, the tubular seal of Example 27, wherein interface has a minor radius Ri that ranges from about from about 0.020 inches to about 0.040 inches.
- In Example 30, the tubular seal of Example 27, wherein the interface has a transition zone length that ranges from about 0.110 inches to about 0.160 inches.
- In Example 31, the tubular seal of Example 26, wherein the non-elastic fibers include a polyester.
- In Example 32, the tubular seal of Example 26, wherein the elastomeric polymer matrix includes a polymer selected from polycarbonates, polyurethane, silicones, and combinations thereof.
- In Example 33, the tubular seal of Example 26, wherein the inflow end region includes a first substantially uniform thickness and the outflow end region includes median thickness that is less than the first substantially uniform thickness.
- In Example 34, the tubular seal of Example 26, wherein a thickness for the inflow end region ranges from about 0.0016 inches to about 0.0023 inches, or from about 40 microns to about 60 microns.
- In Example 35, a method includes forming at least a portion of a tubular seal that includes a woven fabric within a matrix by dipping a mandrel with a first coating composition that includes at least one elastomeric polymer. The method can also include drying the first coating composition and positioning the woven fabric on the mandrel such that fibers within the fabric are oriented at an angle of about 45 degrees with respect to a central axis of the tubular seal. The method can further include applying a second coating composition on the mandrel, the second coating composition being different than the first coating composition and removing the tubular seal from the mandrel.
- Prosthetic heart valves provided herein can additionally have a reduced unexpanded profile. In some cases, prosthetic heart valves provided herein include a plurality of anchor elements. In some cases, anchor elements can be secured to an expandable tubular member. In some cases, the expandable tubular member can be a braided stent. In some cases, prosthetic heart valves provided herein include three or more leaflets. In some cases, the leaflets can have a body portion and sleeve portions one or both sides. In some cases, sides of the body portions can be secured together and sleeve portions secured to anchor elements (e.g., anchor elements attached to a braided stent). In some cases, prosthetic heart valves provided herein can include a tubular seal. In some cases, the tubular seal can be secured to bottom edges of body portions of the leaflets. In some cases, the seal can be secured to a blood inlet side of an expandable member.
- Although tubular seals provided herein can be applied to a variety of prosthetic heart valves provided herein (and within the scope of the claims), additional details about the overall structure of an exemplary prosthetic heart valve are provided below.
- The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
-
FIGS. 1A-1I illustrate an exemplary prosthetic heart valve and an exemplary deployment device provided herein.FIGS. 1A and 1B are perspective views of the heart valve provided herein connected to the deployment device.FIG. 1C is a side view of the exemplary prosthetic heart valve.FIGS. 1D-1I illustrate how the exemplary heart valve provided herein can be delivered by the deployment device. -
FIGS. 2A-2C illustrates an exemplary leaflet, which can be used in prosthetic heart valves provided herein.FIG. 2A illustrates a rounded notch in a leaflet where a leaflet can be secured to an adjacent leaflet.FIGS. 2B and 2C illustrate a side portion of the exemplary leaflet.FIG. 2B depicts the rounded notch in an armpit of the exemplary leaflet.FIG. 2C depicts attachment elements in the armpit of the exemplary leaflet. -
FIG. 3 illustrates another exemplary leaflet, which can be used in prosthetic heart valves provided herein.FIG. 3 depicts apertures in a body of the exemplary leaflet. -
FIGS. 4A-4G illustrate how adjacent leaflets can be stitched together in prosthetic heart valves provided herein. -
FIGS. 5A-5C illustrate a cross stich provided herein for connecting a seal to a braided stent in an exemplary prosthetic heart valve provided herein.FIG. 5A shows a front view of a seal having apertures and stitch patterns used for securing the seal to the braided stent.FIG. 5B depicts a close up view of a cross stitch and a portion of a circumferential stitch used for securing the seal to the braided stent.FIG. 5C depicts a cross-sectional view showing the cross stitch and a portion of the circumferential stitch. -
FIG. 6 depicts an apparatus that can be used to form a tubular seal provided herein. -
FIGS. 7A-7G illustrate exemplary tubular seals that include a fabric having a non-linear edge positioned within a polymeric web or matrix in a prosthetic heart valve provided herein. -
FIGS. 8A-8C illustrate an exemplary tubular seal having a scalloped, non-linear edge in a prosthetic heart valve provided herein. - Like reference symbols in the various drawings indicate like elements.
-
FIGS. 1A and 1B illustrate an exemplaryprosthetic heart valve 100 provided herein.FIGS. 1A and 1B are perspective views ofprosthetic heart valve 100 connected to adeployment device 190.FIG. 1C is a side view ofprosthetic heart valve 100. As shown inFIGS. 1A-1C ,prosthetic heart valve 100 includes anexpandable member 110, threeleaflets 200, threeanchor elements 120 thatsecure sleeve portions 216 ofleaflets 200 toexpandable member 110, and atubular seal 130 secured around a blood inflow end ofprosthetic heart valve 100. To facilitate better understanding,FIG. 1A does not show components that are located underneathtubular seal 130, butFIG. 1B does show these components sincetubular seal 130 can be made of transparent materials that would normally allow these components to be visible.Anchor elements 120 can include postleg compression elements 122 and clampingsupport structures 126 adapted to provide support along opposite sides of thesleeve portions 216.Expandable member 110 in -
FIGS. 1A-1I is a braided stent (which can also be described as a braided anchor element), which is adapted to transition between a restricted state having a smaller diameter and an expanded state having a larger diameter.Expandable member 110 can be self-expanding, mechanically expanded, or a combination thereof -
FIGS. 1D-1I depict how an exemplary heartvalve delivery system 180 can deliver and deployprosthetic heart valve 100 provided herein within a blood vessel.System 180 can include asheath 182 for retainingprosthetic heart valve 100 with theexpandable member 110 in a restricted state. Tubular seals provided herein can have a uniform thickness or a thickness that has a non-linear interface between an inflow end region and an outflow end region to provide a transition zone between a thinner outflow end region to the thicker inflow end region that facilitates loading ofprosthetic heart valve 100 intosheath 182. For example, a substantially uniform thickness or a transition zone can reduce the probability for sections of the tubular seal to catch on an outer rim ofsheath 182 during loading ofprosthetic heart valve 100 in a restricted state. Additionally, tubular seals provided herein can allow for radial and/or axial expansion of the tubular seal in portions including non-elastic fibers, accordingly, a tubular seal used in prosthetic heart valves provided herein can have a non-expanded diameter that expands to the predetermined outer diameter of the expandable member and that stretches to an axially elongated but radially restricted configuration whenprosthetic heart valve 100 is in a restricted state to further reduce the profile ofprosthetic heart valve 100 withinsheath 182. - Within
sheath 182, anchor elements 120 (FIGS. 1A-1C ) can be connected to pushingprongs 192 and apull line 194 can be connected to anose cap 196, or end cap, which is positioned at the end ofsheath 182. As shown inFIGS. 1A and 1B , thepull line 194 can extend throughexpandable member 110 and through the valve opening between theleaflets 200. As shown byFIGS. 1D-1I , once a distal end ofsheath 182 is delivered through the circulatory system to an appropriate location (e.g., within the heart),prosthetic heart valve 100 can be deployed. By advancing pushingprongs 192 and pullline 194 relative tosheath 182,prosthetic heart valve 100 can be pushed out ofsheath 182. In some cases,expandable member 110 can self-expand upon exitingsheath 182. In some cases,expandable member 110 can self-expand to a first intermediate diameter, andsystem 180 can mechanically expandexpandable member 110 to a larger deployment diameter. For example, anchorelements 120 can include a locking mechanism to clip a portion of expandable member when theexpandable member 110 is expanded to a predetermined locking diameter. In some cases,system 180 can mechanically expandexpandable member 110 to a predetermined locking diameter. In some cases,system 180 can compressexpandable member 110 between pushingprongs 192 andnose cap 196 by movingpull line 194 relative to pushingprongs 192. The predetermined locking diameter can be adapted to set the diameter ofprosthetic heart valve 100 during implantation. Afterprosthetic heart valve 100 is set,system 180 can move pullline 194 andnose cap 196 relative to pushingprongs 192 to move the end cap through the opening betweenleaflets 200 inprosthetic heart valve 100. Pushingprongs 192 can then be retracted fromanchor elements 120 and retracted intosheath 182. In some cases, pushingprongs 192 can include a shape member material adapted to help radially expandexpandable member 110 as theexpandable member 110 exitssheath 182. A control handle 188 can be used to control the relative movements ofsheath 182, pushingprongs 192, and pullwire 194. Prosthetic heart valves provided herein can be adapted to mitigate damage that may occur to valves during delivery and implantation. - In some cases, one or more radiopaque markers can be secured to prosthetic heart valves provided herein. As shown in
FIGS. 1A-1C ,expandable member 110 includes aradiopaque marker 112. Any suitable radiopaque material (such as platinum, palladium, gold, tantalum, or alloys thereof) can be used as the radiopaque material inradiopaque marker 112. One or more radiopaque markers can be used with an imaging system to help a physician ensure that a valve is set in an appropriate location. In some cases, prosthetic heart valves provided herein include at least three radiopaque markers. - Referring to
FIGS. 1A and 1B ,prosthetic heart valve 100 can include a plurality ofleaflets 200. In some cases, as shown,prosthetic heart valve 100 includes threeleaflets 200. In some cases, prosthetic heart valves provided herein can have any suitable number of leaflets, such as two, three, four, five, or more leaflets. In some cases,leaflets 200 are secured to one another. In some cases,leaflets 200 can be secured to one another by a suture (not shown) or a plurality of sutures.Leaflets 200 can be sutured alongside edges of a body portion of each leaflet. In some cases, prosthetic heart valves provided herein can include a single line of sutures, which can be adapted to minimize leaks, minimize the width of a seam, and/or minimize the profile of a replacement heart valve during a percutaneous insertion. In some cases, prosthetic heart valves provided herein can include multiple lines of sutures. -
Expandable member 110 can have any suitable structure, arrangement, or material. In some cases,expandable member 110 can include a braided wire stent. For example, U.S. Publication Number 2005/0143809, titled, “Methods and Apparatus for Endovascularly Replacing a Heart Valve,” and filed on Nov. 5, 2004, which is herein incorporated by reference for its disclosure of possible structures and materials for a braided wire stent, discloses a braided wire stent. In some cases,expandable member 110 includes a shape memory material (e.g., a nickel-titanium alloy or a cobalt-chromium alloy). -
FIGS. 2A-2C provide illustrations of anexemplary leaflet 200 that includes abody portion 214 andsleeve portions 216. In some cases,body portion 214 has abottom edge 222, afirst side edge 226, asecond side edge 228, and afree edge 224. Leaflet 200 further includes a front (i.e., a side facing the blood inflow end of a prosthetic heart valve), a back (i.e., a side facing the blood outflow end), a first side adjacent to thefirst side edge 226, and a second side adjacent to thesecond side edge 228. In some cases, the front ofleaflet 200 has a different texture than the back. In some cases, the back or front can have a non-textured or textured surface to mitigate calcium buildup on the surfaces. For example, in some cases, the back ofleaflet 200 may be prone to calcium build due to a cusp-shaped, concave surface, thus it can be beneficial to have a textured surface on the back ofleaflet 200 to mitigate calcification issues. Leaflets can be made of various synthetic or non-synthetic materials. In some cases, theleaflet 200 is made from tissue obtained from an animal, e.g., a pig or a cow. In some cases,leaflet 200 is made from bovine pericardium. In some cases,leaflets 200 can be made from a synthetic polymers or composites.Leaflets 200 can be assembled into a heart valve by aligning the opposite side regions of at least twoadjacent leaflets 200 and stitching theleaflets 200 together alongstitch line 246, which is shown inFIG. 2C . - Still referring to
FIGS. 2A-2C ,leaflet 200 defines at least onenotch side edges adjacent sleeve portion 216. Eachnotch sleeve portions 216, e.g., at an “armpit” ofleaflet 200 as depicted inFIGS. 2A and 2B . In some cases,leaflet 200 can define a notch along the length of side edges 228, 226. In some cases, a notch can be defined alongsleeve portion 216. In some cases, multiple notches can be located alongsleeve portion 216, side edges 228, 226, and/or at the armpit of theleaflet 200. - As shown in
FIGS. 2A and 2B ,body portion 214 ofleaflet 200 has a conical frustum shape defined bybottom edge 222,first side edge 226,second side edge 228, andfree edge 224. Other suitable shapes for the body portion can include, but are not limited to, for example, a generally square, rectangular, triangular or trapezoidal shaped body portion. - The
sleeve portions 216, as shown inFIGS. 2A-2C , can extend outwardly from thebody portion 214 of theleaflet 200. Eachsleeve portion 216 can oriented at an angle relative to a portion of the body portion, e.g.,free edge 224 ofbody portion 214.Sleeve portions 214, as shown, can be generally rectangular-shaped extensions with lateral free ends. In some cases,sleeve portions 214 can have rounded free ends. - Still referring to
FIGS. 2A-2C ,notches notches notch leaflet 200.Notches - Referring to
FIG. 2C ,notches leg compression elements 122. Postleg compression elements 122 can be a part of anchor elements 120 (shown inFIGS. 1A-1C ) that compress and restrainsleeve portions 216 along the same line as thestitch line 246. As shown inFIG. 2C ,suture 258 can be used to apply an appropriate and consistent compressive force between postleg compression elements 122 in order to prevent leakage throughsleeve portions 216 ofleaflets 200. Sincesuture 258 pass throughnotches body portion 214 at or near the armpit ofleaflet 200. Sutures that pierce the body portion at or near the armpit of the leaflet can pull, stretch and abrade surrounding tissue areas, creating stress concentrations at or near the armpit of the leaflet. These stress concentrators can result in tears forming in the leaflet. The use ofnotches leg compression elements 122, therefore can minimize potential heart valve tearing that might be caused by sutures at or near the armpit location.Notches leaflet 200 can improve valve opening capabilities and the reliability of prosthetic heart valves provided herein. -
FIG. 3 illustrates anotherexemplary leaflet 300, which can be used in prosthetic heart valves provided herein. As shown inFIG. 3 , leaflet 300 can include abody portion 314 and at least twoopposite sleeve portions 316. Thebody portion 314 can be defined by at least twoside edges sleeve portion 316. Leaflet 300 can define twoapertures aperture adjacent sleeve portion 316. - Still referring to
FIG. 3 ,body portion 314 has abottom edge 322, afirst side edge 326, asecond side edge 328, and afree edge 324. Leaflet 300 further includes a front, a back, a first side adjacent to thefirst side edge 326, and a second side adjacent to thesecond side edge 328.Leaflets 300 can be assembled into a heart valve by aligning the opposite side regions of at least twoadjacent leaflets 300 and stitching theleaflets 300 together alongstitch line 246, as shown inFIG. 2C . - As shown in
FIG. 3 ,leaflet 300 definesapertures sleeve portions 316.Apertures apertures more apertures sleeve portions 316 of theleaflet 300. In some cases, multiple apertures can be located in a region that is adjacent to the side edges 328, 326 and thesleeve portions 316. -
Apertures leaflets 300 can allow one leaflet to be secured to an adjacent leaflet. Similar to the notches discussed above,apertures leg compression elements 122. Referring back toFIGS. 1A-1C , postleg compression elements 122 can be a part ofanchor elements 120 that compress and restrainsleeve portions 216 along the same line as thestitch line 246. Asuture 258 can be used to apply an appropriate and consistent compressive force between the postleg compression elements 122 in order to prevent leakage throughsleeve portions 216 of theleaflets 200. As already discussed herein, sutures that pierce thebody portion 214 at or near the armpit of the leaflet can create stress concentrations at or near the armpit of the leaflet that may result in tearing.Apertures leg compression elements 122, however, can minimize this potential tearing caused by sutures near the armpit location by being positioned proximate to the post leg compression elements near the armpit.Apertures suture 258 to pass therethrough without pulling or stretching adjacent tissue areas. Accordingly,leaflets 300 used in prosthetic heart valves provided herein can improve the reliability of prosthetic heart valves. -
FIGS. 4A-4G depict howleaflets 200 can be connected (or jointed) with an improved stitch discussed herein. As shown, stitch 446 can be a single continuous line stitch traveling along a stitch line in a forward direction and back in a reverse direction. In some cases, stitch 446 can run along a leaflet from a bottom edge to a side edge of the leaflet (e.g.,bottom edge 222 to side edge 226 ofleaflet 200 inFIG. 2A-2B ). In some cases, stitch 446 can run from a side edge to a notch of a leaflet (e.g.,side edge 226 to notch 234 ofleaflet 200 inFIG. 2A-2B ). - As shown in
FIGS. 4D-4G ,stitch 446 can include a plurality ofperpendicular loop segments 434 extending through an aperture in the two leaflets, around outer side edges of the two attached leaflets, and back through the aperture.Stitch 446 can include a plurality ofparallel segments 436 extending between adjacent apertures along the stitch line.Stitch 446 can include twoperpendicular loop segments 434 extending through apertures formed in the stitch line. In some cases, a firstperpendicular loop segment 434 for a first aperture in the stitch line is formed when the stitch is formed in the forward direction and a secondperpendicular loop segment 434 for the first aperture is formed in the reverse direction. In some cases,parallel segments 436 made in a forward direction alternate between opposite sides of the two leaflets between each aperture in the stitch line. In some cases,parallel segments 436 made in a reverse direction are formed on an opposite side of the two leaflets fromparallel segments 436 made in a forward direction. In some cases, oppositeparallel segments 436 made in the forward and reverse directions can provide a continuous compressive force along the entire length of the stitch line.Perpendicular loop segments 434 can provide compressive force to reinforce a seal formed between the two leaflets along the stitch line. -
Stitch 446 can include any appropriate number of perpendicular loop segments formed through any appropriate number of apertures. As shown,stitch 446 includes six perpendicular loop segments formed through six apertures (two perpendicular loop segments per aperture). In some cases, stitch 446 can include up to twelve perpendicular loop segments formed through six or more apertures. In some cases, a stitch connecting side edge segments of leaflets can be formed using between 3 and 20 apertures and include between 3 and 40 perpendicular loop segments. In some cases, apertures can be positioned from about 0.2 mm to about 10 mm apart (or about 0.008 inches to about 0.4 inches apart). In some cases, apertures can be positioned from about 0.2 mm to about 10 mm (or about 0.008 inches to about 0.4 inches) away from the side edges of the leaflets. -
Stitch 446 can be formed in a process depicted inFIGS. 4A-4G . As shown inFIG. 4A , athread needle 410 can be passed through aligned leaflet side edges 226 a and 226 b to create a first aperture at a location nearbottom edges 222, e.g., a location approximately 1 mm from thebottom edges 222. The leaflet side edges 226 a and 226 b can be retained in a desired configuration by clamping the leaflets betweenclamp sides Needle 410 pulls aleading end 431 of athread 432 through the first aperture. As shown inFIG. 4B ,needle 410 can then form a second aperture adjacent to the first aperture along the stitch line (towards the leaflet sleeve portion) about 0.5 mm away from the first aperture to pullleading end 431 ofthread 432 through the second aperture to form a first parallel segment. As shown inFIG. 4C , aperpendicular loop segment 434 can be made by guidingneedle 410 around the leaflet side edges and re-enter the second aperture from a backside.Thread 432 can be pulled through the second aperture until it sits firmly against the leaflet material (e.g., leaflet pericardium tissue).FIG. 4D shows a second parallel segment, which can be made by pushingneedle 410 through leaflet tissue along the stitch line to form a third aperture approximately 1 mm from the second aperture (towards the sleeve segments of the leaflet). As shown inFIG. 4E , a secondperpendicular loop segment 434 can be formed by again havingneedle 410 loop around the leaflet side edges and reenter the third aperture through the backside. This is repeated up to notch 234 to form a total of sixparallel segments 436 and sixperpendicular loop segments 434 in a forward direction, as shown inFIG. 4F . The stitch pattern can then be repeated in a reverse direction towards thebottom edges 222 of the leaflets through the previously formed apertures. Accordingly, each aperture can include twoperpendicular loop segments 434 and parallel segments on the opposite sides can be formed from the parallel segments that were created in the forward direction, as shown inFIG. 4G . The method and stitches depicted inFIGS. 4A-4G can be applicable toleaflets -
Stitch 446 and other stitches provided herein can improve the reliability of a seal formed along a stitch line, create fewer apertures through the leaflets, and simplify the stitching operation. Having fewer apertures can help minimize the occurrence of blood leakage through the apertures. The single continuous line ofstitch 446 using a single row of apertures can minimize a width of a side edge portion needed to form a continuous seal along the side edges of the leaflets, thus providing a reduced restricted profile for prosthetic heart valves provided herein. For example, U.S. Pat. No. 8,778,020 describes a variety of ways that leaflets can be sutured together using combinations of whip stitches and running stitches, but these stitches require additional apertures and multiple lines.Perpendicular loop segments 434 can stitch a plurality of leaflets together, similar to the whip stitches discussed in U.S. Pat. No. 8,778,020.Parallel segments 436 can secure valve leaflets to one another, similar to the running stitches discussed in U.S. Pat. No. 8,778,020. Althoughstitch 446 can provide an improved attachment between side edges of leaflets in prosthetic heart valves provided herein, some embodiments of prosthetic heart valves provided herein can use other stitch patterns, such as those described in U.S. Pat. No. 8,778,020, which is hereby incorporated by reference. - Important characteristics of a suture thread can include, but are not limited to, adequate tensile strength, abrasion resistance and creep rupture resistance characteristics that allow the device to be delivered into and sustain implantation within a human anatomy. The thread used for suturing together portions of the heart valve, e.g., side edges of the leaflets, can be composed of biocompatible materials that include, but are not limited to, polyethylene such as ultra high molecular weight polyethylene (UHMWPE), polyester (PET), and a combination thereof.
- Referring back to
FIGS. 1A-1C ,tubular seal 130 ofprosthetic heart valve 100 can be secured to bottom edges 222 (FIG. 2A ) ofbody portion 214 ofleaflet 200 by acircumferential running stitch 134. In some cases,tubular seal 130 can be secured toexpandable member 110 by fasteners, such asgrommets 136, and extended around the outside ofexpandable member 110 to provide a seal that minimizes blood leakage around theleaflets 200 of an implantedprosthetic heart valve 100. The structure and materials oftubular seal 130 are further discussed with reference toFIGS. 6 and 7A-7E . -
FIGS. 5A-5C provide an improved tubular seal stitching pattern can include across stitch 132 betweentubular seal 130 andexpandable member 110. For example, a blood inlet side of expandable member 110 (e.g., braided anchor element) can be secured to a portion of the tubular seal having the woven fabric by a plurality of stitches (e.g., a plurality of cross stitches securing the seal to two crossing members of a braided stent).FIGS. 5A-5C illustrate how thetubular seal 130 can be secured to theexpandable member 110, e.g., a braided stent, by a plurality of cross stitches connecting thetubular seal 130 to a pair of overlapping wire members of the braided stent. As shown inFIGS. 1A-1C and 5A-5C ,expandable member 110 can be a braided stent including one or more wires having a first set ofsegments 114 extending helically in a first direction and a second set ofsegments 116 extending helically in a second direction such that the first set ofsegments 114 cross the second set ofsegments 116 at intersection points 118. As shown, one or more wires can haveinflow crowns 115 at an end of the braided stent where the wires transition fromfirst segments 114 tosecond segments 116. In some cases,cross stitches 132 securetubular seal 130 at anintersection 118 to twocrossing segments circumferential running stitch 134 can be inserted into preformedapertures 133 to secure the adaptive seal tobottom edges 222 ofleaflets 200 shown inFIGS. 2A and 2C . Cross-stitches around theintersections 118 can increase the strength of an attachment oftubular seal 130 to theexpandable member 110 while also allowing for improved load transfer to theexpandable member 110. In some cases, the cross stitches securetubular seal 130 atintersections 118 located immediately above (proximal) the inflow crowns 115.Cross stitches 132 can be formed by passing twostitches intersections 118 and through thetubular seal 130. In some cases, preformedapertures 131 forcross stitch 132 can be formed in thetubular seal 130. In some cases, a portion of thetubular seal 130 that is sutured bycross stitch 132 includes an internal fabric, such as those discussed below. Eachcross stitch 132 can be knotted independently. As shown inFIG. 5C ,cross stitches 132 each include aseparate knot 137. Additionally,cross stitches 132 can be arranged to not pass throughleaflets 200.Cross stitches 132 can be repeated at a plurality of intersections 118 (FIG. 5A ) circumferentially around an inflow end of a prosthetic heart valve provided herein such that an entire circumference oftubular seal 130 is securely attached. In some cases, eachintersection 118 immediately adjacent to inflow crowns 115 is sutured totubular seal 130 via a cross stitch provided herein. The tubular seal stitching pattern provided herein can increase the strength of the attachment between thetubular seal 130 and theexpandable member 110 while also allowing for improved load transfer to theexpandable member 110 through the use of the plurality of cross stitches. - Referring back to
FIGS. 1A-1B ,tubular seal 130 ofprosthetic heart valve 100 can have various suitable structures, arrangements, or materials that allowtubular seal 130 to be secured toleaflets 200 withinprosthetic heart valve 100. Various suitable structures, arrangements, or materials oftubular seal 130 can be used to allowtubular seal 130 to extend around the outside of expandabletubular member 110 to prevent blood leakage aroundleaflets 200. -
FIG. 6 shows anexemplary mandrel 600 that can be used to construct a tubular seal. Themandrel 600 includes a taper which results in a tubular seal having a slightly smaller diameter proximal end compared to the diameter of the distal end. In some cases, the diameter of the proximal end can include a diameter reduction of about 3% to about 30% as compared to the diameter of the distal end. The taper allows the tubular seal to be removed from the mandrel with relative ease upon completion of the fabrication process. The smaller proximal diameter of the tubular seal tends to cause the proximal projections to lie more firmly against an anchor element of the replacement heart valve. In some cases, the surface of the mandrel may be textured to create a tubular seal with a reduced contact area. In some cases, the mandrel can be textured using a bead blasting process. In combination with the selection of a relatively hard outer layer, a textured seal surface is believed to result in a lower friction surface. -
FIG. 7A shows atubular seal 730 that includes aninflow end region 740 and anoutflow end region 750. In some cases, at least a portion oftubular seal 730 can include a polymeric web. In some cases, the polymeric web can be a thin film, a porous layer, a mesh-like or net-like structure, or a porous network, e.g., a polymeric matrix. In some cases, for example,inflow end region 740 oftubular seal 130 can include a polymeric web. In some cases,inflow end region 740 can be a portion of a polymeric web retaining a fabric. In some cases, polymeric web can include an elastic material. In some cases, the polymeric web can include an elastomeric matrix. - In some cases,
inflow end region 740 can be secured to bottom edges of a plurality of leaflets at an inflow end of a prosthetic heart valve provided herein, e.g.,prosthetic heart valve 100, and haveoutflow end region 750 extend around an outer surface of an expandable member (e.g., a braided stent) to restrict blood flow around the leaflets. In some cases, a fabric can be embedded within the polymeric web such that the polymeric web forms a polymeric matrix around the fabric. In some cases, the polymeric web can include an elastic material. In some cases, an elastic polymeric web can conform to adjacent surfaces of a prosthetic heart valve provided herein to prove a resilient seal. The elastomeric polymer matrix can furthermore conform to the expandable member as the expandable member changed between a restricted configuration and an expanded configuration. In some cases, an elastic material can allow the tubular seal to return to its original length when the expandable member returns to the restricted configuration without tearing. - In some cases, at least a portion of the
tubular seal 130, such as the polymeric web or matrix, can include one or more layers of an elastomeric polymer. In some cases,tubular seal 130 can include a polycarbonate, polyurethane, silicone, polytetrafluoroethylene (PTFE), or a combination thereof. Other suitable materials include, but are not limited to, natural and synthetic rubbers, including cis-1,4-polyisoprene rubber, styrene/butadiene copolymers, polybutadiene rubber, styrene/isoprene/butadiene rubber, butyl rubber, halobutyl rubber, polyurethane elastomers including elastomers based on both aromatic and aliphatic isocyanates, flexible polyolefins including flexible polyethylene and polypropylene homopolymers and copolymers, styrenic thermoplastic elastomers, polyamide elastomers, polyamide-ether elastomers, ester-ether or ester-ester elastomers, flexible ionomers, thermoplastic vulcanizates, flexible poly(vinyl chloride) homopolymers and copolymers, acrylic polymers, and a combination thereof. In some cases,tubular seal 130 can include an aliphatic polycarbonate-based thermoplastic urethane. In some cases,tubular seal 130 can include an elastomeric polymer having a hardness ranging from 3.07 MPa to 9.9 MPa, or a durometer ranging from 75 Shore A to 75 Shore D using ASTM standard D2240 in force on Jan. 1, 2014. In some cases,tubular seal 130 can include a polymeric material having the mechanical properties shown in Table I below. Notably, all of the listed ASTM standards refers to the standard in force on Jan. 1, 2014. -
TABLE I ASTM Standard Durometer Range 75 Shore A-75 Shore D D2240 Available Specific Gravity 1.10-1.14 D792 Melt Flow 2-26 g/10 min(205° C./3.26 kg) D1238 ASTM MECHANICAL PROPERTY RANGES Standard Durometer 75A-B20 55D 75D 75D Ultimate Tensile 400-9000 5000-10000 3000-8000 D638 Strength (psi) Tensile (psi) @50% elongation 350-650 1500-1800 3000-8000 D638 @100% elongation 550-850 1800-2200 3000-8000 D638 @200% elongation 600-1200 2800-4200 D638 @300% elongation 1200-2000 4200-10000 D630 Ultimate 350-750 200-400 100-300 D638 Elongation (%) - In some cases, referring back to
FIGS. 1A and 1B ,tubular seal 130 can include attachment structures, e.g.,grommets 136, to improve the attachment of thetubular seal 130 toleaflets 200 and/orexpandable member 110. - In some cases,
tubular seal 730 can include a fabric retained by a polymeric web such that the fabric reinforces the polymeric web to allow the tubular seal to be secured to a prosthetic heart valve provided herein. Referring toFIG. 7A , for example,inflow end region 740 oftubular seal 730 can include a fabric embedded within an elastomeric material. Also shown inFIG. 7A ,outflow end region 750 oftubular seal 730 can include a plurality ofgrommets 732. The fabric ofinflow end region 740 can be a woven material. In some cases, the fabric can have warp threads and/or weft threads. In some cases, the fabric can be composed of fibers having an average thread diameter from about 0.5 microns to about 50 microns (or from about 0.00002 inches to about 0.002 inches), more preferably from about 20 micron to about 40 microns (or about 0.0008 inches to about 0.002 inches). More preferably, in some cases, the fabric is composed of fibers having a thread diameter of about 27 microns (or about 0.0011 inches). - In some cases, the fabric can include non-elastomeric fibers, or non-elastic fibers. Suitable non-elastomeric fiber materials include, but are not limited to, polyolefins, polyesters such as PES 38/31 manufactured by SaatiTech, and polyamides. More particularly, the polyolefins can include, for example, polyethylenes, polypropylenes, polybutenes, ethylene copolymers, propylene copolymers, butene copolymers, and combinations thereof. Because the fabric can include non-elastic fibers,
inflow end region 740 andoutflow end region 750 can have different overall elastic properties. - As shown in
FIG. 7A , the fabric of a tubular seal has a non-linear edge defining aninterface 753 betweeninflow end region 740 and theoutflow end region 750. In some cases,interface 753 between theinflow end region 740 and theoutflow end region 750 can be non-linear due to a non-linear edge of the fabric withininflow end region 740. As shown inFIG. 7A , the non-linear edge can be sinusoidal 753. In some cases, as shown inFIGS. 7C-7F , the non-linear edge can be azigzagged edge 754, a steppededge 755, or ascalloped edge -
FIGS. 7E and 7F provide alternative embodiments oftubular seals circumferential interfaces inflow end region outflow end region Interfaces FIGS. 7E and 7F , have a scalloped shape defined by a major radius Ra, a minor radius Ri, a wavelength (λ) and a transition zone length (l). In some cases, major radius Ra can be the radius proximate the inflow end region and minor radius Ri can be the radius proximate the outflow end region. In some cases, major radius Ra can be the radius proximate the outflow end region and minor radius Ri can be the radius proximate the inflow end region. As shown inFIGS. 7E and 7F , major radius Ra is larger than the minor Ri. In some cases, major and minor radii Ra, Ri are equal and form a sinusoidal-shaped interface. In some cases, the ratio between major radius Ra and minor radius Ri can range from 1:1 to 2:1, 2:1 to 3:1, from 3:1 to 4:1, or from 4:1 to 5:1. In some cases, a necked region 790 (seeFIG. 7F ) can be formed between minor radius Ri and major radius Ra. In some cases, minor radius Ri can form bulbous ends, as shown inFIG. 7F , to increase the interface length and improve durability oftubular seal 780 at or nearinterface 782. The interfaces described herein provide the benefit of preventing or minimizing tear propagation in the tubular seal while providing sufficient bond strength to maintain the bond between the inflow and outflow end regions of the tubular seal. In some cases, the interfaces described herein can prevent or minimize a tear from propagating further at the interface region by redirecting the tear or by providing a barrier to the tear. - In some cases, the major radius Ra and/or the minor radius Ri can range from about 1.3 millimeters to about 2.54 millimeters (or about 0.050 inches to about 0.100 inches), from about 1.8 millimeters to about 2.0 millimeters (or about 0.070 inches to about 0.080 inches), from about 2.0 millimeters to about 2.54 millimeters (or about 0.080 inches to about 0.100 inches), or from about 2.3 millimeters to about 2.4 millimeters (or about 0.090 to about 0.095 inches). In some cases, the major radius Ra and/or the minor radius Ri can range from about 0.51 millimeters to about 0.76 millimeters (or about 0.020 inches to about 0.030 inches), from about 0.76 millimeters to about 1.0 millimeters (or about 0.030 inches to about 0.040 inches), from about 1.0 millimeters to about 1.3 millimeters (or about 0.040 inches to about 0.050 inches), from about 0.51 millimeters to about 1.0 millimeters (about 0.020 inches to about 0.040 inches), or from about 0.51 millimeters to about 1.3 millimeters (or about 0.020 inches to about 0.050 inches). In some cases, the wavelength (λ) of the scalloped-shaped interface, or the length of one repeating scallop shape, can range from about 2.5 millimeters to about 1.0 millimeters (or about 0.10 inches to about 0.40 inches), from about 3.8 millimeters to about 5.1 millimeters (or about 0.15 inches to about 0.20 inches), or from about 5.1 millimeters to about 6.35 millimeters (or about 0.20 inches to about 0.25 inches). There can be various suitable lengths of the transition zone length described herein. The transition zone length can be measured as a distance between the crest of the minor radius Ri and the trough of the major radius Ra. In some cases, the transition zone length can range from about 2.8 millimeters to about 3.0 millimeters (or about 0.110 inches to about 0.120 inches), from about 3.0 millimeters to about 3.3 millimeters (or about 0.120 inches to about 0.130 inches), from about 3.3 millimeters to about 3.6 millimeters (or about 0.130 inches to about 0.140 inches), from about 3.6 millimeters to about 3.8 millimeters (or about 0.140 inches to about 0.150 inches), from about 3.8 millimeters to about 4.1 millimeters (or about 0.150 inches to about 0.160 inches), or from about 2.8 millimeters to about 4.1 millimeters (or about 0.110 inches to about 0.160 inches).
- Referring back to
FIG. 7A , in some cases,inflow end region 740 can be thicker thanoutflow end region 750 because of the presence of a fabric withininflow end region 740. In some cases,inflow end region 740 can have a thickness of about 70 microns (0.0028 inches). In some cases,outflow end region 750 can have a thickness of about 50 microns (about 0.0020 inches). Other suitable thicknesses forinflow end region 740 include thicknesses ranging from about 50 microns to about 90 microns (about 0.0020 inches to about 0.0035 inches), or more preferably, from about 60 microns to about 80 microns (about 0.0025 inches to about 0.0031 inches). Suitable thicknesses foroutflow end region 750 include thicknesses ranging from about 30 microns to about 70 microns (about 0.0011 inches to about 0.0028 inches), or more preferably, from about 40 microns to about 60 microns (about 0.0016 inches to about 0.0023 inches). In some cases, suitable thickness ratios ofinflow end region 740 relative tooutflow end region 750 can range from 1:1 to 1.2:1, from 1.2:1 to 1.4:1, from 1.4:1 to 1.5:1, and from 1.5:1 to 2:1. A non-linear edge can providing a non-linear interface, e.g.,interface 753, betweeninflow end region 740 andoutflow end region 750. A prosthetic heart valve that hasnon-linear interface 753 may have an increased overall diameter that tapers more gradually than a prosthetic heart valve that has a linear interface. The non-linear edge of the fabric can gradually transition the change in elastic properties between theoutflow end region 750 andinflow end region 740, mitigating the formation of stress concentrators along an interface that can cause tearing in the tubular member. Additionally, the non-linear shape ofinterface 753 can minimize or prevent the propagation of tears. - Still referring to
FIG. 7A , in some cases, the fabric can be arranged ininflow end region 740 to allow for the fabric withininflow end region 740 to stretch in axial and/or radial directions to allowtubular seal 730 to stretch along with an expandable member during implantation. When the fabric does not allow a tubular seal to adequately stretch, the seal can cause non-uniform crimping during manufacturing or damage the expandable member during device deployment. In some cases, a woven fabric can be arranged to have the warp and the waft extend in directions oblique to the axis oftubular seal 730. This can allow the fabric to flex in radial and/or axial directions relative to the axis oftubular seal 730, but limit the fabric from stretching in a direction oblique to the axis. In some cases, both the warp and the waft can extend at an angle between 30 degrees and 60 degrees with the axis oftubular seal 730. In some cases, both the warp and the waft can extend at an angle between 5 degrees and 70 degrees with the axis oftubular seal 730. In some cases, the warp and waft can be arranged within thetubular member 730 to form an angle of about 45 degrees with the axis oftubular seal 730. In some cases, the fabric can be a knit fabric arranged to allow for a predetermined amount of stretch in the axial and/or radial directions. Limiting the fabric withininflow end region 740 from stretching in a direction oblique to the axis can prevent the fabric from bunching and minimize non-uniform crimping during manufacturing. - Additional exemplary tubular seals including a fabric and grommets are described in U.S. Patent Application No. 2013/0090729, which is hereby incorporated by reference in its entirety. For example, U.S. Pat. No. 8,778,020 describes a seal that includes a multilayer, cylindrical seal body having projections alternating with recesses along the proximal edge of the seal body with proximal reinforcing grommets and a distal reinforcing band, which may be formed from a woven or nonwoven fabric and either incorporated within the interior of the multilayer seal body or adhered to the surface thereof.
- In some cases, tubular seals described in U.S. Patent Application No. 2013/0090729 can be modified to include a fabric arrangement that allows a seal to stretch in axial and/or radial directions. In some cases, elastomeric materials provided herein can be incorporated into the tubular seals disclosed in U.S. Patent Application No. 2013/0090729. In some cases, the tubular seals described in U.S. Patent Application No. 2013/0090729 can be modified to include the
non-linear interface 753 provided herein. - Still referring to
FIG. 7A ,tubular seal 730 can be created by producing one or more layers of elastomeric polymer, applying the fabric andgrommets 732 to the one or more layers of elastomeric polymer, and overcoating the fabric andgrommets 732 with one or more additional layers of elastomeric material. In some cases, different layers can have different elastomeric properties. In some cases, tubular seals (e.g., 130, 730, or 760) can include a radially innermost layer including at least one elastomeric polymer, e.g., a polycarbonate and a polyurethane; a radially outermost layer including at least one elastomeric polymer, e.g., a polycarbonate and a polyurethane; and at least one inner layer disposed between the radially outermost layer and a radially innermost layer. In some cases, the modulus of elasticity of the innermost layer is less than the modulus of elasticity of the radially innermost outer layer and the modulus of elasticity of the radially outermost outer layer. In some cases, the elongation to break of the inner layer is greater than the elongation to break of the radially innermost outer layer and the elongation to break of the radially outermost outer layer. Although the radially innermost outer layer and the radially outermost outer layer have been depicted as including the same material, it will be appreciated that they may be compositionally the same or different. - The multilayer tubular seals provided herein (e.g., 130, 730, 760) may be formed in a variety of ways. In some cases, multilayer tubular seals provided herein may be formed by successive applications of a polymer solution to an appropriately shaped mandrel, such as that illustrated in
FIG. 6 . Following a careful cleaning of themandrel 600, the mandrel may be mounted to an appropriate holding fixture in a spray booth. A first coating composition including a carrier and at least one polymer may be applied to themandrel 600 and subsequently dried to form a first coated mandrel. In some cases, the first coating composition includes one or more elastomeric polymers, e.g, polycarbonate and/or a polyurethane, and a volatile carrier. The coating composition may be applied as a single layer or multiple layers to achieve the desired dried coating thickness. The grommets 732 (FIG. 7A ) and the fabric may be positioned on the first coated mandrel by inserting locatingpins 620 inapertures 610 in the taperedmandrel 600 ofFIG. 6 that align with corresponding perforations 30 provided in the grommets 32, 34, 36 and the fabric 40. InFIG. 6 , only onepin 620 has been illustrated for clarity. In some instances, it may be desirable to secure the plurality ofgrommets 732 and the fabric to the mandrel or to an underlying coating layer by applying a drop of a first coating composition, or other adhesive composition, to each item to ensure that it remains properly positioned during subsequent processing. The fabric can be cut to a suitable shape having a non-linear edge using any suitable method. In some cases, the fabric can be die cut. In some cases, the fabric can be cut with a blade. In some cases, the fabric can be cut using a femtosecond laser. In some cases, a femtosecond laser cut fabric mitigates the chances of forming stress concentrators along the edge of the fabric. - A second coating composition including a carrier and at least one polymer may be applied to the first coated mandrel, the fabric, and the plurality of grommets. In some cases, the second coating composition includes one or more elastomeric polymers, e.g, polycarbonate and/or a polyurethane, and a volatile carrier. The carrier of the second coating composition may be removed, thereby forming a second coated mandrel. The second coating composition may be applied as a single layer or as multiple layers to achieve the desired dried coating thickness. In some cases, the second coating composition may be different from the first coating composition. In some cases, the second coating composition may be composed of the same material as the first coating composition.
- In some cases, a third coating composition including a carrier and at least one polymer may be applied to the second coated mandrel. In some cases, the third coating composition includes one or more elastomeric polymers, e.g, polycarbonate and/or a polyurethane, and a volatile carrier. The carrier of the third coating composition may be removed thereby forming a tubular seal precursor. The third coating composition may be applied as a single layer or as multiple layers to achieve the desired dried coating thickness. In some cases, the third coating composition may be different from the first coating composition. In some cases, the third coating composition may be the same as the first coating composition. In some cases, the third coating composition may be different from the second coating composition. In some cases, the third coating composition may be the same as the second coating composition. Following removal of the carrier from the third coating composition, the tubular seal precursor may be inspected to ensure that it is fully formed and meets dimensional specifications, such as a thickness specification. In some cases, a suitable thickness for the tubular seal precursor can range from about 30 microns to about 75 microns (about 0.001 inches to about 0.0030 inches) or from about 50 microns to about 120 microns (about 0.002 inches to about 0.0047 inches). Other suitable thicknesses for the tubular seal precursor include a range from about 20 microns to about 40 microns (about 0.0008 inches to about 0.002 inches), about 30 microns to about 50 microns (about 0.001 inches to about 0.002 inches), about 50 microns to about 75 microns (about 0.002 inches to about 0.0029 inches), about 50 microns to about 100 microns (about 0.002 inches to about 0.004 inches), about 100 microns to about 120 microns (about 0.004 inches to about 0.0047 inches), about 100 microns to about 150 microns (about 0.004 inches to about 0.0059 inches), about 150 microns to about 200 microns (about 0.0059 inches to about 0.0079 inches), as well as any thickness value within any of the listed ranges.
- In some cases, the tubular seal precursor may be inspected to ensure that it meets certain functional specifications, e.g., tensile and frictional specifications. The tubular seal precursor may then be trimmed by laser cutting, or blade cutting, to conform to dimensional specifications and removed from the tapered seal-forming mandrel as a formed tubular seal. In some cases, at least some preformed apertures for suturing tubular seal to
expandable member 110 and/or leaflets 200 (seeFIGS. 1A and 1B ) can be performed by laser cutting. In some cases, at least some of the grommets may be formed by a laser cutting operation performed on a tubular seal precursor. In some cases,grommets 732 ofFIG. 7A may be added to the multilayer, generally cylindrical seal, in a step not illustrated, as a proximal band. Subsequent laser cutting of the tubular seal precursor would then simultaneously formgrommets 732 by removing the portions of the proximal band located between the projections. - In some cases, coating compositions may be selected to provide a relatively stiff dried polymer such as a dried polymer having a Shore D hardness of about 55, or a hardness of about 6.21 Megapascals (MPa). In some cases, coating compositions may be selected to provide a relatively elastomeric dried polymer such as a dried polymer having a Shore A hardness of about 80, or a hardness of about 3.45 MPa. In some cases, the first and third dried polymer layers may have a Shore D hardness of 55, or a hardness of 6.21 MPa, and the second layer may have a Shore A hardness of 80, or a hardness of 3.45 MPa.
- Although in some cases described above, three polymer layers were employed, it will be appreciated that a greater or lesser number of layers may be employed and that each of the three or more layers may include two or more sublayers. In some cases, the plurality of grommets and the fabric can be positioned between the first and second coating layers. In some cases, the plurality of grommets and the fabric can be positioned elsewhere within the tubular seal, e.g., within a layer, or on the radially innermost or radially outermost surface of the tubular seal.
- As shown in
FIG. 7G , atubular seal 760 can include a woven or non-woven fabric embedded throughout a polymer or metal matrix structure. In some cases, at least one leaflet of the heart valve can be secured to the tubular seal in a portion of the tubular seal including the woven or non-woven fabric to minimize blood leakage between the tubular seal and the leaflets. -
FIGS. 8A-8C are illustrations of an exemplarytubular seal 800 secured to an exemplary prosthetic heart valve provided herein.Tubular seal 800, as shown inFIGS. 8A-8C , includes anon-linear edge interface 820 between aninflow end region 840 and anoutflow end region 750.FIG. 8A showstubular seal 800 advancing from a distal end of a deployment device provided herein and expanding radially.FIG. 8B provides an illustration oftubular seal 800 in a further radially expanded and deployed state.FIG. 8C provides a close up illustration ofnon-linear interface 820 oftubular seal 800. - Referring to
FIGS. 8B and 8C ,tubular seal 800 includes a fabric ininflow end region 840 that has a non-linear edge defining a non-linearcircumferential interface 820 betweeninflow end region 840 andoutflow end region 850. As shown inFIGS. 8A-8C , the non-linear edge of the fabric forms a scalloped-shapedinterface 820. In some cases, the non-linear edge can form a sinusoidal, scalloped, or zigzagged shaped interface. The non-linear interface betweeninflow end region 840 andoutflow end region 850 can disperse stress that forms along the interface during stretching of the tubular seal, limit or redirect tear propagation inoutflow end region 850 back towardsinflow end region 840, and provide a transition zone where the overall outer diameter of the tubular member transitions between a thinner outflow end region thickness to a thicker inflow end region thickness. Variations in thickness betweeninflow end region 840 andoutflow end region 850 can be due to the presence of the fabric withininflow end region 840. In some cases, a tubular seal having a non-linear interface can exhibit a different tensile failure mode than a tubular seal with a linear interface, because the tear propagation has been limited or redirected atinterface 820. Advantages of havingnon-linear interface 820 thus includes increasing the durability oftubular seal 800 atinterface 820. - In some cases, prosthetic heart valves provided herein include a tubular seal including a woven fabric within an elastomeric matrix where the woven fabric has a non-linear edge within the elastomeric matrix around the circumference of the tubular seal. In some cases, the matrix structure can be made of elastomeric material. In some cases,
tubular seal 800 can be made of the fabric alone. - Still referring to
FIGS. 8A-8C ,non-elastic fibers 860 can be part of a knit fabric used in tubular seals provided herein. In some cases, the fabric is a woven or nonwoven fabric havingnon-elastic fibers 860 arranged to allow the seal radially expand. The fabric can, for example, includenon-elastic fiber 860 arranged to allow a portion oftubular seal 800 to stretch in axial and/or radial directions relative to the axis of thetubular seal 800. In some cases, the woven fabric havingnon-elastic fiber 860 can be positioned along a front edge of a tubular seal positioned to be secured to an expandable member. In some cases, thenon-elastic fiber 860 can be arranged at an of between 5 degrees and 70 degrees relative to a central axis of the tubular seal such that thenon-elastic fiber 860 allow for a limited stretching of the tubular seal in an axial direction and/or a radial direction. For example, thenon-elastic fiber 860 can be part of a woven fabric having fiber in a warp direction and fibers in a waft direction each oriented at an angle of between 5 degrees and 70 degrees relative to a central axis of the tubular seal. Although thenon-elastic fiber 860 do not individually stretch, a woven structure can be stretched in directions non-parallel with the orientation of thefiber 860. In some cases, thenon-elastic fiber 860 can be arranged within thetubular member 760 to form an angle of about 45 degrees with the axis of the tubular seal. In some cases, the fabric can be a knit fabric arranged to allow for a predetermined amount of stretch in the axial and/or radial directions. - In some cases,
fibers 860 of the fabric can allow for the expandable member to be secured to the leaflets and/or to the expandable member. For example, stitches or sutures can extend around thenon-elastic fiber 860 within the matrix to ensure that the stitches or sutures do not cause the tubular seal to tear. Tears in the tubular seal can result in leakage of blood past a prosthetic heart valve, which can result in heart failure. - In some cases, the
non-elastic fiber 860 within the tubular seal can be dispersed throughout a matrix structure, e.g., an elastomeric polymer matrix. In some cases, a fabric of thenon-elastic fiber 860 can be throughout the tubular seal. The fabric within the matrix, e.g., an elastomeric polymer matrix, can be arranged to allow for a limited amount of expansion of the tubular seal in a radial direction and/or an axial direction. As discussed below in further detail,non-elastic fiber 860 dispersed throughout the tubular seal can simplify the production of the tubular seal, allow for sutures to be used to attach any section of the tubular seal to one or more other portions of a prosthetic heart valve provided herein, and provide a substantially uniform thickness. A tubular seal having a uniform thickness can facilitate loading of a prosthetic heart valve provided herein into a delivery sheath because non-uniform sections of a seal can catch on a delivery sheath and potentially tear the tubular seal. - In some cases, a tubular seal provided herein can include an inflow end region and an outflow end region with the inflow end region including a fabric of
non-elastic fiber 860. The inflow end region can be secured to the bottom edges of leaflets and/or an inflow end of the expandable member by stitches and/or sutures. In some cases, an outflow end region can include grommets for attachment to an outer surface of the expandable member. In some cases, the fabric can be arranged to allow for the inflow end region to be expanded in a radial and/or axial direction, which can mitigate the transition in elasticity at the interface between an inflow end region and the outflow end region. An abrupt transition in elasticity between the inflow end region and the outflow end region can result in a stress concentrator along the interface, which can result in a tear along the interface. By having a fabric oriented in the inflow end region to allow axial and/or radial expansion of the inflow end region can disperse stresses formed along the interface during stretching of the tubular seal. - In some cases, the fabric can be made of polymeric materials that include, but are not limited to, polyesters, polyolefins such as polyethylene and polypropylene, polyamides, nylons, and combinations thereof. In some cases, the fabric can have a thickness ranging from about 40 to about 80 microns (about 0.002 inches to about 0.003 inches). In some cases, the fabric can be woven such that spacings between
individual fiber 860 create openings in the fabric that together constitutes from about 20% to about 40% of a fabric surface. - A tubular seal having a fabric embedded throughout the elastomeric material can simplify the manufacturing process. For example, instead of requiring the use of the
mandrel 600 to build up layers of elastomeric polymer and position a fabric in select portions of the tubular seal,tubular seal 800 can be created by coating a continuous tube of fabric includingnon-elastic fiber 860 with an elastomeric polymer and cutting the tube into individual tubular seals or portions of tubular seals. In some cases, portions of the tubular seal having fabric can be created on a separate mandrel and later bonded to portions of the tubular seal that do not have fabric. In some cases, a tube of fabric can be stretched in an axial direction during the coating of the fabric with the elastomeric polymer to enable the tubular seal to have more stretch in a radial direction than an axial direction. - A number of embodiments of the invention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. Accordingly, other embodiments are within the scope of the following claims.
Claims (1)
1. A prosthetic heart valve comprising:
an expandable tubular member;
a plurality of leaflets secured together alongside edges and retained within the expandable tubular member, each leaflet having a bottom edge at a blood inflow end of the expandable tubular member and a free edge at a blood outflow end of the expandable tubular member; and
a tubular seal comprising a polymeric web secured to the bottom edge of each leaflet and along an outer portion of the expandable tubular member, wherein the tubular seal comprising an outflow end region and an inflow end region, the inflow end region being a portion of polymeric web retaining a woven fabric, wherein the woven fabric has a non-linear edge defining the interface between the inflow end region and the outflow end region.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/351,868 US20210307902A1 (en) | 2015-03-13 | 2021-06-18 | Prosthetic Heart Valve Having an Improved Tubular Seal |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562133048P | 2015-03-13 | 2015-03-13 | |
US15/059,840 US10080652B2 (en) | 2015-03-13 | 2016-03-03 | Prosthetic heart valve having an improved tubular seal |
US16/139,256 US11065113B2 (en) | 2015-03-13 | 2018-09-24 | Prosthetic heart valve having an improved tubular seal |
US17/351,868 US20210307902A1 (en) | 2015-03-13 | 2021-06-18 | Prosthetic Heart Valve Having an Improved Tubular Seal |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/139,256 Continuation US11065113B2 (en) | 2015-03-13 | 2018-09-24 | Prosthetic heart valve having an improved tubular seal |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210307902A1 true US20210307902A1 (en) | 2021-10-07 |
Family
ID=56887160
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/059,840 Active 2036-04-27 US10080652B2 (en) | 2015-03-13 | 2016-03-03 | Prosthetic heart valve having an improved tubular seal |
US16/139,256 Active 2036-07-18 US11065113B2 (en) | 2015-03-13 | 2018-09-24 | Prosthetic heart valve having an improved tubular seal |
US17/351,868 Pending US20210307902A1 (en) | 2015-03-13 | 2021-06-18 | Prosthetic Heart Valve Having an Improved Tubular Seal |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/059,840 Active 2036-04-27 US10080652B2 (en) | 2015-03-13 | 2016-03-03 | Prosthetic heart valve having an improved tubular seal |
US16/139,256 Active 2036-07-18 US11065113B2 (en) | 2015-03-13 | 2018-09-24 | Prosthetic heart valve having an improved tubular seal |
Country Status (4)
Country | Link |
---|---|
US (3) | US10080652B2 (en) |
EP (1) | EP3267945A1 (en) |
CN (1) | CN107592804B (en) |
WO (1) | WO2016148942A1 (en) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050148925A1 (en) | 2001-04-20 | 2005-07-07 | Dan Rottenberg | Device and method for controlling in-vivo pressure |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US9681948B2 (en) | 2006-01-23 | 2017-06-20 | V-Wave Ltd. | Heart anchor device |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
ES2903231T3 (en) | 2008-02-26 | 2022-03-31 | Jenavalve Tech Inc | Stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
WO2010128501A1 (en) | 2009-05-04 | 2010-11-11 | V-Wave Ltd. | Device and method for regulating pressure in a heart chamber |
US9034034B2 (en) | 2010-12-22 | 2015-05-19 | V-Wave Ltd. | Devices for reducing left atrial pressure, and methods of making and using same |
US10076403B1 (en) | 2009-05-04 | 2018-09-18 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US20210161637A1 (en) | 2009-05-04 | 2021-06-03 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
JP2013526388A (en) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent |
US9629715B2 (en) | 2011-07-28 | 2017-04-25 | V-Wave Ltd. | Devices for reducing left atrial pressure having biodegradable constriction, and methods of making and using same |
US11135054B2 (en) | 2011-07-28 | 2021-10-05 | V-Wave Ltd. | Interatrial shunts having biodegradable material, and methods of making and using same |
CN105555204B (en) * | 2013-05-21 | 2018-07-10 | V-波有限责任公司 | For delivering the equipment for the device for reducing left atrial pressure |
JP6563394B2 (en) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Radially foldable frame for an artificial valve and method for manufacturing the frame |
CA2975361A1 (en) * | 2015-02-02 | 2016-08-11 | Symetis Sa | Stent seals and method of production |
EP4403138A3 (en) | 2015-05-01 | 2024-10-09 | JenaValve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
EP3291773A4 (en) | 2015-05-07 | 2019-05-01 | The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center | Temporary interatrial shunts |
CN109475419B (en) | 2016-05-13 | 2021-11-09 | 耶拿阀门科技股份有限公司 | Heart valve prosthesis delivery systems and methods for delivering heart valve prostheses through guide sheaths and loading systems |
US20170340460A1 (en) | 2016-05-31 | 2017-11-30 | V-Wave Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US10835394B2 (en) | 2016-05-31 | 2020-11-17 | V-Wave, Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US10813749B2 (en) * | 2016-12-20 | 2020-10-27 | Edwards Lifesciences Corporation | Docking device made with 3D woven fabric |
US10653523B2 (en) | 2017-01-19 | 2020-05-19 | 4C Medical Technologies, Inc. | Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves |
US10561495B2 (en) | 2017-01-24 | 2020-02-18 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
US11197754B2 (en) | 2017-01-27 | 2021-12-14 | Jenavalve Technology, Inc. | Heart valve mimicry |
US11291807B2 (en) | 2017-03-03 | 2022-04-05 | V-Wave Ltd. | Asymmetric shunt for redistributing atrial blood volume |
AU2018228451B2 (en) | 2017-03-03 | 2022-12-08 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US12029647B2 (en) | 2017-03-07 | 2024-07-09 | 4C Medical Technologies, Inc. | Systems, methods and devices for prosthetic heart valve with single valve leaflet |
US10820992B2 (en) | 2017-04-05 | 2020-11-03 | Opus Medical Therapies, LLC | Transcatheter atrial sealing skirt, anchor, and tether and methods of implantation |
US11103351B2 (en) | 2017-04-05 | 2021-08-31 | Opus Medical Therapies, LLC | Transcatheter atrial sealing skirt and related method |
US11123187B2 (en) | 2017-04-05 | 2021-09-21 | Opus Medical Therapies, LLC | Transcatheter atrial anchors and methods of implantation |
US10820991B2 (en) | 2017-04-05 | 2020-11-03 | Opus Medical Therapies, LLC | Transcatheter atrial sealing skirt, anchor, and tether and methods of implantation |
US11337685B2 (en) | 2017-04-05 | 2022-05-24 | Opus Medical Therapies, LLC | Transcatheter anchoring assembly for a mitral valve, a mitral valve, and related methods |
US12036113B2 (en) | 2017-06-14 | 2024-07-16 | 4C Medical Technologies, Inc. | Delivery of heart chamber prosthetic valve implant |
CN109452990B (en) | 2017-09-04 | 2023-10-31 | 杭州启明医疗器械股份有限公司 | Peripheral leakage prevention support device with lifting unit fold skirt, processing method, skirt fold method and heart valve |
US11458287B2 (en) | 2018-01-20 | 2022-10-04 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
US10898698B1 (en) | 2020-05-04 | 2021-01-26 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
WO2019142152A1 (en) | 2018-01-20 | 2019-07-25 | V-Wave Ltd. | Devices and methods for providing passage between heart chambers |
US20210259831A1 (en) * | 2018-06-20 | 2021-08-26 | W. L. Gore & Associates, Inc. | Support structure for an implantable device with enhanced compressive stiffness region(s) |
PL238746B1 (en) | 2018-07-24 | 2021-09-27 | American Heart Of Poland Spolka Akcyjna | Method of forming prefabricated elements used in production of transcatheter aortic valve implantation systems |
US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
DE102018126828A1 (en) * | 2018-10-26 | 2020-04-30 | Nvt Ag | Heart valve prosthesis |
US11612385B2 (en) | 2019-04-03 | 2023-03-28 | V-Wave Ltd. | Systems and methods for delivering implantable devices across an atrial septum |
US11439504B2 (en) | 2019-05-10 | 2022-09-13 | Boston Scientific Scimed, Inc. | Replacement heart valve with improved cusp washout and reduced loading |
US11865282B2 (en) | 2019-05-20 | 2024-01-09 | V-Wave Ltd. | Systems and methods for creating an interatrial shunt |
WO2021030431A1 (en) * | 2019-08-14 | 2021-02-18 | Boston Scientific Scimed, Inc. | Replacement heart valve locking element |
WO2021150913A1 (en) | 2020-01-22 | 2021-07-29 | Opus Medical Therapies, LLC | Transcatheter anchor support, systems and methods of implantation |
US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
US12053375B2 (en) | 2020-03-05 | 2024-08-06 | 4C Medical Technologies, Inc. | Prosthetic mitral valve with improved atrial and/or annular apposition and paravalvular leakage mitigation |
US11992403B2 (en) | 2020-03-06 | 2024-05-28 | 4C Medical Technologies, Inc. | Devices, systems and methods for improving recapture of prosthetic heart valve device with stent frame having valve support with inwardly stent cells |
US20220087814A1 (en) * | 2020-09-24 | 2022-03-24 | Cephea Valve Technologies, Inc. | Controlled Expression of Expandable Heart Valve |
WO2022072687A1 (en) | 2020-10-01 | 2022-04-07 | Opus Medical Therapies, LLC | Transcatheter anchor support and methods of implantation |
US11234702B1 (en) | 2020-11-13 | 2022-02-01 | V-Wave Ltd. | Interatrial shunt having physiologic sensor |
AU2023252664A1 (en) | 2022-04-14 | 2024-10-17 | V-Wave Ltd. | Interatrial shunt with expanded neck region |
CN116251238B (en) * | 2023-02-28 | 2023-11-21 | 上海心纪元医疗科技有限公司 | Bionic valve leaflet with three-layer structure and manufacturing method thereof |
Family Cites Families (698)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US15192A (en) | 1856-06-24 | Tubular | ||
US1080652A (en) | 1913-05-13 | 1913-12-09 | Arthur E Peters | Spring-cover. |
US2682057A (en) | 1951-07-24 | 1954-06-29 | Harry A Lord | Heart valve |
US2701559A (en) | 1951-08-02 | 1955-02-08 | William A Cooper | Apparatus for exfoliating and collecting diagnostic material from inner walls of hollow viscera |
US2832078A (en) | 1956-10-17 | 1958-04-29 | Battelle Memorial Institute | Heart valve |
US3099016A (en) | 1960-08-11 | 1963-07-30 | Edwards Miles Lowell | Heart valve |
US3130418A (en) | 1960-11-25 | 1964-04-28 | Louis R Head | Artificial heart valve and method for making same |
US3113586A (en) | 1962-09-17 | 1963-12-10 | Physio Control Company Inc | Artificial heart valve |
US3143742A (en) | 1963-03-19 | 1964-08-11 | Surgitool Inc | Prosthetic sutureless heart valve |
US3367364A (en) | 1964-10-19 | 1968-02-06 | Univ Minnesota | Prosthetic heart valve |
US3334629A (en) | 1964-11-09 | 1967-08-08 | Bertram D Cohn | Occlusive device for inferior vena cava |
GB1127325A (en) | 1965-08-23 | 1968-09-18 | Henry Berry | Improved instrument for inserting artificial heart valves |
US3587115A (en) | 1966-05-04 | 1971-06-28 | Donald P Shiley | Prosthetic sutureless heart valves and implant tools therefor |
US3445916A (en) | 1967-04-19 | 1969-05-27 | Rudolf R Schulte | Method for making an anatomical check valve |
US3548417A (en) | 1967-09-05 | 1970-12-22 | Ronnie G Kischer | Heart valve having a flexible wall which rotates between open and closed positions |
US3540431A (en) | 1968-04-04 | 1970-11-17 | Kazi Mobin Uddin | Collapsible filter for fluid flowing in closed passageway |
US3570014A (en) | 1968-09-16 | 1971-03-16 | Warren D Hancock | Stent for heart valve |
US3671979A (en) | 1969-09-23 | 1972-06-27 | Univ Utah | Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve |
US3628535A (en) | 1969-11-12 | 1971-12-21 | Nibot Corp | Surgical instrument for implanting a prosthetic heart valve or the like |
US3592184A (en) | 1969-12-16 | 1971-07-13 | David H Watkins | Heart assist method and catheter |
US3642004A (en) | 1970-01-05 | 1972-02-15 | Life Support Equipment Corp | Urethral valve |
US3657744A (en) | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
US3714671A (en) | 1970-11-30 | 1973-02-06 | Cutter Lab | Tissue-type heart valve with a graft support ring or stent |
US3755823A (en) | 1971-04-23 | 1973-09-04 | Hancock Laboratories Inc | Flexible stent for heart valve |
US3868956A (en) | 1972-06-05 | 1975-03-04 | Ralph J Alfidi | Vessel implantable appliance and method of implanting it |
US3839741A (en) | 1972-11-17 | 1974-10-08 | J Haller | Heart valve and retaining means therefor |
US3795246A (en) | 1973-01-26 | 1974-03-05 | Bard Inc C R | Venocclusion device |
US3874388A (en) | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US4291420A (en) | 1973-11-09 | 1981-09-29 | Medac Gesellschaft Fur Klinische Spezialpraparate Mbh | Artificial heart valve |
US3997923A (en) | 1975-04-28 | 1976-12-21 | St. Jude Medical, Inc. | Heart valve prosthesis and suturing assembly and method of implanting a heart valve prosthesis in a heart |
US4035849A (en) | 1975-11-17 | 1977-07-19 | William W. Angell | Heart valve stent and process for preparing a stented heart valve prosthesis |
CA1069652A (en) | 1976-01-09 | 1980-01-15 | Alain F. Carpentier | Supported bioprosthetic heart valve with compliant orifice ring |
US4056854A (en) | 1976-09-28 | 1977-11-08 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Aortic heart valve catheter |
US5876419A (en) | 1976-10-02 | 1999-03-02 | Navius Corporation | Stent and method for making a stent |
US4297749A (en) | 1977-04-25 | 1981-11-03 | Albany International Corp. | Heart valve prosthesis |
US4233690A (en) | 1978-05-19 | 1980-11-18 | Carbomedics, Inc. | Prosthetic device couplings |
US4222126A (en) | 1978-12-14 | 1980-09-16 | The United States Of America As Represented By The Secretary Of The Department Of Health, Education & Welfare | Unitized three leaflet heart valve |
US4265694A (en) | 1978-12-14 | 1981-05-05 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Method of making unitized three leaflet heart valve |
US4574803A (en) | 1979-01-19 | 1986-03-11 | Karl Storz | Tissue cutter |
GB2056023B (en) | 1979-08-06 | 1983-08-10 | Ross D N Bodnar E | Stent for a cardiac valve |
US4373216A (en) | 1980-10-27 | 1983-02-15 | Hemex, Inc. | Heart valves having edge-guided occluders |
US4388735A (en) | 1980-11-03 | 1983-06-21 | Shiley Inc. | Low profile prosthetic xenograft heart valve |
US4326306A (en) | 1980-12-16 | 1982-04-27 | Lynell Medical Technology, Inc. | Intraocular lens and manipulating tool therefor |
US4339831A (en) | 1981-03-27 | 1982-07-20 | Medtronic, Inc. | Dynamic annulus heart valve and reconstruction ring |
US4470157A (en) | 1981-04-27 | 1984-09-11 | Love Jack W | Tricuspid prosthetic tissue heart valve |
US4323358A (en) | 1981-04-30 | 1982-04-06 | Vascor, Inc. | Method for inhibiting mineralization of natural tissue during implantation |
US4345340A (en) | 1981-05-07 | 1982-08-24 | Vascor, Inc. | Stent for mitral/tricuspid heart valve |
US4501030A (en) | 1981-08-17 | 1985-02-26 | American Hospital Supply Corporation | Method of leaflet attachment for prosthetic heart valves |
US4865600A (en) | 1981-08-25 | 1989-09-12 | Baxter International Inc. | Mitral valve holder |
US4425908A (en) | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US4406022A (en) | 1981-11-16 | 1983-09-27 | Kathryn Roy | Prosthetic valve means for cardiovascular surgery |
US4423809A (en) | 1982-02-05 | 1984-01-03 | Staar Surgical Company, Inc. | Packaging system for intraocular lens structures |
FR2523810B1 (en) | 1982-03-23 | 1988-11-25 | Carpentier Alain | ORGANIC GRAFT FABRIC AND PROCESS FOR ITS PREPARATION |
SE445884B (en) | 1982-04-30 | 1986-07-28 | Medinvent Sa | DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION |
US4484579A (en) | 1982-07-19 | 1984-11-27 | University Of Pittsburgh | Commissurotomy catheter apparatus and method |
IT1212547B (en) | 1982-08-09 | 1989-11-30 | Iorio Domenico | INSTRUMENT FOR SURGICAL USE INTENDED TO MAKE INTERVENTIONS FOR THE IMPLANTATION OF BIOPROTESIS IN HUMAN ORGANS EASIER AND SAFER |
DE3230858C2 (en) | 1982-08-19 | 1985-01-24 | Ahmadi, Ali, Dr. med., 7809 Denzlingen | Ring prosthesis |
US4885005A (en) | 1982-11-12 | 1989-12-05 | Baxter International Inc. | Surfactant treatment of implantable biological tissue to inhibit calcification |
US5215541A (en) | 1982-11-12 | 1993-06-01 | Baxter International Inc. | Surfactant treatment of implantable biological tissue to inhibit calcification |
US4680031A (en) | 1982-11-29 | 1987-07-14 | Tascon Medical Technology Corporation | Heart valve prosthesis |
GB8300636D0 (en) | 1983-01-11 | 1983-02-09 | Black M M | Heart valve replacements |
US4535483A (en) | 1983-01-17 | 1985-08-20 | Hemex, Inc. | Suture rings for heart valves |
US4834755A (en) | 1983-04-04 | 1989-05-30 | Pfizer Hospital Products Group, Inc. | Triaxially-braided fabric prosthesis |
US4610688A (en) | 1983-04-04 | 1986-09-09 | Pfizer Hospital Products Group, Inc. | Triaxially-braided fabric prosthesis |
AR229309A1 (en) | 1983-04-20 | 1983-07-15 | Barone Hector Daniel | MOUNT FOR CARDIAC VALVES |
US4612011A (en) | 1983-07-22 | 1986-09-16 | Hans Kautzky | Central occluder semi-biological heart valve |
US4531943A (en) | 1983-08-08 | 1985-07-30 | Angiomedics Corporation | Catheter with soft deformable tip |
US4665906A (en) | 1983-10-14 | 1987-05-19 | Raychem Corporation | Medical devices incorporating sim alloy elements |
US4585705A (en) | 1983-11-09 | 1986-04-29 | Dow Corning Corporation | Hard organopolysiloxane release coating |
US4787899A (en) | 1983-12-09 | 1988-11-29 | Lazarus Harrison M | Intraluminal graft device, system and method |
US5693083A (en) | 1983-12-09 | 1997-12-02 | Endovascular Technologies, Inc. | Thoracic graft and delivery catheter |
US4627436A (en) | 1984-03-01 | 1986-12-09 | Innoventions Biomedical Inc. | Angioplasty catheter and method for use thereof |
US4617932A (en) | 1984-04-25 | 1986-10-21 | Elliot Kornberg | Device and method for performing an intraluminal abdominal aortic aneurysm repair |
US4592340A (en) | 1984-05-02 | 1986-06-03 | Boyles Paul W | Artificial catheter means |
US5007896A (en) | 1988-12-19 | 1991-04-16 | Surgical Systems & Instruments, Inc. | Rotary-catheter for atherectomy |
US4979939A (en) | 1984-05-14 | 1990-12-25 | Surgical Systems & Instruments, Inc. | Atherectomy system with a guide wire |
US4883458A (en) | 1987-02-24 | 1989-11-28 | Surgical Systems & Instruments, Inc. | Atherectomy system and method of using the same |
DE3426300A1 (en) | 1984-07-17 | 1986-01-30 | Doguhan Dr.med. 6000 Frankfurt Baykut | TWO-WAY VALVE AND ITS USE AS A HEART VALVE PROSTHESIS |
US4580568A (en) | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
DE3442088A1 (en) | 1984-11-17 | 1986-05-28 | Beiersdorf Ag, 2000 Hamburg | HEART VALVE PROSTHESIS |
SU1271508A1 (en) | 1984-11-29 | 1986-11-23 | Горьковский государственный медицинский институт им.С.М.Кирова | Artificial heart valve |
US4759758A (en) | 1984-12-07 | 1988-07-26 | Shlomo Gabbay | Prosthetic heart valve |
US4738666A (en) | 1985-06-11 | 1988-04-19 | Genus Catheter Technologies, Inc. | Variable diameter catheter |
US4662885A (en) | 1985-09-03 | 1987-05-05 | Becton, Dickinson And Company | Percutaneously deliverable intravascular filter prosthesis |
GB2181057B (en) | 1985-10-23 | 1989-09-27 | Blagoveshchensk G Med Inst | Prosthetic valve holder |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
DE3640745A1 (en) | 1985-11-30 | 1987-06-04 | Ernst Peter Prof Dr M Strecker | Catheter for producing or extending connections to or between body cavities |
US4710192A (en) | 1985-12-30 | 1987-12-01 | Liotta Domingo S | Diaphragm and method for occlusion of the descending thoracic aorta |
SU1371700A1 (en) | 1986-02-21 | 1988-02-07 | МВТУ им.Н.Э.Баумана | Prosthesis of heart valve |
CH672247A5 (en) | 1986-03-06 | 1989-11-15 | Mo Vysshee Tekhnicheskoe Uchil | |
US4878906A (en) | 1986-03-25 | 1989-11-07 | Servetus Partnership | Endoprosthesis for repairing a damaged vessel |
US4777951A (en) | 1986-09-19 | 1988-10-18 | Mansfield Scientific, Inc. | Procedure and catheter instrument for treating patients for aortic stenosis |
IL83966A (en) | 1986-09-26 | 1992-03-29 | Schering Ag | Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them |
AU613886B2 (en) | 1986-11-29 | 1991-08-15 | Terumo Kabushiki Kaisha | Catheter equipped with balloon |
US4878495A (en) | 1987-05-15 | 1989-11-07 | Joseph Grayzel | Valvuloplasty device with satellite expansion means |
US4872874A (en) | 1987-05-29 | 1989-10-10 | Taheri Syde A | Method and apparatus for transarterial aortic graft insertion and implantation |
US4796629A (en) | 1987-06-03 | 1989-01-10 | Joseph Grayzel | Stiffened dilation balloon catheter device |
US4829990A (en) | 1987-06-25 | 1989-05-16 | Thueroff Joachim | Implantable hydraulic penile erector |
JPH088933B2 (en) | 1987-07-10 | 1996-01-31 | 日本ゼオン株式会社 | Catheter |
US4851001A (en) | 1987-09-17 | 1989-07-25 | Taheri Syde A | Prosthetic valve for a blood vein and an associated method of implantation of the valve |
US5159937A (en) | 1987-09-30 | 1992-11-03 | Advanced Cardiovascular Systems, Inc. | Steerable dilatation catheter |
US4755181A (en) | 1987-10-08 | 1988-07-05 | Matrix Medica, Inc. | Anti-suture looping device for prosthetic heart valves |
US4819751A (en) | 1987-10-16 | 1989-04-11 | Baxter Travenol Laboratories, Inc. | Valvuloplasty catheter and method |
US4873978A (en) | 1987-12-04 | 1989-10-17 | Robert Ginsburg | Device and method for emboli retrieval |
JPH01290639A (en) | 1988-05-17 | 1989-11-22 | Daikin Ind Ltd | Production of 1,1,1-trifluoro-2,2-dichloroethane |
US4909252A (en) | 1988-05-26 | 1990-03-20 | The Regents Of The Univ. Of California | Perfusion balloon catheter |
US5032128A (en) | 1988-07-07 | 1991-07-16 | Medtronic, Inc. | Heart valve prosthesis |
US4917102A (en) | 1988-09-14 | 1990-04-17 | Advanced Cardiovascular Systems, Inc. | Guidewire assembly with steerable adjustable tip |
US4950227A (en) | 1988-11-07 | 1990-08-21 | Boston Scientific Corporation | Stent delivery system |
DE8815082U1 (en) | 1988-11-29 | 1989-05-18 | Biotronik Meß- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin, 1000 Berlin | Heart valve prosthesis |
US4927426A (en) | 1989-01-03 | 1990-05-22 | Dretler Stephen P | Catheter device |
US4856516A (en) | 1989-01-09 | 1989-08-15 | Cordis Corporation | Endovascular stent apparatus and method |
US4966604A (en) | 1989-01-23 | 1990-10-30 | Interventional Technologies Inc. | Expandable atherectomy cutter with flexibly bowed blades |
US4994077A (en) | 1989-04-21 | 1991-02-19 | Dobben Richard L | Artificial heart valve for implantation in a blood vessel |
CA2054728C (en) | 1989-05-31 | 2003-07-29 | Rodolfo C. Quijano | Biological valvular prosthesis |
US5609626A (en) | 1989-05-31 | 1997-03-11 | Baxter International Inc. | Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts |
US5047041A (en) | 1989-08-22 | 1991-09-10 | Samuels Peter B | Surgical apparatus for the excision of vein valves in situ |
US4986830A (en) | 1989-09-22 | 1991-01-22 | Schneider (U.S.A.) Inc. | Valvuloplasty catheter with balloon which remains stable during inflation |
US5089015A (en) | 1989-11-28 | 1992-02-18 | Promedica International | Method for implanting unstented xenografts and allografts |
US5002559A (en) | 1989-11-30 | 1991-03-26 | Numed | PTCA catheter |
US5591185A (en) | 1989-12-14 | 1997-01-07 | Corneal Contouring Development L.L.C. | Method and apparatus for reprofiling or smoothing the anterior or stromal cornea by scraping |
US5141494A (en) | 1990-02-15 | 1992-08-25 | Danforth Biomedical, Inc. | Variable wire diameter angioplasty dilatation balloon catheter |
US5238004A (en) | 1990-04-10 | 1993-08-24 | Boston Scientific Corporation | High elongation linear elastic guidewire |
US5037434A (en) | 1990-04-11 | 1991-08-06 | Carbomedics, Inc. | Bioprosthetic heart valve with elastic commissures |
DK124690D0 (en) | 1990-05-18 | 1990-05-18 | Henning Rud Andersen | FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION |
US5411552A (en) | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
US5085635A (en) | 1990-05-18 | 1992-02-04 | Cragg Andrew H | Valved-tip angiographic catheter |
US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
US5197979A (en) | 1990-09-07 | 1993-03-30 | Baxter International Inc. | Stentless heart valve and holder |
US5161547A (en) | 1990-11-28 | 1992-11-10 | Numed, Inc. | Method of forming an intravascular radially expandable stent |
US5217483A (en) | 1990-11-28 | 1993-06-08 | Numed, Inc. | Intravascular radially expandable stent |
US6165292A (en) | 1990-12-18 | 2000-12-26 | Advanced Cardiovascular Systems, Inc. | Superelastic guiding member |
US5152771A (en) | 1990-12-31 | 1992-10-06 | The Board Of Supervisors Of Louisiana State University | Valve cutter for arterial by-pass surgery |
US5282847A (en) | 1991-02-28 | 1994-02-01 | Medtronic, Inc. | Prosthetic vascular grafts with a pleated structure |
DE69222933T2 (en) | 1991-03-01 | 1998-04-02 | Applied Med Resources | CHOLANGIOGRAPHY CATHETER |
JPH05184611A (en) | 1991-03-19 | 1993-07-27 | Kenji Kusuhara | Valvular annulation retaining member and its attaching method |
US5295958A (en) | 1991-04-04 | 1994-03-22 | Shturman Cardiology Systems, Inc. | Method and apparatus for in vivo heart valve decalcification |
US5167628A (en) | 1991-05-02 | 1992-12-01 | Boyles Paul W | Aortic balloon catheter assembly for indirect infusion of the coronary arteries |
US5350398A (en) | 1991-05-13 | 1994-09-27 | Dusan Pavcnik | Self-expanding filter for percutaneous insertion |
US5397351A (en) | 1991-05-13 | 1995-03-14 | Pavcnik; Dusan | Prosthetic valve for percutaneous insertion |
IT1245750B (en) | 1991-05-24 | 1994-10-14 | Sorin Biomedica Emodialisi S R | CARDIAC VALVE PROSTHESIS, PARTICULARLY FOR REPLACING THE AORTIC VALVE |
US5209741A (en) | 1991-07-08 | 1993-05-11 | Endomedix Corporation | Surgical access device having variable post-insertion cross-sectional geometry |
US5370685A (en) | 1991-07-16 | 1994-12-06 | Stanford Surgical Technologies, Inc. | Endovascular aortic valve replacement |
US6866650B2 (en) | 1991-07-16 | 2005-03-15 | Heartport, Inc. | System for cardiac procedures |
US5571215A (en) | 1993-02-22 | 1996-11-05 | Heartport, Inc. | Devices and methods for intracardiac procedures |
US5769812A (en) | 1991-07-16 | 1998-06-23 | Heartport, Inc. | System for cardiac procedures |
CA2117088A1 (en) | 1991-09-05 | 1993-03-18 | David R. Holmes | Flexible tubular device for use in medical applications |
US5258042A (en) | 1991-12-16 | 1993-11-02 | Henry Ford Health System | Intravascular hydrogel implant |
US5756476A (en) | 1992-01-14 | 1998-05-26 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibition of cell proliferation using antisense oligonucleotides |
US5507767A (en) | 1992-01-15 | 1996-04-16 | Cook Incorporated | Spiral stent |
EP0552579B1 (en) | 1992-01-22 | 1996-01-03 | Guy-Henri Muller | Prosthetic implants for plastic surgery |
US5489297A (en) | 1992-01-27 | 1996-02-06 | Duran; Carlos M. G. | Bioprosthetic heart valve with absorbable stent |
US5163953A (en) | 1992-02-10 | 1992-11-17 | Vince Dennis J | Toroidal artificial heart valve stent |
US5258023A (en) | 1992-02-12 | 1993-11-02 | Reger Medical Development, Inc. | Prosthetic heart valve |
AU678350B2 (en) | 1992-05-08 | 1997-05-29 | Schneider (Usa) Inc. | Esophageal stent and delivery tool |
US5332402A (en) | 1992-05-12 | 1994-07-26 | Teitelbaum George P | Percutaneously-inserted cardiac valve |
US5409019A (en) | 1992-10-30 | 1995-04-25 | Wilk; Peter J. | Coronary artery by-pass method |
JP2935751B2 (en) | 1993-01-14 | 1999-08-16 | ミードックス メディカルズ インコーポレイテッド | Radially expandable tubular prosthesis |
US5713951A (en) | 1993-02-22 | 1998-02-03 | Heartport, Inc. | Thoracoscopic valve prosthesis delivery device |
US5431676A (en) | 1993-03-05 | 1995-07-11 | Innerdyne Medical, Inc. | Trocar system having expandable port |
US5772609A (en) | 1993-05-11 | 1998-06-30 | Target Therapeutics, Inc. | Guidewire with variable flexibility due to polymeric coatings |
US5480423A (en) | 1993-05-20 | 1996-01-02 | Boston Scientific Corporation | Prosthesis delivery |
GB9312666D0 (en) | 1993-06-18 | 1993-08-04 | Vesely Ivan | Bioprostetic heart valve |
US5415633A (en) | 1993-07-28 | 1995-05-16 | Active Control Experts, Inc. | Remotely steered catheterization device |
US5443495A (en) | 1993-09-17 | 1995-08-22 | Scimed Lifesystems Inc. | Polymerization angioplasty balloon implant device |
KR970004845Y1 (en) | 1993-09-27 | 1997-05-21 | 주식회사 수호메디테크 | Stent for expanding a lumen |
US5545209A (en) | 1993-09-30 | 1996-08-13 | Texas Petrodet, Inc. | Controlled deployment of a medical device |
US5389106A (en) | 1993-10-29 | 1995-02-14 | Numed, Inc. | Impermeable expandable intravascular stent |
US5713950A (en) | 1993-11-01 | 1998-02-03 | Cox; James L. | Method of replacing heart valves using flexible tubes |
US5480424A (en) | 1993-11-01 | 1996-01-02 | Cox; James L. | Heart valve replacement using flexible tubes |
EP0657147B1 (en) | 1993-11-04 | 1999-08-04 | C.R. Bard, Inc. | Non-migrating vascular prosthesis |
RU2089131C1 (en) | 1993-12-28 | 1997-09-10 | Сергей Апполонович Пульнев | Stent-expander |
US5476506A (en) | 1994-02-08 | 1995-12-19 | Ethicon, Inc. | Bi-directional crimped graft |
US5609627A (en) | 1994-02-09 | 1997-03-11 | Boston Scientific Technology, Inc. | Method for delivering a bifurcated endoluminal prosthesis |
US5443477A (en) | 1994-02-10 | 1995-08-22 | Stentco, Inc. | Apparatus and method for deployment of radially expandable stents by a mechanical linkage |
US5549663A (en) | 1994-03-09 | 1996-08-27 | Cordis Corporation | Endoprosthesis having graft member and exposed welded end junctions, method and procedure |
US5556413A (en) | 1994-03-11 | 1996-09-17 | Advanced Cardiovascular Systems, Inc. | Coiled stent with locking ends |
US5476510A (en) | 1994-04-21 | 1995-12-19 | Medtronic, Inc. | Holder for heart valve |
DE4415359C2 (en) | 1994-05-02 | 1997-10-23 | Aesculap Ag | Surgical tubular shaft instrument |
US6139510A (en) | 1994-05-11 | 2000-10-31 | Target Therapeutics Inc. | Super elastic alloy guidewire |
US5765418A (en) | 1994-05-16 | 1998-06-16 | Medtronic, Inc. | Method for making an implantable medical device from a refractory metal |
US5824041A (en) | 1994-06-08 | 1998-10-20 | Medtronic, Inc. | Apparatus and methods for placement and repositioning of intraluminal prostheses |
US5728068A (en) | 1994-06-14 | 1998-03-17 | Cordis Corporation | Multi-purpose balloon catheter |
ES2340142T3 (en) | 1994-07-08 | 2010-05-31 | Ev3 Inc. | SYSTEM TO CARRY OUT AN INTRAVASCULAR PROCEDURE. |
DE4424242A1 (en) | 1994-07-09 | 1996-01-11 | Ernst Peter Prof Dr M Strecker | Endoprosthesis implantable percutaneously in a patient's body |
US5554185A (en) | 1994-07-18 | 1996-09-10 | Block; Peter C. | Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same |
US5545133A (en) | 1994-09-16 | 1996-08-13 | Scimed Life Systems, Inc. | Balloon catheter with improved pressure source |
TR199501643A2 (en) | 1994-12-21 | 1996-07-21 | Nova Nordisk As | Method for the treatment of wool with enzymes. |
US5674277A (en) | 1994-12-23 | 1997-10-07 | Willy Rusch Ag | Stent for placement in a body tube |
BE1009085A3 (en) | 1995-02-10 | 1996-11-05 | De Fays Robert Dr | Intra-aortic prosthesis and surgical instruments for the introduction, implementation and fixing in the aortic prosthesis. |
US5575818A (en) | 1995-02-14 | 1996-11-19 | Corvita Corporation | Endovascular stent with locking ring |
EP0810845A2 (en) | 1995-02-22 | 1997-12-10 | Menlo Care Inc. | Covered expanding mesh stent |
DE69626105T2 (en) | 1995-03-30 | 2003-10-23 | Heartport, Inc. | ENDOVASCULAR CATHETER FOR LEADING FROM THE HEART |
WO1996030072A1 (en) | 1995-03-30 | 1996-10-03 | Heartport, Inc. | System and methods for performing endovascular procedures |
US5709713A (en) | 1995-03-31 | 1998-01-20 | Cardiovascular Concepts, Inc. | Radially expansible vascular prosthesis having reversible and other locking structures |
US5667523A (en) | 1995-04-28 | 1997-09-16 | Impra, Inc. | Dual supported intraluminal graft |
US5824064A (en) | 1995-05-05 | 1998-10-20 | Taheri; Syde A. | Technique for aortic valve replacement with simultaneous aortic arch graft insertion and apparatus therefor |
US5534007A (en) | 1995-05-18 | 1996-07-09 | Scimed Life Systems, Inc. | Stent deployment catheter with collapsible sheath |
US5571175A (en) | 1995-06-07 | 1996-11-05 | St. Jude Medical, Inc. | Suture guard for prosthetic heart valve |
US5728152A (en) | 1995-06-07 | 1998-03-17 | St. Jude Medical, Inc. | Bioresorbable heart valve support |
US5716417A (en) | 1995-06-07 | 1998-02-10 | St. Jude Medical, Inc. | Integral supporting structure for bioprosthetic heart valve |
DE19532846A1 (en) | 1995-09-06 | 1997-03-13 | Georg Dr Berg | Valve for use in heart |
US5807405A (en) | 1995-09-11 | 1998-09-15 | St. Jude Medical, Inc. | Apparatus for attachment of heart valve holder to heart valve prosthesis |
US5735842A (en) | 1995-09-11 | 1998-04-07 | St. Jude Medical, Inc. | Low profile manipulators for heart valve prostheses |
US6287336B1 (en) | 1995-10-16 | 2001-09-11 | Medtronic, Inc. | Variable flexibility stent |
US5591195A (en) | 1995-10-30 | 1997-01-07 | Taheri; Syde | Apparatus and method for engrafting a blood vessel |
DE19546692C2 (en) | 1995-12-14 | 2002-11-07 | Hans-Reiner Figulla | Self-expanding heart valve prosthesis for implantation in the human body via a catheter system |
US5861028A (en) | 1996-09-09 | 1999-01-19 | Shelhigh Inc | Natural tissue heart valve and stent prosthesis and method for making the same |
US5855602A (en) | 1996-09-09 | 1999-01-05 | Shelhigh, Inc. | Heart valve prosthesis |
ATE290832T1 (en) | 1996-01-05 | 2005-04-15 | Medtronic Inc | EXPANDABLE ENDOLUMINAL PROSTHESES |
US5843158A (en) | 1996-01-05 | 1998-12-01 | Medtronic, Inc. | Limited expansion endoluminal prostheses and methods for their use |
WO1997027959A1 (en) | 1996-01-30 | 1997-08-07 | Medtronic, Inc. | Articles for and methods of making stents |
JPH09215753A (en) | 1996-02-08 | 1997-08-19 | Schneider Usa Inc | Self-expanding stent made of titanium alloy |
US6402736B1 (en) | 1996-02-16 | 2002-06-11 | Joe E. Brown | Apparatus and method for filtering intravascular fluids and for delivering diagnostic and therapeutic agents |
US5716370A (en) | 1996-02-23 | 1998-02-10 | Williamson, Iv; Warren | Means for replacing a heart valve in a minimally invasive manner |
US6402780B2 (en) | 1996-02-23 | 2002-06-11 | Cardiovascular Technologies, L.L.C. | Means and method of replacing a heart valve in a minimally invasive manner |
US5695498A (en) | 1996-02-28 | 1997-12-09 | Numed, Inc. | Stent implantation system |
US5720391A (en) | 1996-03-29 | 1998-02-24 | St. Jude Medical, Inc. | Packaging and holder for heart valve prosthesis |
US5891191A (en) | 1996-04-30 | 1999-04-06 | Schneider (Usa) Inc | Cobalt-chromium-molybdenum alloy stent and stent-graft |
US5885228A (en) | 1996-05-08 | 1999-03-23 | Heartport, Inc. | Valve sizer and method of use |
WO1997042879A1 (en) | 1996-05-14 | 1997-11-20 | Embol-X, Inc. | Aortic occluder with associated filter and methods of use during cardiac surgery |
DE69719237T2 (en) | 1996-05-23 | 2003-11-27 | Samsung Electronics Co., Ltd. | Flexible, self-expandable stent and method for its manufacture |
US7238197B2 (en) | 2000-05-30 | 2007-07-03 | Devax, Inc. | Endoprosthesis deployment system for treating vascular bifurcations |
JP4014226B2 (en) | 1996-06-20 | 2007-11-28 | ヴァスキュテック リミテッド | Repair of the body's path by prosthesis |
US5855601A (en) | 1996-06-21 | 1999-01-05 | The Trustees Of Columbia University In The City Of New York | Artificial heart valve and method and device for implanting the same |
US5662671A (en) | 1996-07-17 | 1997-09-02 | Embol-X, Inc. | Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries |
US5755783A (en) | 1996-07-29 | 1998-05-26 | Stobie; Robert | Suture rings for rotatable artificial heart valves |
US6764509B2 (en) | 1996-09-06 | 2004-07-20 | Carbomedics Inc. | Prosthetic heart valve with surface modification |
US6702851B1 (en) | 1996-09-06 | 2004-03-09 | Joseph A. Chinn | Prosthetic heart valve with surface modification |
US5800531A (en) | 1996-09-30 | 1998-09-01 | Baxter International Inc. | Bioprosthetic heart valve implantation device |
US6022370A (en) | 1996-10-01 | 2000-02-08 | Numed, Inc. | Expandable stent |
US5749890A (en) | 1996-12-03 | 1998-05-12 | Shaknovich; Alexander | Method and system for stent placement in ostial lesions |
NL1004827C2 (en) | 1996-12-18 | 1998-06-19 | Surgical Innovations Vof | Device for regulating blood circulation. |
EP0850607A1 (en) | 1996-12-31 | 1998-07-01 | Cordis Corporation | Valve prosthesis for implantation in body channels |
GB9701479D0 (en) | 1997-01-24 | 1997-03-12 | Aortech Europ Ltd | Heart valve |
US6241757B1 (en) | 1997-02-04 | 2001-06-05 | Solco Surgical Instrument Co., Ltd. | Stent for expanding body's lumen |
CA2281519A1 (en) | 1997-02-19 | 1998-08-27 | Condado Medical Devices Corporation | Multi-purpose catheters, catheter systems, and radiation treatment |
US6152946A (en) | 1998-03-05 | 2000-11-28 | Scimed Life Systems, Inc. | Distal protection device and method |
US5830229A (en) | 1997-03-07 | 1998-11-03 | Micro Therapeutics Inc. | Hoop stent |
US6416510B1 (en) | 1997-03-13 | 2002-07-09 | Biocardia, Inc. | Drug delivery catheters that attach to tissue and methods for their use |
US5817126A (en) | 1997-03-17 | 1998-10-06 | Surface Genesis, Inc. | Compound stent |
US5824053A (en) | 1997-03-18 | 1998-10-20 | Endotex Interventional Systems, Inc. | Helical mesh endoprosthesis and methods of use |
US5824055A (en) | 1997-03-25 | 1998-10-20 | Endotex Interventional Systems, Inc. | Stent graft delivery system and methods of use |
US5928281A (en) | 1997-03-27 | 1999-07-27 | Baxter International Inc. | Tissue heart valves |
US5868783A (en) | 1997-04-16 | 1999-02-09 | Numed, Inc. | Intravascular stent with limited axial shrinkage |
US5860966A (en) | 1997-04-16 | 1999-01-19 | Numed, Inc. | Method of securing a stent on a balloon catheter |
JP4083241B2 (en) | 1997-04-23 | 2008-04-30 | アーテミス・メディカル・インコーポレイテッド | Bifurcated stent and distal protection system |
US5957949A (en) | 1997-05-01 | 1999-09-28 | World Medical Manufacturing Corp. | Percutaneous placement valve stent |
US6206917B1 (en) | 1997-05-02 | 2001-03-27 | St. Jude Medical, Inc. | Differential treatment of prosthetic devices |
US6245102B1 (en) | 1997-05-07 | 2001-06-12 | Iowa-India Investments Company Ltd. | Stent, stent graft and stent valve |
US6162245A (en) | 1997-05-07 | 2000-12-19 | Iowa-India Investments Company Limited | Stent valve and stent graft |
US5855597A (en) | 1997-05-07 | 1999-01-05 | Iowa-India Investments Co. Limited | Stent valve and stent graft for percutaneous surgery |
US5911734A (en) | 1997-05-08 | 1999-06-15 | Embol-X, Inc. | Percutaneous catheter and guidewire having filter and medical device deployment capabilities |
US6676682B1 (en) | 1997-05-08 | 2004-01-13 | Scimed Life Systems, Inc. | Percutaneous catheter and guidewire having filter and medical device deployment capabilities |
US6258120B1 (en) | 1997-12-23 | 2001-07-10 | Embol-X, Inc. | Implantable cerebral protection device and methods of use |
JP3645399B2 (en) | 1997-06-09 | 2005-05-11 | 住友金属工業株式会社 | Endovascular stent |
AU8337898A (en) | 1997-06-17 | 1999-01-04 | Sante Camilli | Implantable valve for blood vessels |
US5861024A (en) | 1997-06-20 | 1999-01-19 | Cardiac Assist Devices, Inc | Electrophysiology catheter and remote actuator therefor |
US5906619A (en) | 1997-07-24 | 1999-05-25 | Medtronic, Inc. | Disposable delivery device for endoluminal prostheses |
US6340367B1 (en) | 1997-08-01 | 2002-01-22 | Boston Scientific Scimed, Inc. | Radiopaque markers and methods of using the same |
US5984957A (en) | 1997-08-12 | 1999-11-16 | Schneider (Usa) Inc | Radially expanded prostheses with axial diameter control |
US5954766A (en) | 1997-09-16 | 1999-09-21 | Zadno-Azizi; Gholam-Reza | Body fluid flow control device |
US6056722A (en) | 1997-09-18 | 2000-05-02 | Iowa-India Investments Company Limited Of Douglas | Delivery mechanism for balloons, drugs, stents and other physical/mechanical agents and methods of use |
US5984959A (en) | 1997-09-19 | 1999-11-16 | United States Surgical | Heart valve replacement tools and procedures |
US5925063A (en) | 1997-09-26 | 1999-07-20 | Khosravi; Farhad | Coiled sheet valve, filter or occlusive device and methods of use |
US6361545B1 (en) | 1997-09-26 | 2002-03-26 | Cardeon Corporation | Perfusion filter catheter |
US6071308A (en) | 1997-10-01 | 2000-06-06 | Boston Scientific Corporation | Flexible metal wire stent |
ATE452598T1 (en) | 1997-11-07 | 2010-01-15 | Salviac Ltd | EMBOLIC PROTECTION DEVICE |
AU1675199A (en) | 1997-12-15 | 1999-07-05 | Domnick Hunter Limited | Filter assembly |
US6695864B2 (en) | 1997-12-15 | 2004-02-24 | Cardeon Corporation | Method and apparatus for cerebral embolic protection |
US6165209A (en) | 1997-12-15 | 2000-12-26 | Prolifix Medical, Inc. | Vascular stent for reduction of restenosis |
CA2315211A1 (en) | 1997-12-29 | 1999-07-08 | The Cleveland Clinic Foundation | System for minimally invasive insertion of a bioprosthetic heart valve |
US6530952B2 (en) | 1997-12-29 | 2003-03-11 | The Cleveland Clinic Foundation | Bioprosthetic cardiovascular valve system |
US6096074A (en) | 1998-01-27 | 2000-08-01 | United States Surgical | Stapling apparatus and method for heart valve replacement |
US5944738A (en) | 1998-02-06 | 1999-08-31 | Aga Medical Corporation | Percutaneous catheter directed constricting occlusion device |
JP2003522550A (en) | 1998-02-10 | 2003-07-29 | アーテミス・メディカル・インコーポレイテッド | Occlusion, fixation, tensioning, and diverting devices and methods of use |
WO1999039648A1 (en) | 1998-02-10 | 1999-08-12 | Dubrul William R | Entrapping apparatus and method for use |
EP0935978A1 (en) | 1998-02-16 | 1999-08-18 | Medicorp S.A. | Angioplasty and stent delivery catheter |
US6623521B2 (en) | 1998-02-17 | 2003-09-23 | Md3, Inc. | Expandable stent with sliding and locking radial elements |
US6280467B1 (en) | 1998-02-26 | 2001-08-28 | World Medical Manufacturing Corporation | Delivery system for deployment and endovascular assembly of a multi-stage stented graft |
US5938697A (en) | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US7491232B2 (en) | 1998-09-18 | 2009-02-17 | Aptus Endosystems, Inc. | Catheter-based fastener implantation apparatus and methods with implantation force resolution |
EP0943300A1 (en) | 1998-03-17 | 1999-09-22 | Medicorp S.A. | Reversible action endoprosthesis delivery device. |
US6776791B1 (en) | 1998-04-01 | 2004-08-17 | Endovascular Technologies, Inc. | Stent and method and device for packing of same |
US6074418A (en) | 1998-04-20 | 2000-06-13 | St. Jude Medical, Inc. | Driver tool for heart valve prosthesis fasteners |
US6450989B2 (en) | 1998-04-27 | 2002-09-17 | Artemis Medical, Inc. | Dilating and support apparatus with disease inhibitors and methods for use |
US6319241B1 (en) | 1998-04-30 | 2001-11-20 | Medtronic, Inc. | Techniques for positioning therapy delivery elements within a spinal cord or a brain |
US6059827A (en) | 1998-05-04 | 2000-05-09 | Axya Medical, Inc. | Sutureless cardiac valve prosthesis, and devices and methods for implanting them |
JP4583597B2 (en) | 1998-05-05 | 2010-11-17 | ボストン サイエンティフィック リミテッド | Smooth end stent |
US6352554B2 (en) | 1998-05-08 | 2002-03-05 | Sulzer Vascutek Limited | Prosthetic tubular aortic conduit and method for manufacturing the same |
US6093203A (en) | 1998-05-13 | 2000-07-25 | Uflacker; Renan | Stent or graft support structure for treating bifurcated vessels having different diameter portions and methods of use and implantation |
US7452371B2 (en) | 1999-06-02 | 2008-11-18 | Cook Incorporated | Implantable vascular device |
AU754156B2 (en) | 1998-06-02 | 2002-11-07 | Cook Incorporated | Multiple-sided intraluminal medical device |
US6630001B2 (en) | 1998-06-24 | 2003-10-07 | International Heart Institute Of Montana Foundation | Compliant dehyrated tissue for implantation and process of making the same |
AU749930B2 (en) | 1998-07-10 | 2002-07-04 | Shin Ishimaru | Stent (or stent graft) indwelling device |
US6159239A (en) | 1998-08-14 | 2000-12-12 | Prodesco, Inc. | Woven stent/graft structure |
US6179860B1 (en) | 1998-08-19 | 2001-01-30 | Artemis Medical, Inc. | Target tissue localization device and method |
US6312461B1 (en) | 1998-08-21 | 2001-11-06 | John D. Unsworth | Shape memory tubular stent |
US6358276B1 (en) | 1998-09-30 | 2002-03-19 | Impra, Inc. | Fluid containing endoluminal stent |
US6051014A (en) | 1998-10-13 | 2000-04-18 | Embol-X, Inc. | Percutaneous filtration catheter for valve repair surgery and methods of use |
US6475239B1 (en) | 1998-10-13 | 2002-11-05 | Sulzer Carbomedics Inc. | Method for making polymer heart valves with leaflets having uncut free edges |
US6254612B1 (en) | 1998-10-22 | 2001-07-03 | Cordis Neurovascular, Inc. | Hydraulic stent deployment system |
US6146366A (en) | 1998-11-03 | 2000-11-14 | Ras Holding Corp | Device for the treatment of macular degeneration and other eye disorders |
US6508803B1 (en) | 1998-11-06 | 2003-01-21 | Furukawa Techno Material Co., Ltd. | Niti-type medical guide wire and method of producing the same |
US6214036B1 (en) | 1998-11-09 | 2001-04-10 | Cordis Corporation | Stent which is easily recaptured and repositioned within the body |
US6336937B1 (en) | 1998-12-09 | 2002-01-08 | Gore Enterprise Holdings, Inc. | Multi-stage expandable stent-graft |
DE19857887B4 (en) | 1998-12-15 | 2005-05-04 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Anchoring support for a heart valve prosthesis |
US6363938B2 (en) | 1998-12-22 | 2002-04-02 | Angiotrax, Inc. | Methods and apparatus for perfusing tissue and/or stimulating revascularization and tissue growth |
FR2788217A1 (en) | 1999-01-12 | 2000-07-13 | Brice Letac | PROSTHETIC VALVE IMPLANTABLE BY CATHETERISM, OR SURGICAL |
US6736845B2 (en) | 1999-01-26 | 2004-05-18 | Edwards Lifesciences Corporation | Holder for flexible heart valve |
DK1154738T3 (en) | 1999-01-27 | 2010-07-26 | Medtronic Inc | Cardiac arrest devices |
US6896690B1 (en) | 2000-01-27 | 2005-05-24 | Viacor, Inc. | Cardiac valve procedure methods and devices |
AU766108C (en) | 1999-02-01 | 2004-07-22 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
EP1576937B1 (en) | 1999-02-01 | 2012-10-31 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delvery of the same |
WO2000044309A2 (en) | 1999-02-01 | 2000-08-03 | Board Of Regents, The University Of Texas System | Woven bifurcated and trifurcated stents and methods for making the same |
DE19904975A1 (en) | 1999-02-06 | 2000-09-14 | Impella Cardiotech Ag | Device for intravascular heart valve surgery |
US6425916B1 (en) | 1999-02-10 | 2002-07-30 | Michi E. Garrison | Methods and devices for implanting cardiac valves |
US20020138094A1 (en) | 1999-02-12 | 2002-09-26 | Thomas Borillo | Vascular filter system |
DE19907646A1 (en) | 1999-02-23 | 2000-08-24 | Georg Berg | Valve for blood vessels uses flap holders and counterpart holders on stent to latch together in place and all channeled for guide wire. |
US6171327B1 (en) | 1999-02-24 | 2001-01-09 | Scimed Life Systems, Inc. | Intravascular filter and method |
US6905743B1 (en) | 1999-02-25 | 2005-06-14 | Boston Scientific Scimed, Inc. | Dimensionally stable balloons |
US6231551B1 (en) | 1999-03-01 | 2001-05-15 | Coaxia, Inc. | Partial aortic occlusion devices and methods for cerebral perfusion augmentation |
US6743196B2 (en) | 1999-03-01 | 2004-06-01 | Coaxia, Inc. | Partial aortic occlusion devices and methods for cerebral perfusion augmentation |
IL128938A0 (en) | 1999-03-11 | 2000-02-17 | Mind Guard Ltd | Implantable stroke treating device |
US6673089B1 (en) | 1999-03-11 | 2004-01-06 | Mindguard Ltd. | Implantable stroke treating device |
US6319281B1 (en) | 1999-03-22 | 2001-11-20 | Kumar R. Patel | Artificial venous valve and sizing catheter |
US7226467B2 (en) | 1999-04-09 | 2007-06-05 | Evalve, Inc. | Fixation device delivery catheter, systems and methods of use |
US6309417B1 (en) | 1999-05-12 | 2001-10-30 | Paul A. Spence | Heart valve and apparatus for replacement thereof |
WO2000067661A2 (en) | 1999-05-12 | 2000-11-16 | Spence Paul A | Heart valve and apparatus for replacement thereof, blood vessel leak detector and temporary pacemaker lead |
US6858034B1 (en) | 1999-05-20 | 2005-02-22 | Scimed Life Systems, Inc. | Stent delivery system for prevention of kinking, and method of loading and using same |
US6790229B1 (en) | 1999-05-25 | 2004-09-14 | Eric Berreklouw | Fixing device, in particular for fixing to vascular wall tissue |
JP3755862B2 (en) | 1999-05-26 | 2006-03-15 | キヤノン株式会社 | Synchronized position control apparatus and method |
EP1057460A1 (en) | 1999-06-01 | 2000-12-06 | Numed, Inc. | Replacement valve assembly and method of implanting same |
EP1057459A1 (en) | 1999-06-01 | 2000-12-06 | Numed, Inc. | Radially expandable stent |
US7628803B2 (en) | 2001-02-05 | 2009-12-08 | Cook Incorporated | Implantable vascular device |
AU6000200A (en) | 1999-07-16 | 2001-02-05 | Biocompatibles Limited | Braided stent |
US6179859B1 (en) | 1999-07-16 | 2001-01-30 | Baff Llc | Emboli filtration system and methods of use |
US6544279B1 (en) | 2000-08-09 | 2003-04-08 | Incept, Llc | Vascular device for emboli, thrombus and foreign body removal and methods of use |
US6371970B1 (en) | 1999-07-30 | 2002-04-16 | Incept Llc | Vascular filter having articulation region and methods of use in the ascending aorta |
US6142987A (en) | 1999-08-03 | 2000-11-07 | Scimed Life Systems, Inc. | Guided filter with support wire and methods of use |
US6346116B1 (en) | 1999-08-03 | 2002-02-12 | Medtronic Ave, Inc. | Distal protection device |
US6168579B1 (en) | 1999-08-04 | 2001-01-02 | Scimed Life Systems, Inc. | Filter flush system and methods of use |
US6235044B1 (en) | 1999-08-04 | 2001-05-22 | Scimed Life Systems, Inc. | Percutaneous catheter and guidewire for filtering during ablation of mycardial or vascular tissue |
US6299637B1 (en) | 1999-08-20 | 2001-10-09 | Samuel M. Shaolian | Transluminally implantable venous valve |
US6187016B1 (en) | 1999-09-14 | 2001-02-13 | Daniel G. Hedges | Stent retrieval device |
US6829497B2 (en) | 1999-09-21 | 2004-12-07 | Jamil Mogul | Steerable diagnostic catheters |
IT1307268B1 (en) | 1999-09-30 | 2001-10-30 | Sorin Biomedica Cardio Spa | DEVICE FOR HEART VALVE REPAIR OR REPLACEMENT. |
US6371983B1 (en) | 1999-10-04 | 2002-04-16 | Ernest Lane | Bioprosthetic heart valve |
US6364895B1 (en) | 1999-10-07 | 2002-04-02 | Prodesco, Inc. | Intraluminal filter |
FR2799364B1 (en) | 1999-10-12 | 2001-11-23 | Jacques Seguin | MINIMALLY INVASIVE CANCELING DEVICE |
US6383171B1 (en) | 1999-10-12 | 2002-05-07 | Allan Will | Methods and devices for protecting a passageway in a body when advancing devices through the passageway |
US6352708B1 (en) | 1999-10-14 | 2002-03-05 | The International Heart Institute Of Montana Foundation | Solution and method for treating autologous tissue for implant operation |
WO2001026584A1 (en) | 1999-10-14 | 2001-04-19 | United Stenting, Inc. | Stents with multilayered struts |
US6440164B1 (en) | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
US6585758B1 (en) | 1999-11-16 | 2003-07-01 | Scimed Life Systems, Inc. | Multi-section filamentary endoluminal stent |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
FR2815844B1 (en) | 2000-10-31 | 2003-01-17 | Jacques Seguin | TUBULAR SUPPORT FOR THE PERCUTANEOUS POSITIONING OF A REPLACEMENT HEART VALVE |
FR2800984B1 (en) | 1999-11-17 | 2001-12-14 | Jacques Seguin | DEVICE FOR REPLACING A HEART VALVE PERCUTANEOUSLY |
US7018406B2 (en) | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
US6849085B2 (en) | 1999-11-19 | 2005-02-01 | Advanced Bio Prosthetic Surfaces, Ltd. | Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same |
US7195641B2 (en) | 1999-11-19 | 2007-03-27 | Advanced Bio Prosthetic Surfaces, Ltd. | Valvular prostheses having metal or pseudometallic construction and methods of manufacture |
US6379383B1 (en) | 1999-11-19 | 2002-04-30 | Advanced Bio Prosthetic Surfaces, Ltd. | Endoluminal device exhibiting improved endothelialization and method of manufacture thereof |
US6458153B1 (en) | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
BR0107897A (en) | 2000-01-27 | 2002-11-05 | 3F Therapeutics Inc | Prosthetic heart valve without stent, semi-lunar heart valve without stent, process for producing a prosthetic tubular heart valve without stent, process for making a prosthetic heart valve, and, process for producing a prosthetic valve |
US6872226B2 (en) | 2001-01-29 | 2005-03-29 | 3F Therapeutics, Inc. | Method of cutting material for use in implantable medical device |
PL211544B1 (en) | 2000-01-31 | 2012-05-31 | Cook Biotech Inc | Heart valve device containing set of valve stent |
US6652571B1 (en) | 2000-01-31 | 2003-11-25 | Scimed Life Systems, Inc. | Braided, branched, implantable device and processes for manufacture thereof |
US6622604B1 (en) | 2000-01-31 | 2003-09-23 | Scimed Life Systems, Inc. | Process for manufacturing a braided bifurcated stent |
US6398807B1 (en) | 2000-01-31 | 2002-06-04 | Scimed Life Systems, Inc. | Braided branching stent, method for treating a lumen therewith, and process for manufacture therefor |
US6797002B2 (en) | 2000-02-02 | 2004-09-28 | Paul A. Spence | Heart valve repair apparatus and methods |
US6821297B2 (en) | 2000-02-02 | 2004-11-23 | Robert V. Snyders | Artificial heart valve, implantation instrument and method therefor |
US20050267560A1 (en) | 2000-02-03 | 2005-12-01 | Cook Incorporated | Implantable bioabsorbable valve support frame |
US6540768B1 (en) | 2000-02-09 | 2003-04-01 | Cordis Corporation | Vascular filter system |
US6344044B1 (en) | 2000-02-11 | 2002-02-05 | Edwards Lifesciences Corp. | Apparatus and methods for delivery of intraluminal prosthesis |
DE10010073B4 (en) | 2000-02-28 | 2005-12-22 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Anchoring for implantable heart valve prostheses |
DE10010074B4 (en) | 2000-02-28 | 2005-04-14 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Device for fastening and anchoring heart valve prostheses |
EP1253871B1 (en) | 2000-03-10 | 2007-02-14 | Anthony T. Don Michael | Vascular embolism preventon device employing filters |
US6695865B2 (en) | 2000-03-20 | 2004-02-24 | Advanced Bio Prosthetic Surfaces, Ltd. | Embolic protection device |
US6468303B1 (en) | 2000-03-27 | 2002-10-22 | Aga Medical Corporation | Retrievable self expanding shunt |
US6454799B1 (en) | 2000-04-06 | 2002-09-24 | Edwards Lifesciences Corporation | Minimally-invasive heart valves and methods of use |
GB2369575A (en) | 2000-04-20 | 2002-06-05 | Salviac Ltd | An embolic protection system |
US7686842B2 (en) | 2000-05-04 | 2010-03-30 | Oregon Health Sciences University | Endovascular stent graft |
IL136213A0 (en) | 2000-05-17 | 2001-05-20 | Xtent Medical Inc | Selectively expandable and releasable stent |
US20050043757A1 (en) | 2000-06-12 | 2005-02-24 | Michael Arad | Medical devices formed from shape memory alloys displaying a stress-retained martensitic state and method for use thereof |
SE522805C2 (en) | 2000-06-22 | 2004-03-09 | Jan Otto Solem | Stent Application System |
US6527800B1 (en) | 2000-06-26 | 2003-03-04 | Rex Medical, L.P. | Vascular device and method for valve leaflet apposition |
US6676698B2 (en) | 2000-06-26 | 2004-01-13 | Rex Medicol, L.P. | Vascular device with valve for approximating vessel wall |
EP1401358B1 (en) | 2000-06-30 | 2016-08-17 | Medtronic, Inc. | Apparatus for performing a procedure on a cardiac valve |
US6419696B1 (en) | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
US6572643B1 (en) | 2000-07-19 | 2003-06-03 | Vascular Architects, Inc. | Endoprosthesis delivery catheter assembly and method |
ES2365208T3 (en) | 2000-07-24 | 2011-09-26 | Jeffrey Grayzel | CATHETER WITH RIGIDIZED BALLOON FOR DILATATION AND IMPLEMENTATION OF ENDOVASCULAR PROSTHESIS. |
US6773454B2 (en) | 2000-08-02 | 2004-08-10 | Michael H. Wholey | Tapered endovascular stent graft and method of treating abdominal aortic aneurysms and distal iliac aneurysms |
US6485501B1 (en) | 2000-08-11 | 2002-11-26 | Cordis Corporation | Vascular filter system with guidewire and capture mechanism |
US6572652B2 (en) | 2000-08-29 | 2003-06-03 | Venpro Corporation | Method and devices for decreasing elevated pulmonary venous pressure |
US6543610B1 (en) | 2000-09-12 | 2003-04-08 | Alok Nigam | System for packaging and handling an implant and method of use |
US7510572B2 (en) | 2000-09-12 | 2009-03-31 | Shlomo Gabbay | Implantation system for delivery of a heart valve prosthesis |
US7381220B2 (en) | 2000-09-20 | 2008-06-03 | Ample Medical, Inc. | Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet |
US6893459B1 (en) | 2000-09-20 | 2005-05-17 | Ample Medical, Inc. | Heart valve annulus device and method of using same |
US6461382B1 (en) | 2000-09-22 | 2002-10-08 | Edwards Lifesciences Corporation | Flexible heart valve having moveable commissures |
US6602288B1 (en) | 2000-10-05 | 2003-08-05 | Edwards Lifesciences Corporation | Minimally-invasive annuloplasty repair segment delivery template, system and method of use |
DE10049813C1 (en) | 2000-10-09 | 2002-04-18 | Universitaetsklinikum Freiburg | Instrument for the local removal of built-up matter at an aortic valve, in a human or animal heart, is a hollow catheter with a cutting unit at the far end within a closure cap for minimum invasion |
DE10049814B4 (en) | 2000-10-09 | 2006-10-19 | Universitätsklinikum Freiburg | Device for supporting surgical procedures within a vessel, in particular for minimally invasive explantation and implantation of heart valves |
DE10049815B4 (en) | 2000-10-09 | 2005-10-13 | Universitätsklinikum Freiburg | Device for local ablation of an aortic valve on the human or animal heart |
DE10049812B4 (en) | 2000-10-09 | 2004-06-03 | Universitätsklinikum Freiburg | Device for filtering out macroscopic particles from the bloodstream during local removal of an aortic valve on the human or animal heart |
EP1326672A4 (en) | 2000-10-18 | 2007-03-07 | Nmt Medical Inc | Over-the-wire interlock attachment/detachment mechanism |
EP1341435A4 (en) | 2000-11-07 | 2005-08-17 | Artemis Medical Inc | Tissue separator assembly and method |
US6482228B1 (en) | 2000-11-14 | 2002-11-19 | Troy R. Norred | Percutaneous aortic valve replacement |
US6843802B1 (en) | 2000-11-16 | 2005-01-18 | Cordis Corporation | Delivery apparatus for a self expanding retractable stent |
CA2436803C (en) | 2000-11-21 | 2009-09-15 | Rex Medical, L.P. | Percutaneous aortic valve |
US6974476B2 (en) | 2003-05-05 | 2005-12-13 | Rex Medical, L.P. | Percutaneous aortic valve |
EP1347794A2 (en) | 2000-11-27 | 2003-10-01 | Medtronic, Inc. | Stents and methods for preparing stents from wires having hydrogel coating layers thereon |
US6953332B1 (en) | 2000-11-28 | 2005-10-11 | St. Jude Medical, Inc. | Mandrel for use in forming valved prostheses having polymer leaflets by dip coating |
US6663588B2 (en) | 2000-11-29 | 2003-12-16 | C.R. Bard, Inc. | Active counterforce handle for use in bidirectional deflectable tip instruments |
US6494909B2 (en) | 2000-12-01 | 2002-12-17 | Prodesco, Inc. | Endovascular valve |
US20040093075A1 (en) | 2000-12-15 | 2004-05-13 | Titus Kuehne | Stent with valve and method of use thereof |
US6471708B2 (en) | 2000-12-21 | 2002-10-29 | Bausch & Lomb Incorporated | Intraocular lens and additive packaging system |
US20020120328A1 (en) | 2000-12-21 | 2002-08-29 | Pathak Chandrashekhar Prabhakar | Mechanical heart valve packaged in a liquid |
US6468660B2 (en) | 2000-12-29 | 2002-10-22 | St. Jude Medical, Inc. | Biocompatible adhesives |
WO2002056955A1 (en) | 2001-01-18 | 2002-07-25 | Edwards Lifesciences Corporation | Arterial cannula with perforated filter lumen |
US6610077B1 (en) | 2001-01-23 | 2003-08-26 | Endovascular Technologies, Inc. | Expandable emboli filter and thrombectomy device |
US6623518B2 (en) | 2001-02-26 | 2003-09-23 | Ev3 Peripheral, Inc. | Implant delivery system with interlock |
US20020123755A1 (en) | 2001-03-01 | 2002-09-05 | Scimed Life Systems, Inc. | Embolic protection filter delivery sheath |
US6562058B2 (en) | 2001-03-02 | 2003-05-13 | Jacques Seguin | Intravascular filter system |
US6488704B1 (en) | 2001-05-07 | 2002-12-03 | Biomed Solutions, Llc | Implantable particle measuring apparatus |
US20030057156A1 (en) | 2001-03-08 | 2003-03-27 | Dean Peterson | Atrial filter implants |
US6503272B2 (en) | 2001-03-21 | 2003-01-07 | Cordis Corporation | Stent-based venous valves |
US7374571B2 (en) | 2001-03-23 | 2008-05-20 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of manufacture |
US6733525B2 (en) | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
US7556646B2 (en) | 2001-09-13 | 2009-07-07 | Edwards Lifesciences Corporation | Methods and apparatuses for deploying minimally-invasive heart valves |
US6911036B2 (en) | 2001-04-03 | 2005-06-28 | Medtronic Vascular, Inc. | Guidewire apparatus for temporary distal embolic protection |
WO2002083224A2 (en) | 2001-04-17 | 2002-10-24 | Salviac Limited | A catheter |
ATE373449T1 (en) | 2001-04-27 | 2007-10-15 | Bard Inc C R | HANDLE DESIGN FOR A MEDICAL CATHETER |
US6676692B2 (en) | 2001-04-27 | 2004-01-13 | Intek Technology L.L.C. | Apparatus for delivering, repositioning and/or retrieving self-expanding stents |
US6746469B2 (en) | 2001-04-30 | 2004-06-08 | Advanced Cardiovascular Systems, Inc. | Balloon actuated apparatus having multiple embolic filters, and method of use |
DE10121210B4 (en) | 2001-04-30 | 2005-11-17 | Universitätsklinikum Freiburg | Anchoring element for the intraluminal anchoring of a heart valve replacement and method for its production |
US20050021123A1 (en) | 2001-04-30 | 2005-01-27 | Jurgen Dorn | Variable speed self-expanding stent delivery system and luer locking connector |
US7374560B2 (en) | 2001-05-01 | 2008-05-20 | St. Jude Medical, Cardiology Division, Inc. | Emboli protection devices and related methods of use |
US6716238B2 (en) | 2001-05-10 | 2004-04-06 | Scimed Life Systems, Inc. | Stent with detachable tethers and method of using same |
US6682558B2 (en) | 2001-05-10 | 2004-01-27 | 3F Therapeutics, Inc. | Delivery system for a stentless valve bioprosthesis |
US6663663B2 (en) | 2001-05-14 | 2003-12-16 | M.I. Tech Co., Ltd. | Stent |
US6936067B2 (en) | 2001-05-17 | 2005-08-30 | St. Jude Medical Inc. | Prosthetic heart valve with slit stent |
US6821291B2 (en) | 2001-06-01 | 2004-11-23 | Ams Research Corporation | Retrievable stent and method of use thereof |
KR100393548B1 (en) | 2001-06-05 | 2003-08-02 | 주식회사 엠아이텍 | Stent |
DE60115104T2 (en) | 2001-06-08 | 2006-08-03 | Rex Medical, L.P. | VASCULAR FLAP DEVICE FOR APPROACHING THE VESSEL WALL |
US6818013B2 (en) | 2001-06-14 | 2004-11-16 | Cordis Corporation | Intravascular stent device |
GB0114918D0 (en) | 2001-06-19 | 2001-08-08 | Vortex Innovation Ltd | Devices for repairing aneurysms |
US7544206B2 (en) | 2001-06-29 | 2009-06-09 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
FR2826863B1 (en) | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
US7377938B2 (en) | 2001-07-19 | 2008-05-27 | The Cleveland Clinic Foundation | Prosthetic cardiac value and method for making same |
FR2828091B1 (en) | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
US6755854B2 (en) | 2001-07-31 | 2004-06-29 | Advanced Cardiovascular Systems, Inc. | Control device and mechanism for deploying a self-expanding medical device |
FR2828263B1 (en) | 2001-08-03 | 2007-05-11 | Philipp Bonhoeffer | DEVICE FOR IMPLANTATION OF AN IMPLANT AND METHOD FOR IMPLANTATION OF THE DEVICE |
US6896002B2 (en) | 2001-08-21 | 2005-05-24 | Scimed Life Systems, Inc | Pressure transducer protection valve |
WO2003018100A1 (en) | 2001-08-22 | 2003-03-06 | Hasan Semih Oktay | Flexible mems actuated controlled expansion stent |
US7097665B2 (en) | 2003-01-16 | 2006-08-29 | Synecor, Llc | Positioning tools and methods for implanting medical devices |
US20030229390A1 (en) | 2001-09-17 | 2003-12-11 | Control Delivery Systems, Inc. | On-stent delivery of pyrimidines and purine analogs |
US6616682B2 (en) | 2001-09-19 | 2003-09-09 | Jomed Gmbh | Methods and apparatus for distal protection during a medical procedure |
US20030065386A1 (en) | 2001-09-28 | 2003-04-03 | Weadock Kevin Shaun | Radially expandable endoprosthesis device with two-stage deployment |
US7172572B2 (en) | 2001-10-04 | 2007-02-06 | Boston Scientific Scimed, Inc. | Manifold system for a medical device |
US6976974B2 (en) | 2002-10-23 | 2005-12-20 | Scimed Life Systems, Inc. | Rotary manifold syringe |
US6790237B2 (en) | 2001-10-09 | 2004-09-14 | Scimed Life Systems, Inc. | Medical stent with a valve and related methods of manufacturing |
US6893460B2 (en) | 2001-10-11 | 2005-05-17 | Percutaneous Valve Technologies Inc. | Implantable prosthetic valve |
US6866669B2 (en) | 2001-10-12 | 2005-03-15 | Cordis Corporation | Locking handle deployment mechanism for medical device and method |
US6939352B2 (en) | 2001-10-12 | 2005-09-06 | Cordis Corporation | Handle deployment mechanism for medical device and method |
US7144363B2 (en) | 2001-10-16 | 2006-12-05 | Extensia Medical, Inc. | Systems for heart treatment |
GB0125925D0 (en) | 2001-10-29 | 2001-12-19 | Univ Glasgow | Mitral valve prosthesis |
US6712843B2 (en) | 2001-11-20 | 2004-03-30 | Scimed Life Systems, Inc | Stent with differential lengthening/shortening members |
US6890340B2 (en) | 2001-11-29 | 2005-05-10 | Medtronic Vascular, Inc. | Apparatus for temporary intraluminal protection |
US7294146B2 (en) | 2001-12-03 | 2007-11-13 | Xtent, Inc. | Apparatus and methods for delivery of variable length stents |
EP1461112B1 (en) | 2001-12-05 | 2012-11-21 | Sagax Inc. | Endovascular device for entrapment of particulate matter and method for use |
US7041139B2 (en) | 2001-12-11 | 2006-05-09 | Boston Scientific Scimed, Inc. | Ureteral stents and related methods |
US6676668B2 (en) | 2001-12-12 | 2004-01-13 | C.R. Baed | Articulating stone basket |
US7189258B2 (en) | 2002-01-02 | 2007-03-13 | Medtronic, Inc. | Heart valve system |
US8308797B2 (en) | 2002-01-04 | 2012-11-13 | Colibri Heart Valve, LLC | Percutaneously implantable replacement heart valve device and method of making same |
US20030130729A1 (en) | 2002-01-04 | 2003-07-10 | David Paniagua | Percutaneously implantable replacement heart valve device and method of making same |
US6723116B2 (en) | 2002-01-14 | 2004-04-20 | Syde A. Taheri | Exclusion of ascending/descending aorta and/or aortic arch aneurysm |
US20030135162A1 (en) | 2002-01-17 | 2003-07-17 | Scimed Life Systems, Inc. | Delivery and retrieval manifold for a distal protection filter |
US6730377B2 (en) | 2002-01-23 | 2004-05-04 | Scimed Life Systems, Inc. | Balloons made from liquid crystal polymer blends |
US6689144B2 (en) | 2002-02-08 | 2004-02-10 | Scimed Life Systems, Inc. | Rapid exchange catheter and methods for delivery of vaso-occlusive devices |
US7708771B2 (en) * | 2002-02-26 | 2010-05-04 | Endovascular Technologies, Inc. | Endovascular graft device and methods for attaching components thereof |
US6974464B2 (en) | 2002-02-28 | 2005-12-13 | 3F Therapeutics, Inc. | Supportless atrioventricular heart valve and minimally invasive delivery systems thereof |
WO2003073962A1 (en) | 2002-03-05 | 2003-09-12 | Salviac Limited | An embolic protection system |
US20030176884A1 (en) | 2002-03-12 | 2003-09-18 | Marwane Berrada | Everted filter device |
US7163556B2 (en) | 2002-03-21 | 2007-01-16 | Providence Health System - Oregon | Bioprosthesis and method for suturelessly making same |
US20030187495A1 (en) | 2002-04-01 | 2003-10-02 | Cully Edward H. | Endoluminal devices, embolic filters, methods of manufacture and use |
US6752828B2 (en) | 2002-04-03 | 2004-06-22 | Scimed Life Systems, Inc. | Artificial valve |
US7052511B2 (en) | 2002-04-04 | 2006-05-30 | Scimed Life Systems, Inc. | Delivery system and method for deployment of foreshortening endoluminal devices |
US20030195609A1 (en) | 2002-04-10 | 2003-10-16 | Scimed Life Systems, Inc. | Hybrid stent |
US7125418B2 (en) | 2002-04-16 | 2006-10-24 | The International Heart Institute Of Montana Foundation | Sigmoid valve and method for its percutaneous implantation |
US20030199759A1 (en) | 2002-04-18 | 2003-10-23 | Richard Merwin F. | Coronary catheter with radiopaque length markers |
US8721713B2 (en) | 2002-04-23 | 2014-05-13 | Medtronic, Inc. | System for implanting a replacement valve |
US20030199971A1 (en) | 2002-04-23 | 2003-10-23 | Numed, Inc. | Biological replacement valve assembly |
WO2003092554A1 (en) | 2002-05-03 | 2003-11-13 | The General Hospital Corporation | Involuted endovascular valve and method of construction |
US8070769B2 (en) | 2002-05-06 | 2011-12-06 | Boston Scientific Scimed, Inc. | Inverted embolic protection filter |
US6830575B2 (en) | 2002-05-08 | 2004-12-14 | Scimed Life Systems, Inc. | Method and device for providing full protection to a stent |
US7141064B2 (en) | 2002-05-08 | 2006-11-28 | Edwards Lifesciences Corporation | Compressed tissue for heart valve leaflets |
US7351256B2 (en) | 2002-05-10 | 2008-04-01 | Cordis Corporation | Frame based unidirectional flow prosthetic implant |
EP1507492A1 (en) | 2002-05-10 | 2005-02-23 | Cordis Corporation | Method of making a medical device having a thin wall tubular membrane over a structural frame |
US20030225445A1 (en) | 2002-05-14 | 2003-12-04 | Derus Patricia M. | Surgical stent delivery devices and methods |
US7585309B2 (en) | 2002-05-16 | 2009-09-08 | Boston Scientific Scimed, Inc. | Aortic filter |
US20040117004A1 (en) | 2002-05-16 | 2004-06-17 | Osborne Thomas A. | Stent and method of forming a stent with integral barbs |
EP1870018A3 (en) | 2002-05-30 | 2008-08-06 | The Board of Trustees of The Leland Stanford Junior University | Apparatus and methods for coronary sinus access |
US7717934B2 (en) | 2002-06-14 | 2010-05-18 | Ev3 Inc. | Rapid exchange catheters usable with embolic protection devices |
US7329268B2 (en) | 2002-07-02 | 2008-02-12 | Warsaw Orthopedic, Inc. | Expandable percutaneous sheath |
US7166120B2 (en) | 2002-07-12 | 2007-01-23 | Ev3 Inc. | Catheter with occluding cuff |
US7232452B2 (en) | 2002-07-12 | 2007-06-19 | Ev3 Inc. | Device to create proximal stasis |
US7141063B2 (en) | 2002-08-06 | 2006-11-28 | Icon Medical Corp. | Stent with micro-latching hinge joints |
EP1388328A1 (en) | 2002-08-07 | 2004-02-11 | Abbott Laboratories Vascular Enterprises Limited | Apparatus for delivering and deployment of an expandable stent within a blood vessel |
US6969395B2 (en) | 2002-08-07 | 2005-11-29 | Boston Scientific Scimed, Inc. | Electroactive polymer actuated medical devices |
DE20321838U1 (en) | 2002-08-13 | 2011-02-10 | JenaValve Technology Inc., Wilmington | Device for anchoring and aligning heart valve prostheses |
US6863668B2 (en) | 2002-08-16 | 2005-03-08 | Edwards Lifesciences Corporation | Articulation mechanism for medical devices |
US7041132B2 (en) | 2002-08-16 | 2006-05-09 | 3F Therapeutics, Inc, | Percutaneously delivered heart valve and delivery means thereof |
WO2004019817A1 (en) | 2002-08-27 | 2004-03-11 | Amir Belson | Embolic protection device |
US20040092858A1 (en) | 2002-08-28 | 2004-05-13 | Heart Leaflet Technologies, Inc. | Leaflet valve |
ES2349952T3 (en) | 2002-08-29 | 2011-01-13 | St. Jude Medical, Cardiology Division, Inc. | IMPLANTABLE DEVICES FOR CONTROLLING THE INTERNAL CIRCUMFERENCE OF AN ANATOMICAL ORIFICE OR LUMEN. |
KR100442330B1 (en) | 2002-09-03 | 2004-07-30 | 주식회사 엠아이텍 | Stent and manufacturing method the same |
AU2003268379A1 (en) | 2002-09-03 | 2004-03-29 | John R. Fagan | Arterial embolic filter deployed from catheter |
US6875231B2 (en) | 2002-09-11 | 2005-04-05 | 3F Therapeutics, Inc. | Percutaneously deliverable heart valve |
CO5500017A1 (en) | 2002-09-23 | 2005-03-31 | 3F Therapeutics Inc | MITRAL PROTESTIC VALVE |
US20040059409A1 (en) | 2002-09-24 | 2004-03-25 | Stenzel Eric B. | Method of applying coatings to a medical device |
US7998163B2 (en) | 2002-10-03 | 2011-08-16 | Boston Scientific Scimed, Inc. | Expandable retrieval device |
WO2004037128A1 (en) | 2002-10-24 | 2004-05-06 | Boston Scientific Limited | Venous valve apparatus and method |
US7481823B2 (en) | 2002-10-25 | 2009-01-27 | Boston Scientific Scimed, Inc. | Multiple membrane embolic protection filter |
US7766820B2 (en) | 2002-10-25 | 2010-08-03 | Nmt Medical, Inc. | Expandable sheath tubing |
US6814746B2 (en) | 2002-11-01 | 2004-11-09 | Ev3 Peripheral, Inc. | Implant delivery system with marker interlock |
WO2004041126A1 (en) | 2002-11-08 | 2004-05-21 | Jacques Seguin | Endoprosthesis for vascular bifurcation |
WO2004043273A2 (en) | 2002-11-13 | 2004-05-27 | Rosengart Todd K | Apparatus and method for cutting a heart valve |
WO2004043293A2 (en) | 2002-11-13 | 2004-05-27 | Viacor, Inc. | Cardiac valve procedure methods and devices |
US7527636B2 (en) | 2002-11-14 | 2009-05-05 | Medtronic Vascular, Inc | Intraluminal guidewire with hydraulically collapsible self-expanding protection device |
US20040098022A1 (en) | 2002-11-14 | 2004-05-20 | Barone David D. | Intraluminal catheter with hydraulically collapsible self-expanding protection device |
US7141061B2 (en) | 2002-11-14 | 2006-11-28 | Synecor, Llc | Photocurable endoprosthesis system |
US7001425B2 (en) | 2002-11-15 | 2006-02-21 | Scimed Life Systems, Inc. | Braided stent method for its manufacture |
US7485143B2 (en) | 2002-11-15 | 2009-02-03 | Abbott Cardiovascular Systems Inc. | Apparatuses and methods for heart valve repair |
FR2847155B1 (en) | 2002-11-20 | 2005-08-05 | Younes Boudjemline | METHOD FOR MANUFACTURING A MEDICAL IMPLANT WITH ADJUSTED STRUCTURE AND IMPLANT OBTAINED THEREBY |
AU2003283792A1 (en) | 2002-11-29 | 2004-06-23 | Mindguard Ltd. | Braided intraluminal device for stroke prevention |
US7678068B2 (en) | 2002-12-02 | 2010-03-16 | Gi Dynamics, Inc. | Atraumatic delivery devices |
US7025791B2 (en) | 2002-12-02 | 2006-04-11 | Gi Dynamics, Inc. | Bariatric sleeve |
US6984242B2 (en) | 2002-12-20 | 2006-01-10 | Gore Enterprise Holdings, Inc. | Implantable medical device assembly |
US8551162B2 (en) | 2002-12-20 | 2013-10-08 | Medtronic, Inc. | Biologically implantable prosthesis |
US6945957B2 (en) | 2002-12-30 | 2005-09-20 | Scimed Life Systems, Inc. | Valve treatment catheter and methods |
US6830585B1 (en) | 2003-01-14 | 2004-12-14 | 3F Therapeutics, Inc. | Percutaneously deliverable heart valve and methods of implantation |
US20040138694A1 (en) | 2003-01-15 | 2004-07-15 | Scimed Life Systems, Inc. | Intravascular filtering membrane and method of making an embolic protection filter device |
US7753945B2 (en) | 2003-01-17 | 2010-07-13 | Gore Enterprise Holdings, Inc. | Deployment system for an endoluminal device |
US7762044B2 (en) | 2003-01-27 | 2010-07-27 | Medtronic Vascular, Inc. | Packaging for stent delivery systems |
GB2398245B (en) | 2003-02-06 | 2007-03-28 | Great Ormond Street Hospital F | Valve prosthesis |
US7740644B2 (en) | 2003-02-24 | 2010-06-22 | Boston Scientific Scimed, Inc. | Embolic protection filtering device that can be adapted to be advanced over a guidewire |
WO2004078065A2 (en) | 2003-03-03 | 2004-09-16 | Sinus Rhythm Technologies, Inc. | Electrical conduction block implant device |
US7399315B2 (en) | 2003-03-18 | 2008-07-15 | Edwards Lifescience Corporation | Minimally-invasive heart valve with cusp positioners |
GB2407146B (en) | 2003-03-20 | 2006-04-26 | Aortech Internat Plc | Valve leaflet for use in cardiac valve prosthesis |
US20060271081A1 (en) | 2003-03-30 | 2006-11-30 | Fidel Realyvasquez | Apparatus and methods for valve repair |
US7871434B2 (en) | 2003-04-01 | 2011-01-18 | Cook Incorporated | Percutaneously deployed vascular valves |
US7530995B2 (en) | 2003-04-17 | 2009-05-12 | 3F Therapeutics, Inc. | Device for reduction of pressure effects of cardiac tricuspid valve regurgitation |
US7175656B2 (en) | 2003-04-18 | 2007-02-13 | Alexander Khairkhahan | Percutaneous transcatheter heart valve replacement |
US7591832B2 (en) | 2003-04-24 | 2009-09-22 | Medtronic, Inc. | Expandable guide sheath and apparatus with distal protection and methods for use |
DE602004023350D1 (en) | 2003-04-30 | 2009-11-12 | Medtronic Vascular Inc | Percutaneous inserted provisional valve |
US6969396B2 (en) | 2003-05-07 | 2005-11-29 | Scimed Life Systems, Inc. | Filter membrane with increased surface area |
US7235093B2 (en) | 2003-05-20 | 2007-06-26 | Boston Scientific Scimed, Inc. | Mechanism to improve stent securement |
US20040243221A1 (en) | 2003-05-27 | 2004-12-02 | Fawzi Natalie V. | Endovascular graft including substructure for positioning and sealing within vasculature |
US7625364B2 (en) | 2003-05-27 | 2009-12-01 | Cardia, Inc. | Flexible center connection for occlusion device |
ATE481057T1 (en) | 2003-05-28 | 2010-10-15 | Cook Inc | VALVE PROSTHESIS WITH VESSEL FIXING DEVICE |
AU2003237985A1 (en) | 2003-06-09 | 2005-01-28 | 3F Therapeutics, Inc. | Atrioventricular heart valve and minimally invasive delivery systems thereof |
KR20060112705A (en) | 2003-07-08 | 2006-11-01 | 벤터 테크놀로지 리미티드 | Implantable prosthetic devices particularly for transarterial delivery in the treatment of aortic stenosis, and methods of implanting such devices |
US7201772B2 (en) | 2003-07-08 | 2007-04-10 | Ventor Technologies, Ltd. | Fluid flow prosthetic device |
US7744620B2 (en) | 2003-07-18 | 2010-06-29 | Intervalve, Inc. | Valvuloplasty catheter |
ATE442107T1 (en) | 2003-07-21 | 2009-09-15 | Univ Pennsylvania | PERCUTANE HEART VALVE |
DE10334868B4 (en) | 2003-07-29 | 2013-10-17 | Pfm Medical Ag | Implantable device as a replacement organ valve, its manufacturing process and basic body and membrane element for it |
US7153324B2 (en) | 2003-07-31 | 2006-12-26 | Cook Incorporated | Prosthetic valve devices and methods of making such devices |
WO2005011535A2 (en) | 2003-07-31 | 2005-02-10 | Cook Incorporated | Prosthetic valve for implantation in a body vessel |
DE10340265A1 (en) | 2003-08-29 | 2005-04-07 | Sievers, Hans-Hinrich, Prof. Dr.med. | Prosthesis for the replacement of the aortic and / or mitral valve of the heart |
US20050049692A1 (en) | 2003-09-02 | 2005-03-03 | Numamoto Michael J. | Medical device for reduction of pressure effects of cardiac tricuspid valve regurgitation |
WO2005023358A1 (en) | 2003-09-03 | 2005-03-17 | Acumen Medical, Inc. | Expandable sheath for delivering instruments and agents into a body lumen |
US7993384B2 (en) | 2003-09-12 | 2011-08-09 | Abbott Cardiovascular Systems Inc. | Delivery system for medical devices |
US8535344B2 (en) | 2003-09-12 | 2013-09-17 | Rubicon Medical, Inc. | Methods, systems, and devices for providing embolic protection and removing embolic material |
US7758625B2 (en) | 2003-09-12 | 2010-07-20 | Abbott Vascular Solutions Inc. | Delivery system for medical devices |
EG24012A (en) | 2003-09-24 | 2008-03-23 | Wael Mohamed Nabil Lotfy | Valved balloon stent |
US9579194B2 (en) * | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
US10219899B2 (en) | 2004-04-23 | 2019-03-05 | Medtronic 3F Therapeutics, Inc. | Cardiac valve replacement systems |
US20050075728A1 (en) | 2003-10-06 | 2005-04-07 | Nguyen Tuoc Tan | Minimally invasive valve replacement system |
EP1684671B1 (en) | 2003-10-06 | 2020-09-30 | Medtronic 3F Therapeutics, Inc. | Minimally invasive valve replacement system |
WO2005037338A1 (en) | 2003-10-14 | 2005-04-28 | Cook Incorporated | Hydrophilic coated medical device |
ATE464864T1 (en) | 2003-10-15 | 2010-05-15 | Cook Inc | HOLDING DEVICE FOR A PROSTHESIS STORAGE SYSTEM |
US7175654B2 (en) | 2003-10-16 | 2007-02-13 | Cordis Corporation | Stent design having stent segments which uncouple upon deployment |
US7004176B2 (en) | 2003-10-17 | 2006-02-28 | Edwards Lifesciences Ag | Heart valve leaflet locator |
US7419498B2 (en) | 2003-10-21 | 2008-09-02 | Nmt Medical, Inc. | Quick release knot attachment system |
US7070616B2 (en) | 2003-10-31 | 2006-07-04 | Cordis Corporation | Implantable valvular prosthesis |
US7347869B2 (en) | 2003-10-31 | 2008-03-25 | Cordis Corporation | Implantable valvular prosthesis |
WO2005048883A1 (en) | 2003-11-13 | 2005-06-02 | Fidel Realyvasquez | Methods and apparatus for valve repair |
US6972025B2 (en) | 2003-11-18 | 2005-12-06 | Scimed Life Systems, Inc. | Intravascular filter with bioabsorbable centering element |
US9241735B2 (en) | 2003-12-05 | 2016-01-26 | Onset Medical Corporation | Expandable percutaneous sheath |
US7186265B2 (en) | 2003-12-10 | 2007-03-06 | Medtronic, Inc. | Prosthetic cardiac valves and systems and methods for implanting thereof |
US20050137683A1 (en) | 2003-12-19 | 2005-06-23 | Medtronic Vascular, Inc. | Medical devices to treat or inhibit restenosis |
US20050137694A1 (en) | 2003-12-23 | 2005-06-23 | Haug Ulrich R. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US9005273B2 (en) | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US7445631B2 (en) | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US20050137696A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Apparatus and methods for protecting against embolization during endovascular heart valve replacement |
US8328868B2 (en) | 2004-11-05 | 2012-12-11 | Sadra Medical, Inc. | Medical devices and delivery systems for delivering medical devices |
US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US20120041550A1 (en) | 2003-12-23 | 2012-02-16 | Sadra Medical, Inc. | Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements |
US7748389B2 (en) | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US8287584B2 (en) | 2005-11-14 | 2012-10-16 | Sadra Medical, Inc. | Medical implant deployment tool |
US8603160B2 (en) | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
US8828078B2 (en) | 2003-12-23 | 2014-09-09 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US7824442B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
EP2529699B1 (en) | 2003-12-23 | 2014-01-29 | Sadra Medical, Inc. | Repositionable heart valve |
US7824443B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Medical implant delivery and deployment tool |
US20050137687A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Heart valve anchor and method |
US20050137686A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical, A Delaware Corporation | Externally expandable heart valve anchor and method |
US7326236B2 (en) | 2003-12-23 | 2008-02-05 | Xtent, Inc. | Devices and methods for controlling and indicating the length of an interventional element |
US7381219B2 (en) | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US8579962B2 (en) | 2003-12-23 | 2013-11-12 | Sadra Medical, Inc. | Methods and apparatus for performing valvuloplasty |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
US9526609B2 (en) | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US20050137691A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Two piece heart valve and anchor |
US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
WO2005069850A2 (en) | 2004-01-15 | 2005-08-04 | Macoviak John A | Trestle heart valve replacement |
US7468070B2 (en) | 2004-01-23 | 2008-12-23 | Boston Scientific Scimed, Inc. | Stent delivery catheter |
US7597711B2 (en) | 2004-01-26 | 2009-10-06 | Arbor Surgical Technologies, Inc. | Heart valve assembly with slidable coupling connections |
US7470285B2 (en) | 2004-02-05 | 2008-12-30 | Children's Medical Center Corp. | Transcatheter delivery of a replacement heart valve |
US7311730B2 (en) | 2004-02-13 | 2007-12-25 | Shlomo Gabbay | Support apparatus and heart valve prosthesis for sutureless implantation |
CA2813136A1 (en) | 2004-02-27 | 2005-09-15 | Aortx, Inc. | Prosthetic heart valve delivery systems and methods |
ITTO20040135A1 (en) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
WO2005086888A2 (en) | 2004-03-09 | 2005-09-22 | Fidel Realyvasquez | Off pump aortic valve replacement for valve prosthesis |
EP2308425B2 (en) | 2004-03-11 | 2023-10-18 | Percutaneous Cardiovascular Solutions Pty Limited | Percutaneous Heart Valve Prosthesis |
CA2561188A1 (en) | 2004-03-31 | 2005-10-20 | Med Institute, Inc. | Endoluminal graft with a prosthetic valve |
US7637937B2 (en) | 2004-04-08 | 2009-12-29 | Cook Incorporated | Implantable medical device with optimized shape |
ATE367132T1 (en) | 2004-05-25 | 2007-08-15 | Cook William Europ | STENT AND STENT REMOVING DEVICE |
US7122020B2 (en) | 2004-06-25 | 2006-10-17 | Mogul Enterprises, Inc. | Linkage steering mechanism for deflectable catheters |
US7462191B2 (en) | 2004-06-30 | 2008-12-09 | Edwards Lifesciences Pvt, Inc. | Device and method for assisting in the implantation of a prosthetic valve |
US7276078B2 (en) | 2004-06-30 | 2007-10-02 | Edwards Lifesciences Pvt | Paravalvular leak detection, sealing, and prevention |
US8500785B2 (en) | 2004-07-13 | 2013-08-06 | Boston Scientific Scimed, Inc. | Catheter |
FR2874813B1 (en) | 2004-09-07 | 2007-06-22 | Perouse Soc Par Actions Simpli | VALVULAR PROSTHESIS |
EP1819391B1 (en) | 2004-09-09 | 2020-02-19 | Onset Medical Corporation | Expandable transluminal sheath |
US6951571B1 (en) | 2004-09-30 | 2005-10-04 | Rohit Srivastava | Valve implanting device |
WO2006055982A2 (en) | 2004-11-22 | 2006-05-26 | Avvrx | Ring-shaped valve prosthesis attachment device |
US7989157B2 (en) | 2005-01-11 | 2011-08-02 | Medtronic, Inc. | Solution for storing bioprosthetic tissue used in a biological prosthesis |
US7918880B2 (en) | 2005-02-16 | 2011-04-05 | Boston Scientific Scimed, Inc. | Self-expanding stent and delivery system |
US20060195183A1 (en) | 2005-02-18 | 2006-08-31 | The Cleveland Clinic Foundation | Apparatus and methods for replacing a cardiac valve |
US7722666B2 (en) | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
CN101180010B (en) | 2005-05-24 | 2010-12-01 | 爱德华兹生命科学公司 | Rapid deployment prosthetic heart valve |
EP1915105B1 (en) | 2005-05-27 | 2016-08-03 | HLT, Inc. | Stentless support structure |
US8092481B2 (en) | 2005-06-03 | 2012-01-10 | Onset Medical Corporation | Expandable percutaneous sheath |
US7938851B2 (en) | 2005-06-08 | 2011-05-10 | Xtent, Inc. | Devices and methods for operating and controlling interventional apparatus |
US20060287668A1 (en) | 2005-06-16 | 2006-12-21 | Fawzi Natalie V | Apparatus and methods for intravascular embolic protection |
WO2007005799A1 (en) | 2005-06-30 | 2007-01-11 | Abbott Laboratories | Delivery system for a medical device |
US8968379B2 (en) | 2005-09-02 | 2015-03-03 | Medtronic Vascular, Inc. | Stent delivery system with multiple evenly spaced pullwires |
US7712606B2 (en) | 2005-09-13 | 2010-05-11 | Sadra Medical, Inc. | Two-part package for medical implant |
US20080188928A1 (en) | 2005-09-16 | 2008-08-07 | Amr Salahieh | Medical device delivery sheath |
US20070173918A1 (en) | 2005-09-30 | 2007-07-26 | Dreher James H | Apparatus and methods for locating an ostium of a vessel |
DE102005052628B4 (en) | 2005-11-04 | 2014-06-05 | Jenavalve Technology Inc. | Self-expanding, flexible wire mesh with integrated valvular prosthesis for the transvascular heart valve replacement and a system with such a device and a delivery catheter |
EP1988851A2 (en) | 2006-02-14 | 2008-11-12 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
EP1991168B1 (en) | 2006-02-16 | 2016-01-27 | Transcatheter Technologies GmbH | Minimally invasive heart valve replacement |
EP2023860A2 (en) | 2006-04-29 | 2009-02-18 | Arbor Surgical Technologies, Inc. | Multiple component prosthetic heart valve assemblies and apparatus and methods for delivering them |
US8376865B2 (en) | 2006-06-20 | 2013-02-19 | Cardiacmd, Inc. | Torque shaft and torque shaft drive |
US20080033541A1 (en) | 2006-08-02 | 2008-02-07 | Daniel Gelbart | Artificial mitral valve |
CN101662999B (en) | 2006-09-28 | 2016-01-20 | 心叶科技公司 | For the means of delivery of percutaneous conveying prosthese |
WO2008103283A2 (en) | 2007-02-16 | 2008-08-28 | Medtronic, Inc. | Delivery systems and methods of implantation for replacement prosthetic heart valves |
US7753949B2 (en) | 2007-02-23 | 2010-07-13 | The Trustees Of The University Of Pennsylvania | Valve prosthesis systems and methods |
US8070802B2 (en) | 2007-02-23 | 2011-12-06 | The Trustees Of The University Of Pennsylvania | Mitral valve system |
US9138315B2 (en) | 2007-04-13 | 2015-09-22 | Jenavalve Technology Gmbh | Medical device for treating a heart valve insufficiency or stenosis |
ES2475144T3 (en) | 2007-06-26 | 2014-07-10 | St. Jude Medical, Inc. | Apparatus for implanting prosthetic heart valves folding / expandable |
US8828079B2 (en) | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
US8192351B2 (en) | 2007-08-13 | 2012-06-05 | Paracor Medical, Inc. | Medical device delivery system having integrated introducer |
EP2185107B1 (en) | 2007-09-07 | 2017-01-25 | Edwards Lifesciences Corporation | Active holder for annuloplasty ring delivery |
US20090171456A1 (en) | 2007-12-28 | 2009-07-02 | Kveen Graig L | Percutaneous heart valve, system, and method |
US8157853B2 (en) | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US8052607B2 (en) | 2008-04-22 | 2011-11-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ultrasound imaging catheter with pivoting head |
US8696743B2 (en) | 2008-04-23 | 2014-04-15 | Medtronic, Inc. | Tissue attachment devices and methods for prosthetic heart valves |
US8323335B2 (en) | 2008-06-20 | 2012-12-04 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves and methods for using |
CN102170833B (en) | 2008-08-08 | 2014-03-26 | 因赛普特有限责任公司 | Apparatus and methods for accessing and removing material from body lumens |
US8652202B2 (en) | 2008-08-22 | 2014-02-18 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
US8690936B2 (en) | 2008-10-10 | 2014-04-08 | Edwards Lifesciences Corporation | Expandable sheath for introducing an endovascular delivery device into a body |
US8308798B2 (en) | 2008-12-19 | 2012-11-13 | Edwards Lifesciences Corporation | Quick-connect prosthetic heart valve and methods |
US20100217382A1 (en) | 2009-02-25 | 2010-08-26 | Edwards Lifesciences | Mitral valve replacement with atrial anchoring |
EP4129238A1 (en) | 2010-03-05 | 2023-02-08 | Edwards Lifesciences Corporation | Retaining mechanisms for prosthetic valves |
US9155619B2 (en) | 2011-02-25 | 2015-10-13 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
US9173736B2 (en) * | 2011-04-28 | 2015-11-03 | Medtronic Vascular, Inc. | Method of making an endoluminal vascular prosthesis |
EP2731550B1 (en) | 2011-07-12 | 2016-02-24 | Boston Scientific Scimed, Inc. | Coupling system for a replacement valve |
US9119716B2 (en) | 2011-07-27 | 2015-09-01 | Edwards Lifesciences Corporation | Delivery systems for prosthetic heart valve |
CA2847687C (en) | 2011-09-09 | 2017-10-17 | Endoluminal Sciences Pty Ltd. | Means for controlled sealing of endovascular devices |
JP6184963B2 (en) | 2011-10-05 | 2017-08-23 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Thin seal material for replacement heart valve and method of forming the same |
US8778020B2 (en) | 2011-11-08 | 2014-07-15 | Boston Scientific Scimed, Inc. | Replacement heart valve leaflet stitching method and device |
EP2779945B1 (en) | 2011-11-15 | 2021-07-14 | Boston Scientific Scimed, Inc. | Medical device with keyed locking structures |
WO2013096644A1 (en) | 2011-12-20 | 2013-06-27 | Boston Scientific Scimed, Inc. | Apparatus for endovascularly replacing a heart valve |
US10172708B2 (en) | 2012-01-25 | 2019-01-08 | Boston Scientific Scimed, Inc. | Valve assembly with a bioabsorbable gasket and a replaceable valve implant |
EP2846736B1 (en) | 2012-05-09 | 2018-02-28 | Boston Scientific Scimed, Inc. | Reduced profile valve with locking elements |
WO2014011888A1 (en) | 2012-07-12 | 2014-01-16 | Boston Scientific Scimed, Inc. | Low profile heart valve delivery system and method |
US9398951B2 (en) * | 2013-03-12 | 2016-07-26 | St. Jude Medical, Cardiology Division, Inc. | Self-actuating sealing portions for paravalvular leak protection |
US20140350668A1 (en) | 2013-03-13 | 2014-11-27 | Symetis Sa | Prosthesis Seals and Methods for Sealing an Expandable Prosthesis |
CA2900367C (en) * | 2013-03-15 | 2020-12-22 | Edwards Lifesciences Corporation | Valved aortic conduits |
EP4183373A1 (en) * | 2013-03-15 | 2023-05-24 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems |
US10098734B2 (en) | 2013-12-05 | 2018-10-16 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
CN103705315B (en) * | 2013-12-12 | 2015-10-21 | 宁波健世生物科技有限公司 | Prevent the aortic valve stent of perivalvular leakage |
WO2015175450A1 (en) * | 2014-05-16 | 2015-11-19 | St. Jude Medical, Cardiology Division, Inc. | Transcatheter valve with paravalvular leak sealing ring |
-
2016
- 2016-03-03 US US15/059,840 patent/US10080652B2/en active Active
- 2016-03-04 CN CN201680027710.0A patent/CN107592804B/en active Active
- 2016-03-04 EP EP16710065.0A patent/EP3267945A1/en active Pending
- 2016-03-04 WO PCT/US2016/020898 patent/WO2016148942A1/en unknown
-
2018
- 2018-09-24 US US16/139,256 patent/US11065113B2/en active Active
-
2021
- 2021-06-18 US US17/351,868 patent/US20210307902A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20160262878A1 (en) | 2016-09-15 |
US20190021853A1 (en) | 2019-01-24 |
US10080652B2 (en) | 2018-09-25 |
CN107592804B (en) | 2021-05-25 |
EP3267945A1 (en) | 2018-01-17 |
CN107592804A (en) | 2018-01-16 |
US11065113B2 (en) | 2021-07-20 |
WO2016148942A1 (en) | 2016-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210307902A1 (en) | Prosthetic Heart Valve Having an Improved Tubular Seal | |
US10201417B2 (en) | Prosthetic heart valve having tubular seal | |
US9788942B2 (en) | Prosthetic heart valve having tubular seal | |
US9839512B2 (en) | Prosthetic heart valve having notched leaflet | |
US9861477B2 (en) | Prosthetic heart valve square leaflet-leaflet stitch | |
US11744700B2 (en) | Prosthetic heart valve having multi-level sealing member | |
US11273031B2 (en) | Prosthetic heart valve with reduced stitching | |
CA3072814C (en) | Prosthetic valve with expandable frame and associated systems and methods | |
US6494909B2 (en) | Endovascular valve | |
JP2022181217A (en) | Skirt assembly for implantable prosthetic valve | |
JP2021514745A (en) | Artificial mitral valve with improved anchors and seals | |
JP7521829B2 (en) | Heart valve prosthesis, artificial valve therefrom and manufacturing method | |
CN217409070U (en) | Implantable medical device | |
JP2024530811A (en) | Textiles, methods for making same, and medical devices using same - Patents.com |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |